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1.	  Abstract	  	  In	  metazoans,	  the	  exon	  junction	  complex	  (EJC)	  is	  a	  central	  component	  of	  spliced	  messenger	   ribonucleoprotein	   particles	   (mRNPs).	   EJCs	   are	   assembled	   by	   the	  spliceosome	   and	   deposited	   upstream	   of	   exon-­‐exon	   boundaries	   in	   the	   nucleus.	  The	   heterotetrameric	   core	   of	   the	   EJC	   is	   composed	   of	   the	   proteins	   eIF4A3	  (DDX48),	   MAGOH,	   RBM8	   (Y14)	   and	   CASC3/MLN51/Barentsz	   (BTZ).	   EJCs	  contribute	   to	   different	   steps	   of	   post-­‐transcriptional	   gene	   expression	   including	  splicing,	   translation	   and	   nonsense-­‐mediated	   mRNA	   decay	   (NMD).	   BTZ	   is	   an	  important	  functional	  component	  and	  is	  involved	  in	  the	  stimulation	  of	  translation	  and	  nonsense-­‐mediated	  mRNA	  decay.	  Here,	  I	  show	  that	  both	  the	  N-­‐terminal	  and	  the	   SELOR	   domain	   of	   BTZ	   elicit	   NMD	   in	   a	   tethering	   assay.	   They	   activate	  NMD	  following	   two	   different	   pathways,	   BTZ-­‐dependent	   and	  UPF2	   dependent,	  which	  get	   reunited	   once	   UPF1	   is	   activated.	   In	   contrast,	   the	   C-­‐terminal	   region	   of	   BTZ	  does	   not	   seem	   to	   be	   involved	   in	   NMD.	   Instead,	   this	   region	   plays	   a	   role	   in	   a	  different	   process	   that	   leads	   to	   the	   polyadenylation	   of	   a	   reporter	   mRNA	   at	   an	  upstream,	  non-­‐canonical	  polyadenylation	  site.	  Moreover,	   I	  show	  that	  binding	  of	  the	   SELOR	   domain	   to	   mRNA	   in	   vivo	   is	   EJC-­‐dependent.	   In	   addition	   the	   SELOR	  domain	  in	  vivo	  interacts	  with	  several	  SR	  proteins	  for	  a	  subset	  of	  which	  an	  NMD-­‐activating	  function	  is	  observed.	  These	  findings	  uncover	  novel	  EJC-­‐dependent	  and	  -­‐independent	   functions	   of	   BTZ	   during	   post-­‐transcriptional	   gene	   expression	  regulation.	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1.1	  Deutsche	  Zusammenfassung	  	  In	  Metazoen	  stellt	  der	  Exon-­‐Verbindungs	  Komplex	  (`exon	  junction	  complex´,	  EJC)	  eine	   zentrale	   Komponente	   von	   gespleißten	   Ribonukleoproteinpartikeln	  (mRNPs)	   dar.	   EJCs	   werden	   mithilfe	   von	   Spleißosomen	   im	   Zellkern	  zusammengesetzt	   und	   nahe	   Exon-­‐Exon	   Grenzen	   auf	   der	   mRNA	   platziert.	   Der	  heterotetramere	   Kern	   des	   EJC	   besteht	   aus	   den	   Proteinen	   eIF4A3	   (DDX48),	  MAGOH,	   RBM8	   (Y14)	   und	   CASC3/MLN51/Barentz	   (BTZ).	   EJCs	   sind	   in	  verschiedenste	   Schritte	   der	   posttranskriptionalen	   Genexpression	   involviert,	  unter	   anderem	   das	   Spleißen,	   die	   Translation	   und	   den	   nonsense-­‐vermittelten	  mRNA-­‐Abbau	   (NMD).	  BTZ	   ist	   eine	  wichtige	   funktionale	  Komponente	   innerhalb	  dieser	   Prozesse	   und	   an	   der	   Stimulation	   von	   sowohl	   Translation	   als	   auch	  NMD	  beteiligt.	   In	   dieser	   Arbeit	   wird	   gezeigt,	   dass	   die	   N-­‐terminale	   sowie	   die	   SELOR	  (`Speckle	  Localizer	  and	  RNA-­‐binding´)	  Domäne	  von	  BTZ,	  NMD	  im	  Rahmen	  eines	  Tethering-­‐Assays	   induzieren	   können	   und	   dabei	   zwei	   verschiedene	   Wege	   der	  NMD-­‐Aktivierung	  genutzt	  werden.	  Darüber	  hinaus	  wird	  dargestellt,	  dass	  die	  C-­‐terminale	  Domäne	  eine	  nicht-­‐kanonische	  Polyadenylierungsstelle	   innerhalb	  der	  3ʹ	   UTR	   einer	   Reporter-­‐mRNA	   aktiviert,	   was	   darauf	   hinweist,	   dass	   BTZ	   an	  alternativer	   Polyadenylierung	   beteiligt	   ist.	   Zudem	   wird	   präsentiert,	   dass	   die	  SELOR	  Domäne	   in	   virto	  präferenziell	   bestimmte	  mRNAs	  bindet	   und	   in	   vivo	  die	  mRNA-­	   Interaktion	   von	   SELOR	   EJC-­‐abhängig	   ist.	   die	   Zusätzlich	   konnten	  verschieden	   SR-­‐Proteine	   in	   SELOR-­‐assoziierten	   Proteinkomplexen	   identifiziert	  werden,	   wobei	   für	   einige	   dieser	   SR	   Proteine	   eine	   NMD-­‐aktivierende	   Funktion	  nachgewiesen	  werden	  konnte.	  Diese	  Ergebnisse	  zeigen	  eine	  neue,	  EJC-­‐abhängige	  sowie	   –unabhängige,	   regulatorische	   Funktion	   von	   BTZ	   innerhalb	   der	  posttranskriptionalen	  Geneexpression.	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2.	  Introduction	  	  
2.1	  mRNA	  life:	  from	  transcription	  to	  translation	  	  Eukaryotic	  gene	  expression	  is	  a	  multistep	  process	  that	  requires	  the	  coordination	  of	   several	   events	   that	   are	   spatially	   and	   temporally	   separated	   (Moore,	   2005;	  Moore	  and	  Proudfoot,	  2009;	  Reed,	  2003).	  All	  these	  steps	  are	  needed	  in	  order	  to	  correctly	  decode	  the	  information	  of	  the	  DNA	  into	  a	  functional	  product	  (Figure	  1).	  The	  following	  sections	  describe	  these	  processes	  with	  a	  special	  emphasis	  on	  the	  steps	  most	  important	  for	  this	  work.	  	  Transcription	  Gene	  expression	  begins	  with	  transcription	  of	  DNA	  into	  messenger	  pre-­‐RNA	  (pre-­‐mRNA)	   by	   the	   RNA	   Polymerase	   II	   (Pol	   II)	   (Kornberg,	   1999;	   Sims	   et	   al.,	   2004)	  (Figure	   1).	   The	   different	   steps	   of	   transcription	   (initiation,	   elongation	   and	  termination)	  are	  marked	  by	  rearrangement	  of	  the	  components	  that	  binds	  Pol	  II	  (Cheung	  and	  Cramer,	  2012).	  Transcription	  initiation	  starts	  upon	  addition	  of	  two	  initiating	  nucleoside	  triphosphates	  (NTPs)	  complementary	  to	  the	  DNA	  sequence	  and	  the	  formation	  of	  the	  first	  phosphodiester	  bond.	  When	  the	  pre-­‐mRNA	  is	  23-­‐nt-­‐long	  the	  rearrangement	  of	  the	  transcriptional	  factors	  around	  Pol	  II	  marks	  the	  beginning	   of	   the	   elongation	   phase	   (Pal	   and	   Luse,	   2002;	   Roberts	   et	   al.,	   2004).	  Polyadenylation	   (see	   below)	   and	   specific	   termination	   factors	   mediate	   the	  termination	   of	   transcription	   (Kireeva	   et	   al.,	   2000;	   Lykke-­‐Andersen	   and	   Jensen,	  2007;	  Richard	  and	  Manley,	  2009).	  	  	  5ʹcapping	  The	  5ʹ	   end	  capping	   is	   the	   first	  modification	   that	  nascent	  pre-­‐mRNA	  undergoes,	  when	   it	   is	   22-­‐25	   nt	   long	   and	   emerging	   from	   the	   RNA	   exit	   channel	   of	   Pol	   II	  (Shatkin,	   1976;	   Shatkin	   and	  Manley,	   2000).	   The	   5ʹ	   cap	   protects	  mRNA	   against	  exonucleases	  and	  promotes	  transcription,	  polyadenylation,	  splicing	  and	  nuclear	  export	  (Gu	  and	  Lima,	  2005;	  Lewis	  and	  Izaurralde,	  1997).	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Figure	  1.	  Steps	  of	  gene	  expression.	  1)	  Pol	  II	  transcribes	  the	  information	  of	  DNA	  in	  pre-­‐mRNA.	  5ʹ	  cap	  (m7Gppp)	  is	  added	  when	  the	  pre-­‐mRNA	  is	  22-­‐25	  nt	  long	  and	  is	  subsequently	  bound	  by	  the	  nuclear	  Cap	  Binding	  Complex	  (nCBC:	  CBP20	  and	  CBP80).	  2)	  Splicing	  occurs	   cotranscriptionally	  and	  removes	  the	  introns.	  3)	  As	  a	  consequence	  of	  splicing,	  the	  pre-­‐EJC	  (MAGOH,	  Y14	  and	  eIF4A3)	  is	   deposited	   on	   the	   mRNA.	   At	   the	   end	   of	   transcription,	   the	   mRNA	   is	   polyadenylated,	   and	   the	  poly(A)	  tail	  is	  bound	  by	  the	  nuclear	  Poly(A)	  binding	  protein	  (PABPN).	  Finally,	  the	  export	  complex	  TREX	  addresses	  the	  mRNA	  to	  the	  nuclear	  pore.	  4)	  In	  the	  cytoplasm,	  BTZ	  joins	  the	  EJC	  complex,	  the	  eIF4F	  complex	  (eIF4E,	  eIF4A	  and	  eIF4G)	  replaces	  the	  nCBC,	  the	  cytoplasmic	  PABP	  (PABPC)	  replaces	  PABPN,	  the	  ribosome	  translates	  the	  mRNA	  into	  protein	  and	  PYM	  displaces	  the	  EJC	  upon	  translation.	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mRNA	   capping	   requires	   three	   reactions:	   first,	   the	   5ʹ-­‐γ-­‐phosphate	   group	   of	   the	  first	  transcribed	  nucleotide	  of	  pre-­‐mRNA	  is	  removed	  by	  the	  RNA	  triphosphatase;	  second,	   a	   guanine	   monophosphate	   (GMP)	   nucleotide	   is	   transferred	   by	   a	  guanylyltransferase	   to	   the	   RNA	   5ʹ-­‐diphosphate	   end;	   third,	   a	   RNA	   methyl	  transferase	   adds	   a	   methyl	   group,	   yielding	   the	   7-­‐methylguanosine	   cap	  (m7GpppN)	  (Mao	  et	  al.,	  1995;	  Yue	  et	  al.,	  1997).	  The	  5ʹ	  cap	  is	  bound	  to	  the	  nuclear	  cap	  binding	  complex	  (nCBC)	  in	  the	  nucleus,	  consisting	  of	  the	  cap-­‐binding	  subunit	  CBP20	  and	  the	  auxiliary	  protein	  CBP80	  that	  stabilizes	  the	   interaction	  of	  CBP20	  with	  the	  cap	  (Mazza	  et	  al.,	  2001;	  Mazza	  et	  al.,	  2002).	  After	  the	  mRNA	  is	  exported	  to	   the	   cytoplasm,	   eIF4E	   (eukaryotic	   translation	   initiation	   factor	   4E),	   a	  component	  of	  the	  eIF4F	  complex,	  binds	  the	  cap	  and	  promotes	  the	  recruitment	  of	  the	  small	  ribosomal	  subunit	  for	  translation	  initiation.	  The	  other	  two	  components	  of	  the	  complex	  are	  the	  DEAD-­‐box	  helicase	  eIF4A,	  responsible	  for	  RNA	  unwinding	  (Feoktistova	  et	  al.,	  2013)	  and	  eIF4G.	  eIF4G	  binds	  eIF4E	  and	  PABPC	  via	  its	  C-­‐	  and	  N-­‐terminal	   region,	   respectively	   (see	   polyadenylation).	   These	   interactions	  enhance	  eIF4F	  binding	   to	   the	  cap	  (Kahvejian	  et	  al.,	  2005b),	  as	  well	  as	  enabling	  the	  formation	  of	  the	  so-­‐called	  closed-­‐loop	  which	  facilitates	  re-­‐initiation	  of	  mRNA	  translation	  (Hinnebusch	  and	  Lorsch,	  2012;	  Jackson	  et	  al.,	  2010)	  (Figure	  1).	  	  	  Splicing	  The	   second	  modification	   that	   most	   pre-­‐mRNAs	   undergo	   is	   the	   excision	   of	   the	  intervening	   sequences	   (introns).	   Specific	   elements	   inside	   the	   gene	   sequence	  mark	  the	  position	  of	  an	  intron	  (Clancy,	  2008;	  Konarska	  et	  al.,	  1985)	  (Figure	  2):	  	  
• donor	   site,	   at	   the	   5ʹ	   end	   of	   the	   intron,	   it	   contains	   a	   GU	   sequence,	  surrounded	  by	  a	  less	  conserved	  region;	  
• branch	  site,	  20-­‐50	  nt	  upstream	  of	  the	  acceptor	  site,	  it	  includes	  an	  A;	  
• acceptor	  site,	  at	  the	  3ʹend	  of	  the	  intron,	  it	  contains	  an	  AG	  sequence	  and	  is	  preceded	  by	  a	  polypyrimidine	  tract.	  The	   spliceosome	   is	   a	   complex	   consisting	   of	   several	   small	   nuclear	  ribonucleoproteins	   (snRNP),	  which	  catalyzes	  nuclear	  pre-­‐mRNA	  splicing	   (Wahl	  et	   al.,	   2009).	   The	   spliceosome	   assembly	   is	   spatially-­‐temporally	   organized	   and	  proceeds	  through	  the	  assembly	  of	  the	  complexes	  E,	  A,	  B,	  Bact	  ,	  B*	  and	  C	  (Bessonov	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et	  al.,	  2010).	  Complex	  E	  is	  comprised	  of	  U1	  snRNP	  binding	  the	  donor	  site,	  U2AF	  the	  polyprimidine	  tract	  and	  SF1	  the	  branch	  point	  sequence	  (BPS).	  Subsequently,	  U2	   snRNP	   is	   recruited	   to	   the	  BPS,	   forming	   complex	  A.	  U4/U6	  and	  U5	  are	   then	  recruited	  as	  pre-­‐assembled	  tri-­‐snRNP,	  leading	  to	  the	  formation	  of	  complex	  B.	  	  	  
	  	  
Figure	  2.	   Splicing	   reaction.	   Schematic	   representation	  of	   an	  mRNA,	  with	   indicated	  donor	   site,	  branch	  site,	  polypyrimidine	  tract	  and	  acceptor	  site.	  The	  steps	  required	  for	  the	  splicing	  reaction	  are	  indicated	  with	  the	  name	  of	  the	  complex	  formed	  (E,	  A,	  B,	  Bact	  ,	  B*	  and	  C).	  	  	  This	   complex	   is	   still	   inactive	   and	   requires	   a	   conformational/compositional	  change	   to	   be	   functional:	   U1	   and	   U4	   are	   released	   and	   the	   complex	   becomes	  splicing	  competent	  (complex	  Bact).	  After	  a	  structural	  rearrangement	  into	  complex	  B*,	   the	  splicing	  reaction	   takes	  place	   in	  complex	  C.	  The	   first	   reaction	  consists	  of	  cleaving	  of	  the	  pre-­‐mRNA	  at	  the	  5ʹ	  end	  of	  the	  intron	  and	  lariat	  formation.	  During	  the	   second	   reaction	   the	   exons	   are	   ligated,	   the	   intron	   released	   and	   the	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spliceosome	  disassembled	  with	  the	  snRNP	  being	  recycled	  (Bessonov	  et	  al.,	  2010)	  (Figure	  2).	  	  	  Polyadenylation	  Similary	   to	   5ʹ	   capping,	   3ʹ	   polyadenylation	   is	   required	   for	   maturation	   of	   pre-­‐mRNA	  and	  is	  necessary	  for	  nuclear	  export,	  stability	  of	  the	  mature	  transcript	  and	  efficient	   translation	   (Sachs,	   1990).	   The	   vast	   majority	   of	   eukaryotic	   mRNAs	  contain	   a	   long	   stretch	   of	   untemplated	   adenosines	   in	   their	   3′	   end	   termed	   the	  poly(A)	   tail.	   The	   3ʹ	   end	   polyadenylation	   is	   a	   two-­‐steps	   process	   that	   involves	  endonucleolytic	   cleavage	  of	   the	   transcript	  and	   the	  addition	  of	  a	  poly(A)	   tail.	   In	  human	  cells,	  the	  average	  length	  of	  the	  poly(A)	  tail	  varies	  between	  250	  and	  300	  adenines,	  while	   the	   length	   in	   yeast	   fluctuates	   between	   70	   and	   80	   adenines.	   In	  general,	  the	  number	  of	  adenines	  is	  restricted	  and	  varies	  between	  species	  (Elkon	  et	   al.,	   2013).	   mRNAs	   with	   a	   shortened	   poly(A)	   tail	   are	   normally	   degraded	   or	  stored	   in	   a	   translationally	   dormant	   state	   (DʹAmbrogio	   et	   al.,	   2013;	   Guhaniyogi	  and	   Brewer,	   2001).	   Polyadenylation	   requires	   several	   cis-­‐	   and	   trans–acting	  elements.	  The	  Poly(A)	  signal	  (PAS)	  dictates	  the	  selection	  of	  the	  cleavage	  site	  and	  is	  commonly	  located	  15-­‐20	  nt	  upstream	  of	  it	  (Proudfoot	  and	  Brownlee,	  1976).	  In	  ~	  70%	  of	  human	  mRNAs,	  the	  PAS	  consists	  of	  the	  nucleotide	  sequences	  AAUAAA	  or	   AUUAAA.	   The	   remaining	   ~	   30%	   of	   RNAs	   contain	   other	   sequences,	   such	   as	  UAUAAA,	  AACAAA	  or	  ACUAAA	  (MacDonald	  and	  Redondo,	  2002),	  suggesting	  the	  possibility	  of	  alternative	  polyadenylation	  (APA).	  Alternative	  polyadenylation	  can	  generate	   transcript	   isoforms	   with	   alternative	   3′	   ends	   (Elkon	   et	   al.,	   2013).	   In	  addition	   to	   the	  PAS,	  U-­‐	   or	  GU-­‐rich	  downstream	  sequence	   elements	   (DSEs)	   and	  less	   well-­‐defined	   upstream	   sequence	   elements	   (USEs)	   enhance	   cleavage	  efficiency.	  The	  cleavage	  and	  polyadenylation	  specificity	  factor	  (CPSF)	  recognizes	  the	   PAS,	   the	   cleavage	   stimulating	   factor	   (CSTF)	   binds	   the	   DSEs	   (Mandel	   et	   al.,	  2008;	  Proudfoot,	  2011),	  and	  cleavage	  factors	  Im	  (CFIm)	  and	  IIm	  (CFIIm)	  bind	  the	  USEs	  (Brown	  and	  Gilmartin,	  2003;	  Yang	  et	  al.,	  2011).	  The	  interaction	  of	  PABP	  (in	  humans	   primarily	   PABPC1)	  with	   the	   cap-­‐associated	   eIF4G	   in	   the	   cytoplasm	   is	  thought	   to	   facilitate	   circularization	   of	   mRNAs,	   thereby	   supporting	   efficient	  translation	  termination,	  ribosome	  recycling	  and	  translation	  initiation	  (Amrani	  et	  al.,	  2004;	  Kahvejian	  et	  al.,	  2005a;	  Wells	  et	  al.,	  1998)	  (Figure	  1).	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Export	  After	   the	   completion	   of	   all	   processing	   steps	   (capping,	   splicing	   and	  polyadenylation),	   the	  mature	  mRNA	   needs	   to	   be	   exported	   to	   the	   cytoplasm	   in	  order	   to	   be	   translated	   into	   protein.	   mRNA	   export	   is	   already	   initiated	   during	  splicing	   of	   the	   first	   intron	   when	   the	   transcription	   export	   (TREX)	   complex	   is	  deposited	  at	   the	  5ʹ	   end	  of	   the	  mRNA	   (Cheng	  et	   al.,	   2006;	  Masuda	  et	   al.,	   2005).	  TREX	  is	  a	  multiprotein	  complex	  that	  is	  composed	  of	  the	  THO	  complex,	  the	  RNA	  helicase	   UAP56	   and	   the	   adaptor	   molecule	   Aly/REF	   (Zhou	   et	   al.,	   2000).	   The	  mechanism	   of	   recruitment	   of	   TREX	   to	   the	   mRNA	   is	   still	   unclear.	   Different	  evidence	  suggest	  an	  EJC-­‐dependent	  (Stutz	  et	  al.,	  2000;	  Zhou	  et	  al.,	  2000)	  or	  a	  cap-­‐dependent	   (Cheng	   et	   al.,	   2006;	   Luna	   et	   al.,	   2012)	   recruitment.	   Once	   recruited,	  Aly/REF	  interacts	  with	  the	  heterodimeric	  mRNA	  export	  receptor	  TAP/p15	  (also	  known	   as	   NXF1/NXT1)	   (Viphakone	   et	   al.,	   2012),	   which	   binds	   to	   mRNA	   and	  translocates	  it	  across	  the	  nuclear	  pore	  to	  the	  cytoplasm	  (Hurt	  et	  al.,	  2000;	  Segref	  et	  al.,	  1997)	  (Figure	  1).	  	  Translation	  After	   export	   to	   the	   cytoplasm,	   the	   information	   of	   the	  mRNA	   is	   translated	   into	  protein.	   This	   process	   can	   be	   divided	   into	   different	   steps,	   which	   are	   initiation,	  elongation,	   termination	  and	   recycling.	  Translation	   initiation	   is	   carried	  out	  by	  a	  network	   of	   factors	   and	   involves	   eukaryotic	   initiation	   factors	   (eIFs),	   the	  ribosomal	  subunits	  and	  the	  mRNA	  (Aitken	  and	  Lorsch,	  2012).	  These	  factors	  scan	  the	  mRNA	   until	   an	   AUG	   start	   codon	   is	   encountered	   (Aitken	   and	   Lorsch,	   2012;	  Jackson	  et	  al.,	  2010).	  Specifically,	  eIF3	  in	  the	  initiation	  phase	  interacts	  with	  eIF4F	  and	  contributes	  to	  the	  recognition	  of	  AUG	  (Hinnebusch,	  2006).	  Elongation	  of	  the	  amino	   acid	   chain	   proceeds	   until	   a	   termination	   codon	   is	   reached	   (UAG,	   UAA,	  UGA).	  The	  eukaryotic	  release	  factors	  (RFs)	  are	  responsible	  for	  the	  release	  of	  the	  completed	  protein	  product	  (Jackson	  et	  al.,	  2012).	  At	  this	  step	  the	  ribosome	  is	  still	  assembled	   on	   the	   mRNA.	   The	   recycling	   process	   is	   still	   unclear,	   but	   what	   is	  known	  is	  that	  the	  ribosome	  subunits	  are	  separated	  from	  the	  mRNA.	  This	  enables	  the	   ribosomal	   subunits	   to	   be	   recruited	   again	   to	   the	   AUG	   of	   mRNA	   to	   start	  another	  round	  of	  translation	  (Nurenberg	  and	  Tampe,	  2013).	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2.2	  The	  Exon	  Junction	  Complex	  Messenger	   ribonuceoproteins	   (mRNPs)	   are	  dynamic	   complexes,	   changing	   their	  composition	   during	   the	   lifetime	   of	   an	   mRNA.	   As	   an	   example,	   the	   nuclear	   cap	  binding	  protein	  (CBP20/80)	  binds	  mRNA	  in	  the	  nucleus	  (Lewis	  and	  Izaurralde,	  1997;	   Sonenberg	   and	   Hinnebusch,	   2009),	   while	   the	   eukaryotic	   translation	  initiation	  complex	  4F	  replaces	  CBP20/80	  in	  the	  cytoplasm	  (Jackson	  et	  al.,	  2010;	  Sonenberg	  and	  Hinnebusch,	  2009).	  Similarly,	  the	  nuclear	  poly(A)	  binding	  protein	  PABPN	  (Krause	  et	  al.,	  1994;	  Wahle,	  1991)	  is	  replaced	  by	  PABPC	  in	  the	  cytoplasm	  (Gorlach	  et	  al.,	  1994).	  The	  exon	   junction	  complex	   (EJC)	  differs	   from	  the	  above-­‐mentioned	  mRNPs.	  It	  remains	  bound	  to	  the	  mRNA	  in	  the	  cytoplasm	  after	  being	  deposited	   in	   the	   nucleus	   during	   splicing	   (Le	   Hir	   et	   al.,	   2000a;	   Le	   Hir	   et	   al.,	  2000b).	  	  
2.2.1	  EJC	  structure	  The	  core	  of	   the	  EJC	   consists	  of	   four	  proteins	  known	  as	  MAGOH,	  Y14	   (RMB8A),	  eIF4A3	  (DDX48)	  and	  Barentsz	  (BTZ,	  also	  known	  as	  CASC3	  and	  MLN51)	  (Gehring	  et	  al.,	  2009a)	  (Figure	  3).	  In	  living	  cells,	  the	  EJC	  functions	  as	  a	  binding	  platform	  for	  many	   other	   proteins	   responsible	   for	   different	   processes	   during	   the	  mRNA	   life	  cycle	   (see	   paragraphs	   2.2.3	   and	   2.2.4).	   eIF4A3	   is	   a	  DEAD-­‐box	   helicase	   protein.	  The	  proteins	  of	  the	  DExD/H	  family	  share	  a	  conserved	  helicase	  core,	  consisting	  of	  two	   globular	   RecA-­‐like	   domains,	   the	   N-­‐terminal	   RecA	   domain	   1	   and	   the	   C-­‐terminal	   RecA	   domain	   2	   connected	   by	   a	   flexible	   linker	   (Caruthers	   and	  McKay,	  2002).	  These	  domains	  correspond	  to	  amino	  acids	  38-­‐240	  and	  251-­‐411	  in	  eIF4A3	  respectively.	   Their	   orientation	   is	   not	   defined	   in	   the	   absence	   of	   ATP	   and	   RNA.	  However,	   upon	   binding	   to	   ATP	   and	   RNA,	   the	   RecA-­‐like	   domain	   1	   and	   2	   are	  brought	   in	   close	   proximity	   forming	   a	   cleft	   where	   ATP	   (in	   red)	   binds.	   On	   the	  opposite	   surface	   the	   two	   RecA-­‐like	   domains	   bind	   the	   RNA	   (in	   black).	   This	  binding	   is	   sequence	   independent	   because	   eIF4A3	   binds	   the	   ribose-­‐phosphate	  backbone	  of	  the	  RNA	  (Bono	  et	  al.,	  2006).	  The	  SELOR	  domain	  of	  BTZ	  (aa	  137-­‐286	  (Degot	  et	  al.,	  2004))(in	  orange)	  extends	  with	   two	  separate	   stretches	  over	  both	  domains	  of	   eIF4A3.	  The	  N-­‐terminal	   stretch	   (aa	  168–196)	  binds	   to	  domain	  2	  of	  eIF4A3	   and	   the	   C-­‐terminal	   stretch	   (aa	   214–248)	   binds	   to	   domain	   1.	   These	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stretches	   are	   connected	   by	   a	   flexible	   linker.	   In	   addition,	   the	   SELOR	   domain	   of	  BTZ	   contributes	   to	   the	   interaction	  of	  BTZ	   to	   the	  RNA	  and	   to	  MAGOH	   (in	  blue)	  (Bono	  et	  al.,	  2006).	  The	  structure	  of	  the	  dimer	  MAGOH-­‐Y14	  in	  the	  EJC	  is	  almost	  identical	   to	   one	   of	   the	   isolated	   dimer	   (Fribourg	   et	   al.,	   2003;	   Lau	   et	   al.,	   2003).	  MAGOH	  folds	  into	  flat	  antiparallel	  β	  sheets	  flanked	  on	  one	  side	  by	  two	  parallel	  α	  helices,	  which	  bind	  the	  RNA	  binding	  domain	  (RBD)	  of	  Y14	  (in	  violet).	  In	  the	  EJC	  the	  dimer	  MAGOH/Y14	  interacts	  mainly	  with	  the	  RecA-­‐like	  domain	  2	  of	  eIF4A3	  (Bono	  et	  al.,	  2006).	  Interestingly,	  MAGOH/Y14	  binds	  eIF4A3	  only	  in	  the	  ATP-­‐and	  RNA-­‐bound	   state.	   This	   explains	   why	   in	   vitro	   MAGOH-­‐Y14	   inhibits	   the	   ATPase	  activity	  of	  eIF4A3.	  In	  contrast,	  SELOR	  stimulates	  ATPase	  activity	  of	  eIF4A3	  (Bono	  et	  al.,	  2006).	  	  	  
	  
Figure	   3.	   EJC	   crystal	   structure.	   The	   crystal	   structure	   of	   the	   EJC	   complex	   was	  modeled	   with	  pyMOL	  (PyMOL	  Molecular	  Graphics	  System,	  Version	  1.5.0.4	  Schrödinger,	  LLC)	  and	   the	  PDB	   file	  2J0S	  (Bono	  et	  al.,	  2006).	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2.2.2	  EJC	  assembly	  and	  disassembly	  As	   a	   consequence	   of	   splicing,	   the	   EJC	   is	   deposited	   on	   the	   mRNA	   20-­‐24	   nt	  upstream	  of	   the	  exon-­‐exon	   junction	  marking	  the	  position	  of	   the	   former	   introns	  (Le	   Hir	   et	   al.,	   2000a).	   The	   deposition	   of	   the	   EJC	   on	   the	  mRNA	   is	   a	  multi-­‐step	  process.	  EJC	  assembly	   requires	  CWC22,	   a	   component	  of	   the	   spliceosome	  and	  a	  newly	   identified	   binding	   partner	   of	   eIF4A3	   (Steckelberg	   et	   al.,	   2012).	   Before	  exon-­‐exon	   ligation	   takes	  place,	  CWC22	  brings	  eIF4A3	   in	   close	  proximity	   to	   the	  mRNA	  (in	  the	  spliceosomal	  complex	  B).	  The	  subsequent	  conformational	  change,	  in	  the	  presence	  of	  ATP,	  induces	  the	  binding	  of	  eIF4A3	  to	  the	  mRNA.	  As	  a	  result,	  the	  MAGOH/Y14	  heterodimer	   can	   interact	  with	   eIF4A3	   (spliceosomal	   complex	  Bact),	  stabilizing	  the	  trimeric	  pre-­‐EJC	  on	  the	  mRNA.	  The	  trimeric	  pre-­‐EJC	  remains	  stably	   associated	   to	   the	  mRNA	  while	   the	   introns	   are	   spliced	   out	   (spliceosomal	  complex	   C).	   Next,	   the	  mRNA	   associated	   complex	   is	   exported	   to	   the	   cytoplasm	  where,	   according	   to	   the	   current	   model,	   the	   protein	   BTZ	   joins	   the	   complex	  (Gehring	  et	  al.,	  2009a;	  Steckelberg	  et	  al.,	  2012)	  (Figure	  4,	   from	  1	   to	  5).	   Indeed,	  there	  is	  evidence	  that	  BTZ	  and	  the	  spliceosome	  bind	  the	  same	  eIF4A3	  residues,	  supporting	   the	   hypothesis	   of	   BTZ	   joining	   to	   the	   EJC	   after	   completion	   of	   the	  splicing	   reaction.	   This	   assumption	   is	   corroborated	   by	   previous	   results,	   where	  BTZ	  was	  not	  identified	  in	  purified	  spiceosomal	  complexes	  (Bessonov	  et	  al.,	  2008;	  Gehring	   et	   al.,	   2009a).	   EJC	   proteins	   need	   to	   be	   recycled	   quickly	   and	   efficiently	  because	  of	   the	   limited	   cellular	   amount	  of	  EJC	  proteins	  and	   the	  high	  number	  of	  exon	   junctions	   in	   the	   steady-­‐state	   transcriptome.	   EJCs	   located	  within	   the	   open	  reading	  frame	  (ORF)	  are	  removed	  by	  the	  ribosome	  in	  the	  cytoplasm	  during	  the	  first	  round	  of	  translation	  (Dostie	  and	  Dreyfuss,	  2002;	  Lejeune	  et	  al.,	  2002).	  The	  protein	  PYM	  binds	  the	  dimer	  MAGOH-­‐Y14	  with	  its	  N-­‐terminal	  domain	  (Bono	  et	  al.,	  2004;	  Forler	  et	  al.,	  2003),	  but	  it	  also	  interacts	  with	  the	  ribosome	  (Diem	  et	  al.,	  2007).	  For	   this	   reason,	  PYM	  was	  proposed	   to	  bridge	   the	   ribosome	  and	   the	  EJC	  and	  to	  stimulate	  the	  release	  of	  the	  EJC	  proteins	  from	  the	  mRNA.	  Binding	  of	  PYM	  to	  the	  ribosome	  guarantees	  that	  PYM	  removes	  the	  EJC	  only	  within	  the	  ORF	  from	  translated	   mRNA.	   This	   type	   of	   binding	   represents	   a	   safe	   mechanism	   that	  minimizes	   the	  amount	  of	   free	  PYM,	   in	  order	   to	  avoid	  EJC	  removal	   from	  not	  yet	  translated	  mRNAs	  (Gehring	  et	  al.,	  2009b).	  According	  to	  the	  proposed	  model,	  the	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Figure	  4.	  Model	  of	  EJC	  assembly	  and	  recycle.	  Steps	  1	  to	  5	  show	  the	  assembly	  of	  the	  EJC	  in	  the	  nucleus	   and	   the	   export	   to	   the	   cytoplasm.	   PYM	   displaces	   the	   EJC	   in	   the	   cytoplasm	   during	  translation	  (steps	  6	  and	  7).	  This	  image	  was	  inspired	  by	  N.H.	  Gehring	  drawing.	  	  	  
2.2.3	  Peripheral	  EJC	  components	  As	  explained	   in	  paragraph	  2.2.4,	   the	  EJC	  executes	  several	   functions.	   In	  order	  to	  mediate	   these	   functions,	   it	   needs	   to	   interact	  with	   other	   proteins	   (Degot	   et	   al.,	  2004;	  Diem	  et	  al.,	  2007;	  Ferraiuolo	  et	  al.,	  2004;	  Gatfield	  et	  al.,	  2001;	  Kataoka	  et	  al.,	  2001;	  Kataoka	  et	  al.,	  2000;	  Kim	  et	  al.,	  2001;	  Le	  Hir	  et	  al.,	  2001;	  Le	  Hir	  et	  al.,	  2000a;	  Le	  Hir	  et	  al.,	  2000b;	  Li	  et	  al.,	  2003;	  Luo	  et	  al.,	  2001;	  Lykke-­‐Andersen	  et	  al.,	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2000;	   Palacios	   et	   al.,	   2004;	   Zhou	   et	   al.,	   2000).	   In	   Figure	   5,	   EJC-­‐interacting	  proteins	  are	  shown	  and	  their	  functions	  are	  described	  in	  the	  next	  paragraphs.	  	  
	  	  	  
Figure	  5.	   EJC-­interacting	  proteins	   and	   functions.	   The	   core	   of	   the	   EJC	   (MAGOH,Y14,BTZ	   and	  eIF4A3)	  (dark	  gray	  circle)	   interacts	  with	  several	  peripheral	  EJC	  components	  (middle	  gray)	  and	  with	  transient	  binding	  partners	  (light	  gray)	  to	  execute	  different	  functions,	  e.g.	  NMD,	  export	  and	  splicing	   (The	   proteins	   involved	   in	   a	   common	   function	   are	   enclosed	   in	   an	   oval	   shape,	  with	   the	  function	  indicated).	  	  	  
2.2.4	  EJC	  functions	  The	   EJC	   influences	   the	   life	   of	   an	   mRNA	   through	   several	   processes,	   such	   as	  localization,	  splicing,	  translation	  and	  decay.	  With	  the	  exception	  of	  decay,	  which	  is	  described	   in	   paragraph	   2.3,	   this	   paragraph	   discusses	   how	   the	   EJC	   influences	  these	  processes.	  	  Localization	  The	  EJC	  is	  required	  for	  proper	  localization	  of	  the	  oskar	  mRNA	  in	  D.melanogaster	  oocytes.	  Oskar	  mRNA	  is	  synthesized	  in	  the	  nurse	  cell	  nuclei	  and	  then	  transported	  along	  the	  microtubules	  into	  the	  adjacent	  oocyte	  (St	  Johnston,	  2005).	  Expression	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of	   oskar	  occurs	   exclusively	   at	   the	   posterior	   pole	   is	   precisely	   regulated:	   during	  transport	   along	   the	   microtubules,	   Bruno	   represses	   the	   translation	   of	   oskar	  (Gunkel	  et	  al.,	  1998;	  Kim-­‐Ha	  et	  al.,	  1995).	  Once	  oskar	  reaches	  the	  posterior	  pole,	  Staufen	   activates	   its	   translation	   (Micklem	   et	   al.,	   2000).	   Translation	   occuring	  exclusively	   at	   the	   posterior	   pole	   is	   essential	   for	   the	   formation	   of	   the	   abdomen	  and	   the	   germ	   line	   of	   the	   embryo	   (Johnstone	   and	   Lasko,	   2001).	   Several	   trans-­‐acting	   factors	  control	   repression,	   transport	  and	   translation	  of	   the	  oskar	  mRNA.	  Examples	   of	   these	   controlling	   factors	   include	   the	   D.melanogaster	   EJC	   core	  components	   eIF4A3,	   Barentz,	   Mago	   Nashi	   and	   Tsunagi	   (MAGOH	   and	   Y14	   in	  human)	  (Palacios,	  2002;	  Palacios	  et	  al.,	  2004).	  In	  particular,	  BTZ	  is	  required	  for	  transport	   of	   oskar	   to	   the	   posterior	   pole.	   BTZ	   does,	   however,	   not	   affect	   other	  processes	   such	   as	   transcription,	   export,	   colocalization	   with	   Staufen,	   or	  translation	  (van	  Eeden	  et	  al.,	  2001).	  Similarly,	  van	  Eeden	  and	  collegues	  observed	  that	  mutations	   in	  mago	  nashi	   and	  btz	   resulted	   in	   the	  same	  phenotype	  and	   that	  the	   two	  proteins	  depend	  on	  each	  other	   for	  proper	   localization	  at	   the	  posterior	  pole.	  Subsequently,	  Y14	  and	  eIF4A3	  were	  identified	  to	  be	  responsible	  for	  proper	  
oskar	  localization	  as	  well	  (Hachet	  and	  Ephrussi,	  2001;	  Palacios	  et	  al.,	  2004).	  The	  
oskar	  mRNA	   localization	   is	   the	  best	   studied	  example	  of	   the	   involvement	  of	   the	  EJC	   in	   mRNA	   localization.	   Another	   example	   of	   the	   contribution	   of	   the	   EJC	  proteins	  in	  mRNA	  localization	  comes	  from	  dendrites	  of	  mammalian	  hippocampal	  neurons.	   The	   dendrites	   are	   highly	   polarized	   cells	   and	   require	   translation	   of	  specific	  mRNAs.	  MAGOH,	  Y14	  and	  BTZ	  accumulated	  in	  the	  dendrites	  where	  BTZ	  associates	  with	  the	  mRNA	  transport	  factor	  Staufen1.	  Staufen1	  assembles	  in	  RNPs	  responsible	   to	   transport	   and	   localize	   RNAs	   into	   dendrites	   of	   mature	  hippocampal	  neurons	  (Giorgi	  and	  Moore,	  2007;	  Glanzer	  et	  al.,	  2005;	  Macchi	  et	  al.,	  2003;	  Monshausen	  et	  al.,	  2004).	  	  	  Splicing	  The	  recognition	  of	  the	  splice	  site	  occurs	  in	  two	  different	  ways	  in	  long	  and	  short	  intron	  containing	  genes:	  in	  short	  introns	  (<200	  bp),	  the	  5ʹ	  and	  3ʹ	  splice	  sites	  are	  recognized	  across	  the	  intron	  (intron	  definition);	  in	  long	  introns	  (>250	  bp),	  splice	  sites	  of	  bordering	  exons	  have	   to	  be	   recognized	  before	  splicing	  can	  occur	   (exon	  definition)	  (Fox-­‐Walsh	  et	  al.,	  2005;	  Sterner	  et	  al.,	  1996).	  The	  influence	  of	  the	  EJC	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over	   the	   splicing	   process	   is	   associated	   with	   this	   second	   phenomenon	   of	   exon	  definition.	  In	  D.melanogaster	  the	  nuclear	  EJC	  influences	  splicing	  of	  the	  mapk	  gene	  exclusively.	   The	   splicing	   of	   the	   other	   genes	   of	   the	  RAS1/MAPK	  pathway	   is	   not	  influenced	  by	  the	  EJC,	  indicating	  a	  selective	  choice	  for	  a	  specific	  mRNA	  (Ashton-­‐Beaucage	  et	  al.,	  2010).	  EJC	  removal	  leads	  to	  exon	  skipping	  (Ashton-­‐Beaucage	  et	  al.,	  2010)	  and,	  of	   the	  EJC	  core	  components,	  only	   the	  depletion	  of	  BTZ	  does	  not	  affect	   splicing	  of	   the	  mapk	  pre-­‐mRNA.	  This	   is	   in	   line	  with	   the	  observation	   that	  BTZ	   deposition	   on	   the	  mRNA	   occurs	   after	   completion	   of	   the	   splicing	   reaction	  (Gehring	  et	  al.,	  2009a).	  So	  far	  it	  was	  not	  possible	  to	  define	  if	  the	  effect	  of	  the	  EJC	  was	  direct	  or	  indirect.	  One	  possibility	  is	  that	  the	  EJC	  works	  as	  a	  binding	  platform	  for	  the	  splicing	  effectors	  SRSF	  proteins	  (Long	  and	  Caceres,	  2009).	  Another	  option	  is	  that	  the	  EJC	  stabilizes	  the	  interaction	  between	  the	  spliceosome	  and	  the	  splice	  site	  (Ashton-­‐Beaucage	  et	  al.,	  2010).	  In	  2012,	  Michelle	  and	  collegues	  analyzed	  the	  effect	   of	   three	   categories	   of	   EJC	   components	   on	   splicing	   of	   the	   apoptotic	  regulator	  Bcl-­x:	  core,	  peripheral	  and	  NMD	  associated.	  The	  depletion	  of	   the	  core	  components	  Y14	  and	  eIF4A3	  and	  the	  peripheral	  RNPS1,	  Acinus	  and	  SAP18	  was	  associated	   with	   an	   increase	   of	   the	   proapoptotic	   splicing	   variant	  Bcl-­xs.	   On	   the	  contrary,	  no	  effect	  was	  observed	  when	  the	  export	  factors	  UAP56,	  ALY/REF	  and	  the	  NMD	  proteins	  UPF1,	  UPF2	  and	  UPF3b	  were	  depleted.	  Similarly,	  no	  effect	  was	  observed	  when	  BTZ	  was	  depleted.	  Interestingly,	  the	  function	  and	  the	  deposition	  of the	   EJC	   components	   in	   Bcl-­x	   modulation	   depend	   on	   cis-­‐acting	   elements,	  suggesting	  a	  different	  type	  of	  EJC	  assembly	  and	  regulation	  (Michelle	  et	  al.,	  2012).	  	  	  Translation	  	  It	  was	  first	  observed	  that	  intron-­‐containing	  transcripts	  had	  a	  higher	  translation	  rate	  compared	  to	  the	  intron-­‐less	  upon	  injection	  in	  Xenopus	  oocytes	  (Matsumoto	  et	  al.,	  1998).	  Subsequently,	   in	  mammalian	  cells	  an	   increased	  mRNA	  translation	  was	  observed	  upon	   the	  deposition	  of	   the	  EJC	   (Lu	  and	  Cullen,	  2003;	  Nott	   et	   al.,	  2003).	   No	   detectable	   positive	   effect	   on	   the	   expression	   of	   the	   mRNA	   was	  observed	  for	  the	  human	  β-­‐globin	  gene	  where	  the	  intron	  was	  positioned	  so	  close	  to	  the	  5ʹ	  end	  of	  the	  mRNA	  that	  the	  EJC	  could	  not	  assemble,	  even	  though	  splicing	  of	  this	  mRNA	  still	  occurred.	  In	  contrast,	  tethering	  of	  the	  EJC	  proteins	  RNPS1	  and	  SRm160	   increases	   expression	   of	   intronless	   β-­‐globin	   (Wiegand	   et	   al.,	   2003).	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Similarly,	   Nott	   and	   colleagues	   observed	   that	   tethering	   of	   the	   EJC	   components	  Y14,	   MAGOH	   and	   the	   more	   peripheral	   component	   RNPS1	   led	   to	   translational	  stimulation	  of	   the	  reporter	  transcript.	  The	  EJC	  components	  might	  contribute	  to	  the	   increased	   mRNA	   translation	   in	   different	   ways.	   One	   explanation	   is	   the	  interaction	  of	  PYM	  with	  the	  dimer	  MAGOH/Y14.	  The	  binding	  of	  the	  N-­‐terminus	  of	  PYM	  to	  MAGOH/Y14	  and	  the	  C-­‐terminus	  to	  ribosome	  would	  recruit	  EJC	  bound	  mRNAs	  to	  the	  translation	  machinery	  (Diem	  et	  al.,	  2007).	  This	  model	  is	  supported	  by	   previous	   observation	   that	   cytoplasmic	   polysome	   association	   resulted	   in	  enhanced	  spliced	  mRNAs	  (Nott	  et	  al.,	  2004).	  Another	  possibility	  is	  the	  interaction	  of	  BTZ	  with	  the	  translation	  initiation	  factor	  eIF3	  (paragraph	  2.4.2)	  (Chazal	  et	  al.,	  2013)	   or	   the	   recruitment	   of	   the	   TREX	   complex.	   Export	   of	   the	   mRNA	   to	   the	  cytoplasm	  would	  then	  make	  it	  available	  for	  the	  translation	  machinery	  (Le	  Hir	  et	  al.,	  2001;	  Luo	  and	  Reed,	  1999;	  Luo	  et	  al.,	  2001;	  Zhou	  et	  al.,	  2000).	  	  	  
2.3	  Nonsense-­mediated	  mRNA	  decay	  During	   gene	   expression,	   a	   frequently	   occurring	   error	   is	   the	   generation	   of	  premature	   termination	   codons	   (PTCs).	   PTCs	   can	   arise	   at	   the	   DNA	   level	   as	   a	  consequence	   of	   nonsense	   mutations,	   deletion,	   insertions	   or	   somatic	  rearrangements.	  Alternatively,	  mutations	  in	  functional	  motifs,	  such	  as	  splice	  site	  or	   splice	   regulatory	   elements	   that	   lead	   to	   alternative	   splicing	   events,	   can	  generate	  PTCs	  (Nicholson	  et	  al.,	  2010).	  One-­‐third	  of	  all	  alternative	  splicing	  events	  lead	   to	   the	   formation	  of	  PTCs	  (Lewis	  et	  al.,	  2003).	   In	  principle,	   the	  presence	  of	  PTCs	   can	   lead	   to	   synthesis	   of	   truncated,	   non-­‐functional	   and	   sometimes	  deleterious	   proteins	   (Frischmeyer	   and	   Dietz,	   1999;	   Holbrook	   et	   al.,	   2004).	  Eukaryotes	   have	   acquired	   an	   evolutionary	   conserved	   surveillance	  mechanism,	  named	   nonsense-­‐mediated	  mRNA	   decay	   (NMD),	   to	   identify	   and	   degrade	   these	  aberrant	   mRNAs	   (Amrani	   et	   al.,	   2006;	   Behm-­‐Ansmant	   et	   al.,	   2007;	   Conti	   and	  Izaurralde,	   2005;	   Culbertson,	   1999;	  Muhlemann	   et	   al.,	   2008).	   According	   to	   the	  current	  model,	   in	   higher	   eukaryotes	   a	   stop	   codon	   is	   recognized	   as	   premature	  when	   situated	   more	   that	   50	   nt	   upstream	   of	   an	   exon-­‐exon	   junction	   and,	  consequently,	  of	  a	  deposited	  EJC	  (Figure	  6-­‐1)	  (Nagy	  and	  Maquat,	  1998;	  Zhang	  et	  al.,	   1998a;	   Zhang	   et	   al.,	   1998b).	   Two	   main	   complexes	   are	   required	   for	   NMD	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activation:	   one	   is	   the	   EJC,	   downstream	   of	   the	   stop	   codon,	   the	   other	   the	   SURF	  complex.	  When	  the	  ribosome	  stops	  either	  at	  a	  normal	  stop	  codon	  or	  at	  a	  PTC,	  the	  eukaryotic	  release	  factors	  (eRF)	  1	  and	  3	  interact	  with	  the	  A-­‐site	  of	  the	  ribosome	  (Figure	  6-­‐2).	  For	  efficient	   translation	   termination,	   the	   interaction	  of	   eRF3	  with	  the	   cytoplasmic	   poly(A)-­‐binding	   protein	   (PABPC1)	   is	   required	   (Cosson	   et	   al.,	  2002a;	  Cosson	  et	  al.,	  2002b).	  However	  the	  up-­‐frameshift	  protein	  UPF1	  competes	  with	   PABPC1	   for	   binding	   to	   eRF3,	   affecting	   the	   normal	   termination	   process	  (Ivanov	  et	  al.,	  2008).	  eRF3-­‐bound	  UPF1	  in	  turn	  interacts	  with	  SMG1,	  forming	  the	  so-­‐called	   SURF	   complex	   (SMG1,	   UPF1,	   eRF	   1	   and	   3)	   (Czaplinski	   et	   al.,	   1998;	  Kashima	  et	  al.,	  2006)	  (Figure	  6-­‐3).	  	  	  	  
	  	  
Figure	   6.	  Model	   of	   NMD	  activation.	   1-­‐	   EJC	   is	   deposited	   20-­‐24	   nt	   upstream	   of	   the	   exon-­‐exon	  junction.	  2-­‐	  The	  ribosome	  stalls	  at	  the	  PTC	  and	  recruits	  the	  eukaryotic	  release	  factors	  (eFR1-­‐3).	  3-­‐The	   SURF	   complex	   (SMG1,	   UPF1,	   eRF	   1	   and	   3)	   is	   assembled.	   4-­‐UPF3b	   and	   UPF2	   bridge	   the	  SURF	  complex	  to	  the	  EJC.	  5-­‐	  SMG5,	  SMG	  7	  and	  SMG	  6	  are	  recruited	  and	  activate	  the	  degradation	  process	  6-­‐	  Generation	  of	  the	  two	  unprotected	  RNA	  fragments.	  	  	  The	  up-­‐frameshift	  proteins	  UPF3b	  and	  UPF2	  bridge	  the	  EJC	  to	  the	  SURF	  complex	  through	  binding	  to	  UPF1	  (Chamieh	  et	  al.,	  2008;	  Kashima	  et	  al.,	  2006)(Figure	  6-­‐4).	   This	   bridging	   activates	   the	   kinase	   activity	   of	   SMG1,	   which	   phosphorylates	  UPF1	  (Figure	  6-­‐4)	  (Isken	  and	  Maquat,	  2008;	  Kashima	  et	  al.,	  2006;	  Ohnishi	  et	  al.,	  2003;	   Yamashita	   et	   al.,	   2001).	   Once	   UPF1	   is	   phosphorylated,	   it	   serves	   as	   a	  binding	  platform	   for	   the	  effector	  proteins	  SMG5,	  SMG6	  and	  SMG7	  (Figure	  6-­‐5).	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Two	  possible	   pathways	   are	   activated	   to	   degrade	   the	  mRNA:	   the	   first	   is	   SMG5-­‐SMG7	   dependent	   and	   activates	   deadenylases	   and	   decapping	   enzymes,	   thereby	  leading	   to	   an	   exonucleolytic	   degradation	   of	   the	   mRNA	   (Loh	   et	   al.,	   2013;	  Unterholzner	   and	   Izaurralde,	   2004);	   the	   second	   is	   SMG6	   dependent.	   SMG6	  executes	   an	   endonucleolytic	   cleavage	   of	   the	   substrate,	   thereby	   generating	   two	  unprotected	   RNA	   fragments,	   which	   are	   subsequently	   degraded	   by	   the	   5ʹ-­‐to-­‐3ʹ	  exonuclease	  XRN1	  or	  by	  the	  3ʹ-­‐to-­‐5ʹ	  exosome	  complex	  (Figure	  6-­‐6)	  (Eberle	  et	  al.,	  2009;	  Huntzinger	  et	  al.,	  2008).	   In	  addition	   to	   the	  EJC-­‐dependent	  NMD,	  another	  way	   has	   been	   described	   to	   activate	   NMD.	   In	   presence	   of	   a	   long	   3ʹ	   UTR,	   the	  ribosome	   might	   fail	   to	   terminate	   properly	   due	   to	   the	   long	   distance	   between	  PABPC1	  and	  the	  eRFs	  (“faux”	  3ʹ UTR	  model)	  (Amrani	  et	  al.,	  2004;	  Behm-­‐Ansmant	  et	   al.,	   2007;	   Eberle	   et	   al.,	   2008;	   Singh	   et	   al.,	   2008).	   In	   this	   case,	   as	   well	   as	  described	   above,	   UPF1	   binds	   the	   eRFs,	   activating	   the	   downstream	   cascade	   of	  events	  that	  leads	  to	  the	  mRNA	  degradation	  (Kashima	  et	  al.,	  2006).	  The	  medical	  impact	  of	  NMD	  was	  first	  observed	  in	  β-­‐thalassemia,	  where	  a	  single	  nucleotide	  deletion	  produces	  a	  premature	  stop	  codon,	  leading	  to	  a	  reduced	  half	  life	  of	  the	  corresponding	  mRNA	  (Kinniburgh	  et	  al.,	  1982).	  β-­‐thalassemia	  is	  a	  valid	  example	   of	   the	   correlation	   between	   NMD	   and	   pathologies.	   In	   case	   of	   a	  homozygous	  mutation,	  the	  β-­‐globin	  chain	  is	  not	  produced	  due	  to	  degradation	  of	  its	  mRNA	   via	   NMD.	   In	   heterozygous	  mutations,	   the	   normal	   allele	   can	   produce	  enough	   β-­‐globin	   subunits	   to	   support	   near	   normal	   hemoglobin	   levels	   (Hall	   and	  Thein,	  1994).	  A	  third	  situation	   is	   the	  NMD-­‐insensitive	   last-­‐exon	  PTC	  mutations,	  where	  truncated	  nonfunctional	  β-­‐globin	  is	  produced	  (Thein	  et	  al.,	  1990).	  NMD	  is	  not	   only	   responsible	   for	   the	  degradation	  of	  mutated	  mRNA	   that	  would	   lead	   to	  the	   translation	   of	   truncated	   and	   deleterious	   proteins,	   it	   also	   targets	   5-­‐10%	   of	  naturally	  occurring	  transcript	  (Mendell	  et	  al.,	  2004).	  One	  example	  are	  members	  of	   the	   SR-­‐family	   of	   splicing	   factor:	   SRSF2	   and	   SRSF3	   promote	   the	   alternative	  splicing	   of	   their	   own	  mRNA,	   leading	   to	   NMD	   sensitive	   variants	   (Sureau	   et	   al.,	  2001).	  Another	  example	  is	  the	  regulation	  of	  the	  mammalian	  selenium-­‐dependent	  glutathione	   peroxidase	   1	   (Se-­‐GPx1)	   mRNA.	   This	   mRNA	   contains	   a	   UGA	   codon	  that	   is	   recognized	   as	   a	   codon	   for	   the	   nonstandard	   amino	   acid	   selenocysteine	  (Sec).	  But	   in	  presence	  of	  reduced	  concentrations	  of	  selenium,	  the	  UGA	  codon	  is	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decoded	  as	  a	  stop	  codon,	  leading	  to	  the	  subsequent	  degradation	  of	  the	  transcript	  (Moriarty	  et	  al.,	  1998).	  
	  
2.4	  Barentsz	  Human	  BTZ	  was	  originally	   identified	   in	  a	  screening	  of	  breast	  cancer	  metastatic	  lymph	  node	  cDNAs,	  hence	  also	  being	  known	  as	  MLN51	  (Metastatic	  Lymph	  Node	  51).	   It	   is	   located	   on	   the	   long	   arm	   of	   chromosome	   17	   in	   the	   q11-­‐q21.3	   region	  (Tomasetto	  et	  al.,	  1995).	  The	  name	  CASC3	  (Cancer	  Susceptibility	  Candidate	  Gene	  3)	  derives	  from	  a	  different	  screening	  of	  genes	  of	  which	  expression	  was	  increased	  in	   cancer	   (Arriola	   et	   al.,	   2008),	   while	   the	   name	   BTZ	   derives	   from	   the	  
D.melanogaster	   ortholog.	   The	   protein	   is	   highly	   conserved	   in	   mammals	   (90%	  homology	   with	   cow,	   mouse	   rat	   and	   pig)	   and	   in	   invertebrates	   (41%	   and	   48%	  similarity	  respectively	  with	  C.elegans	   and	  D.melanogaster).	  The	  region	  168-­‐256	  of	  human	  BTZ	  was	  found	  to	  be	  more	  conserved	  than	  the	  rest	  of	  the	  protein,	  with	  100%	  identity	  among	  human,	  rat	  and	  mouse.	  Because	  this	  region	  is	  responsible	  for	  RNA	  binding	  and	   localization	   to	   the	  nuclear	  speckles,	   it	  was	  named	  SELOR,	  for	  speckle	  localizer	  and	  RNA	  binding	  module	  (Degot	  et	  al.,	  2004).	  	  	  
2.4.1	  BTZ	  structure	  The	  ORF	  of	  BTZ	  is	  4119	  bp	  long	  and	  encodes	  a	  703	  aa	  protein	  with	  a	  predicted	  molecular	  weight	  of	  76	  kDa	   (Degot	   et	   al.,	   2002).	   Figure	  7	  displays	  a	   schematic	  representation	   of	   BTZ.	   The	   full-­‐lenght	   protein	   localizes	   to	   the	   cytoplasm,	  with	  the	   nuclei	   weakly	   stained,	   despite	   two	   nuclear	   localization	   signals	   (NLSs)	  (PKGRQRK,	  204	  –	  210;	  PRRIRKP,	  255	  –261)	  being	  present	  in	  the	  SELOR	  domain	  (Degot	   et	   al.,	   2002).	   However,	   these	   NLSs	   are	   functional:	   expressing	   only	   the	  sequence	  containing	  the	  NLS	  (203-­‐261	  and	  1-­‐351)	  of	  BTZ	  in	  cell	  culture	  lead	  to	  localization	  of	  these	  proteins	  to	  the	  nucleus	  (Degot	  et	  al.,	  2002).	  On	  the	  contrary,	  the	  C-­‐terminal	  domain,	  which	  contains	  a	  nuclear	  export	  signal	  (NES)	  (462-­‐472),	  localizes	  to	  the	  cytoplasm	  (Degot	  et	  al.,	  2004).	  According	  to	  the	  running	  behavior	  during	  SDS	  PAGE,	  the	  apparent	  molecular	  weight	  of	  BTZ	  is	  110kD,	  although	  the	  calculated	  weight	  is	  just	  76	  kD.	  Several	  factors	  contribute	  to	  the	  different	  protein	  migration.	  A	  putative	  coiled-­‐coil	  domain	  is	  present	  in	  the	  N-­‐terminal	  part	  of	  the	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protein	  (92	  –	  130)	  contributing	  to	  protein	  oligomerization	  (Degot	  et	  al.,	  2002).	  In	  addition,	   BTZ	   has	   a	   high	   proline	   content	   (14.4%	   of	   the	   total	   amino-­‐acid	  composition),	  especially	  in	  the	  C-­‐terminal	  domain	  (22.7%	  from	  amino	  acids	  352	  –	  703)	  and	  a	  conserved	  glutamine-­‐rich	  region	  (608-­‐675).	  The	  proline-­‐rich	  region	  forms	   relatively	   rigid	   structures	   that	   confer	   a	   retarded	   migration	   on	  conventional	   SDS-­‐containing	   gel	   (Hansen	   et	   al.,	   1998;	   Schreiber	   et	   al.,	   1998).	  Moreover,	  the	  proline-­‐rich	  region	  contributes	  to	  the	  protein	  oligomerization	  by	  binding	   the	   Src	   homology	   region	   3	   (SH3)	   domain	   (Degot	   et	   al.,	   2002).	   Two	  classes	  of	  SH3	  binding	  motifs	  have	  been	  described	  according	  to	  the	  position	  of	  a	  positively	  charged	  residue	  in	  the	  environment	  of	  the	  PXXP	  binding	  motif.	  Class	  I	  and	  class	  II	  SH3	  binding	  motifs	  correspond	  to	  the	  following	  consensus	  sequences	  +XXPXXP	  and	  PXXPX+	  (where	  +	  refers	  to	  a	  positively	  charged	  amino	  acid)	  (Kay	  et	   al.,	   2000).	  One	   class	   I	  motif	   (RPVPEPP,	   528	  –	  534)	   and	   three	   class	   II	  motifs	  (PPPPDR,	  392	  –	  398;	  PTPPTK,	  442	  –	  447;	  PSPPRR	  678	  –	  683)	  are	  present	  in	  BTZ.	  Another	   factor	   contributing	   to	   the	   protein	   oligomerization	   is	   one	   putative	  tyrosine	  phosphorylation	  site	  (Y404)	  (Degot	  et	  al.,	  2002).	  This	  site	  can	  be	  bound	  by	   Src	   homology	   region	   2	   (SH2)	   domains,	   which	   bind	   to	   phospho-­‐tyrosine	  (Mayer	  et	  al.,	  1988;	  Songyang	  et	  al.,	  1993).	  	  	  
	  
	  
Figure	  7.	   Schematic	   representation	  of	  BTZ.	   The	   figure	   is	  drawn	   to	   scale	  with	   the	   coiled-­‐coil	  domain	  in	  red,	  the	  NLSs	  in	  yellow,	  the	  SH3	  domain	  binding	  sites	  in	  black,	  SH2	  in	  green	  and	  the	  NES	  in	  turquoise.	  The	  aa	  position	  is	  indicated	  above.	  	  	  
2.4.2	  BTZ	  functions	  Functionally,	   BTZ	   can	   be	   divided	   in	   three	   regions:	   N-­‐terminus,	   SELOR	   and	   C-­‐terminus	  (Figure	  8).	  The	  role	  of	  the	  SELOR	  domain,	  as	  a	  mediator	  of	  EJC	  and	  RNA	  binding,	   was	   described	   in	   paragraph	   2.2.	   Concerning	   the	   N-­‐terminus,	   the	   only	  function	  reported	  so	  far	  was	  its	  role	  in	  NMD.	  Gehring	  and	  colleagues	  showed	  in	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Figure	   8.	   BTZ	   domain	   structure.	   Three	   functional	   domains	   compose	   the	   protein	   BTZ.	   N-­‐terminus	  (aa	  1-­‐137)	  involved	  in	  mRNA	  degradation;	  SELOR	  (aa	  137-­‐286),	  responsible	  for	  eIF4A3	  and	  mRNA	  binding;	  C-­‐terminus	  (aa	  286-­‐703),	  involved	  in	  stress-­‐granule	  assembly.	  	  	  	  Stress	  granule	  assembly	  The	   C-­‐terminus	   of	   BTZ	   was	   proposed	   to	   be	   the	   region	   responsible	   for	   the	  assembly	   of	   BTZ	   in	   stress	   granules	   (SGs)	   (Baguet	   et	   al.,	   2007).	   SGs	   are	  cytoplasmic	   aggregates	   composed	  of	  proteins	   and	  RNAs	  and	  are	   formed	  under	  unfavorable	   conditions.	   They	   represent	   an	   adaptive	   cellular	   response	   to	  environmental	  stress	  and	  are	  mainly	  known	  as	  dynamic	  cytoplasmic	  foci	  where	  stalled	  48S	  preinitiation	  complexes	  accumulate	  (Kedersha	  et	  al.,	  2002).	  Many	  SG-­‐resident	   proteins	   are	   RNA-­‐binding	   proteins	   involved	   in	   different	   aspects	   of	  mRNA	  function,	  such	  as	  translation	  (TIA1,	  TIAR	  and	  PABP),	  stability	  (HuR,	  TTP),	  degradation	   (G3BP	   and	   PMR1)	   and	   localization	   (Staufen,	   Smaug	   and	   FMRP)	  (Anderson	  and	  Kedersha,	  2006).	  These	  proteins	  shuttle	  rapidly	  in	  and	  out	  of	  SGs,	  supporting	   the	   idea	   that	   SG	   are	   not	   static	   storage	   centers,	   but	   rather	   dynamic	  structures	  (Anderson	  and	  Kedersha,	  2006;	  Kedersha	  and	  Anderson,	  2002).	  BTZ	  also	  shuttles	  rapidly	  in	  and	  out	  of	  the	  SGs,	  with	  the	  isolated	  C-­‐terminus	  having	  a	  higher	   mobility	   compared	   to	   the	   full-­‐length	   protein.	   Specifically,	   the	   220	   C-­‐terminal	  aa	  are	  responsible	  for	  BTZ	  recruitment	  to	  the	  SGs	  (Baguet	  et	  al.,	  2007).	  The	  same	  region	  is	  dispensable	  for	  EJC	  assembly	  (Degot	  et	  al.,	  2004).	  TIA1	  and	  Pumilio	   2	   have	   been	   shown	   to	   be	   targeted	   to	   SGs	   via	   a	   glutamine-­‐rich	   prion-­‐related	  domain	  (PRD),	  which	  is	  responsible	  for	  their	  self	  aggregation	  (Gilks	  et	  al.,	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2004;	   Vessey	   et	   al.,	   2006).	   The	   C-­‐terminal	   domain	   of	   BTZ	   contains	   several	  phosphorylation	   sites	   at	   serine	   residues,	   SH2	   and	   SH3	   binding	   sites	   and	   a	  conserved	  glutamine-­‐rich	   region	   (aa	  608-­‐675)	   (Degot	   et	   al.,	   2004;	  Degot	   et	   al.,	  2002).	  Both	  phosphorylation	  sites	  and	  the	  conserved	  glutamine-­‐rich	  region	  may	  govern	  BTZ	  association	  with	  SGs	  (Baguet	  et	  al.,	  2007).	  	  NMD	  In	   order	   to	   activate	   NMD,	   two	   pathways	   were	   suggested:	   BTZ-­‐dependent	   and	  UPF2-­‐dependent.	   The	   BTZ-­‐dependent	   pathway	   requires	   a	   fully	   assembled	   EJC,	  where	  UPF3b	  binds	  UPF1,	  without	  bridging	  by	  UPF2.	  In	  this	  pathway,	  the	  EJC	  is	  fundamental	   and	   any	   mutation	   in	   the	   four	   core	   components	   that	   affect	   their	  binding	  disrupts	  the	  NMD	  function	  (Gehring	  et	  al.,	  2009a).	  The	  existence	  of	  this	  UPF2-­‐independent	  NMD-­‐activating	  mRNP	  can	  also	  explain	  some	  earlier	  findings.	  UPF3	  proteins	   can	   coimmunoprecipitate	  UPF1	   independently	  of	   the	  binding	   to	  UPF2	   (Ohnishi	  et	   al.,	   2003).	   In	  addition,	  UPF3a	   (short	   isoform)	  and	  UPF1	  have	  both	  been	  detected	  in	  high	  molecular	  weight	  complexes	  lacking	  UPF2	  (Schell	  et	  al.,	   2003).	   Finally,	   the	   interaction	   of	   UPF2	   with	   tethered	   UPF3b	   seems	   to	   be	  dispensable	  for	  NMD,	  a	  finding	  that	  was	  difficult	  to	  reconcile	  with	  a	  linear	  UPF3-­‐UPF2-­‐UPF1	  pathway	  (Gehring	  et	  al.,	  2003).	  The	  second	  proposed	  pathway	  is	  EJC-­‐independent	  and	  UPF2-­‐dependent.	   In	   this	  pathway	  RNPS1	  binds	   the	  mRNA	  via	  its	  RRM	  (RNA	  recognition	  motif)	  domain	  and	  activates	  UPF1	  through	  UPF3b	  and	  UPF2	  (Gehring	  et	  al.,	  2009a).	  	  Translation	  initiation	  BTZ	  has	  been	  identified	  as	  binding	  partner	  of	  eIF3	  and	  was	  proposed	  to	  stabilize	  the	   initiating	   complex,	   promoting	   translation	   initiation	   (Chazal	   et	   al.,	   2013).	  Chazal	   and	   colleagues	   showed	   that	   BTZ	   overexpression	   is	   associated	   with	  increased	  translation	  of	   the	  Firefly	   luciferase	  reporter.	  Similarly,	  BTZ	  depletion	  reduced	  mRNA	   translation,	  whereas	   complementation	   of	   the	   depleted	   extracts	  by	  de	  novo-­‐synthesized	  BTZ	  restored	  translation	  efficiency,	  showing	  that	  BTZ	  is	  a	  bona	  fide	  regulator	  of	  translation.	  Although	  BTZ	  is	  able	  to	  stimulate	  translation	  of	  mRNAs	  that	  have	  not	  undergone	  splicing,	  its	  effect	  is	  much	  more	  pronounced	  on	  spliced	  mRNA.	  This	   function	  of	  BTZ	   is	  EJC-­‐dependent,	  because	  BTZ	  mutants	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that	  cannot	  be	  assembled	  into	  the	  EJC	  (Ballut	  et	  al.,	  2005;	  Daguenet	  et	  al.,	  2012)	  do	  not	   stimulate	   translation.	  Notably,	   this	   function	   is	   specific	   of	  BTZ,	   since	   the	  other	   EJC	   core	   components	   are	   not	   able	   to	   stimulate	   translation	   (Chazal	   et	   al.,	  2013).	  	  	  
2.5	  EJC	  and	  NMD	  in	  D.melanogaster	  and	  C.elegans	  The	   EJC	   core	   proteins	   are,	   like	   the	   NMD	   proteins,	   highly	   conserved	   among	  human,	  C.elegans	  and	  D.melanogaster	  (Bono	  et	  al.,	  2006).	  SMG1,	  SMG5,	  SMG6	  and	  SMG7	  are	  required	  for	  NMD	  in	  C.elegans,	  D.melanogaster	  and	  in	  mammalian	  cells	  (Conti	  and	  Izaurralde,	  2005),	  as	  well	  as	  the	  UPF	  proteins	  (SMG2,	  SMG3	  and	  SMG4	  in	   C.	   elegans)	   (Leeds	   et	   al.,	   1991;	   Leeds	   et	   al.,	   1992).	   While	   in	   mammals	   and	  
D.melanogaster	   NMD	   is	   required	   for	   viability	   (Metzstein	   and	   Krasnow,	   2006;	  Weischenfeldt	   et	   al.,	   2012),	   in	   C.elegans	   genetic	   deletions	   of	   the	   NMD	  components	   are	   associated	   only	   with	   morphogenic	   alteration	   (Hodgkin	   et	   al.,	  1989).	  The	  analysis	  of	  the	  spliceosome	  C	  complex	  in	  D.melanogaster	  revealed	  the	  presence	   of	   the	   EJC	   core	   components	   eIF4A3,	   MAGO	   and	   Y14.	   BTZ	   was	   not	  identified	  in	  the	  C	  complex,	  suggesting	  a	  later	  association	  with	  the	  EJC	  (Herold	  et	  al.,	   2009).	   However,	   it	   has	   not	   been	   finally	   solved	   whether	   NMD	   in	  
D.melanogaster	  is	  EJC-­‐dependent	  or	  not.	  In	  2003,	  Gatfield	  and	  colleagues	  showed	  that	   Y14	   and	   RNPS1	   are	   not	   required	   for	   NMD	   and	   that	   the	   recognition	   of	  premature	  stop	  codons	  is	  EJC-­‐independent.	  They	  postulated	  that	  PTCs	  might	  be	  recognized	   through	   downstream	   sequence	   elements,	   the	   D.melanogaster	  analogue	  of	  the	  exon	  junction,	  to	  which	  the	  UPF	  proteins	  could	  bind	  (Wagner	  and	  Lykke-­‐Andersen,	   2002).	   Interestingly,	   it	   was	   observed	   that	   the	   EJC	   in	  
D.melanogaster	   was	   not	   deposited	   on	   all	   the	   exon-­‐exon	   junctions	   but	   when	  present	   it	   promoted	   NMD.	   Natural	   intron–containing	   3ʹ	   untranslated	   regions	  (UTRs)	   were	   inserted	   downstream	   of	   the	   stop	   codon	   of	   a	   firefly	   luciferase	  reporter.	   These	   reporters	  were	   stabilized	   in	  UPF	  proteins	  depleted	   cells.	  Upon	  immunopurification	   of	   RNA	   associated	   with	   the	   EJC	   components,	   the	   same	  reporters	  were	  specifically	  enriched	  (Sauliere	  et	  al.,	  2010).	  Instead,	   in	  C.elegans	  the	  EJC	  components	  are	  not	  required	  for	  PTC	  definition	  or	  for	  NMD	  (Longman	  et	  al.,	  2007).	  Rather,	  the	  EJC	  proteins	  MAGO,	  Y14	  and	  eIF4A3	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are	   needed	   for	   retention	   in	   the	   nucleus	   of	   improperly	   spliced	   mRNA.	   Even	  though	  they	  do	  not	  affect	  splicing	  efficiency,	  their	  depletion	  is	  associated	  with	  a	  premature	  export	  of	  unspliced	  or	  partially	  spliced	  mRNA.	  Only	  BTZ	  seems	  to	  be	  irrelevant	  for	  this	  phenomenon	  (Shiimori	  et	  al.,	  2013).	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3.	  Aims	  of	  the	  Project	  	  The	  Exon	   Junction	  Complex	  and	   its	  components	  have	  been	  extensively	  studied.	  Much	  is	  known	  about	  the	  role	  of	  the	  EJC	  components	  in	  the	  processes	  of	  splicing,	  translation	  and	  decay.	  However,	  only	  few	  data	  are	  available	  about	  the	  role	  of	  BTZ	  inside	  the	  EJC	  or	  as	  an	  independent	  protein.	  The	  purpose	  of	  this	  project	  is	  to	  better	  define	  the	  functions	  of	  BTZ.	  First	  I	  aim	  to	  dissect	  to	  role	  of	   the	  single	  domains.	  The	  SELOR	  domain	  has	  been	  identified	  as	  the	  RNA	  binding	  and	  eIF4A3	  binding	  domain.	  SELOR	  has	  not	  been	  studied	  before	  
in	   vivo	   as	   an	   isolated	   domain.	   I	   plan	   to	   understand	   if	   some	   of	   the	   previous	  described	  functions	  of	  BTZ	  are	  recapitulated	  by	  the	  short	  SELOR	  domain	  and	  in	  addition,	  if	  these	  functions	  are	  EJC-­‐dependent	  or	  independent.	  Furthermore,	  the	  N-­‐terminus	  and	  C-­‐terminus	  of	  BTZ	  are	  not	  very	  well	  characterized;	  I	  aim	  to	  get	  a	  better	  inside	  in	  the	  role	  of	  these	  two	  regions.	  Moreover,	  to	  better	  define	  the	  role	  of	   BTZ	   in	   cells,	   I	   intend	   to	   identify	   new	   BTZ	   binding	   partners	   and	   possibly	   to	  define	  the	  BTZ	  RNA	  interactome.	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4.	  Results	  BTZ	  and	  its	  molecular	  function	  in	  cells	  has	  been	  mainly	  studied	  as	  a	  constituent	  of	   the	   EJC	   (Bono	   et	   al.,	   2006;	   Bono	   and	   Gehring,	   2011;	   Gehring	   et	   al.,	   2009a;	  Tange	  et	  al.,	  2005).	  The	  aim	  of	  this	  work	  is	  to	  further	  characterize	  the	  role	  of	  BTZ	  as	   a	   core	   component	   of	   the	   EJC	   and	   additonally	   to	   identify	   EJC-­‐independent	  functions.	   The	   results	   chapter	   is	   divided	   in	   4	   parts:	   (1)	   functions	   of	   individual	  domains	  of	  BTZ,	  (2)	  BTZ-­‐induced	  NMD,	  (3)	  BTZ	  binding	  to	  the	  RNA	  and	  (4)	  BTZ	  protein	  interactome.	  	  
4.1	  Functions	  of	  BTZ	  domains	  	  The	  BTZ	  protein	  can	  be	  divided	  in	  three	  regions:	  N-­‐terminus	  (N),	  SELOR	  domain	  (S)	   and	   C-­‐terminus	   (C)	   (see	   paragraph	   2.4.2).	   These	   regions	   have	   not	   been	  studied	  in	  isolation,	  with	  the	  exception	  of	  the	  SELOR	  domain,	  which	  plays	  a	  role	  in	  eIF4A3	  and	  RNA	  binding	  as	  previously	  described	  (see	  paragraph	  2.2).	   In	   the	  following	  paragraphs	  I	  aim	  to	  identify	  their	  specific	  functions.	  	  
4.1.1	  Reduction	  of	  mRNA	  levels	  upon	  BTZ	  mutants	  tethering	  To	   elucidate	   the	   functions	   of	   BTZ	   regions,	   several	   length	   mutants	   were	  generated.	   Besides	   the	   full-­‐length	   construct,	   which	   contains	   the	   three	  aforementioned	   regions	   (FL),	   constructs	  were	   cloned	   containing	   one	   (137-­‐286	  (S),	  286-­‐703	  (C)	  and	  1-­‐137	  (N))	  or	   two	  complete	  regions	  (137-­‐703	  (SC),	  1-­‐286	  (NS))	   or	   regions	   of	   intermediate	   size	   (NSC-­‐short,	   N-­‐long,	   S-­‐long	   and	   C-­‐short)	  (Figure	  9A).	  To	   study	   their	   function,	   eight	  of	   the	  BTZ	  constructs	  were	   selected	  and	   expressed	   in	   cultured	   human	   cells	   as	   λNV5-­‐tagged	   fusion	   proteins	   and	  thereby	   tethered	   to	   the	   co-­‐transfected	   β-­‐globin	   mRNA	   reporter	   construct	  containing	  4boxB	  binding	  site	  in	  its	  3ʹ UTR	  (Gehring	  et	  al.,	  2008).	  In	  this	  way	  the	  protein	  of	   interest	   is	  recruited	  downstream	  of	   the	  natural	  stop	  codon,	  where	   it	  can	  influence	  the	  composition	  of	  the	  mRNP.	  It	   is	  well	  established	  that	  tethering	  of	  NMD	  or	  EJC	  components	   lead	   to	  decreased	  reporter	  mRNA	   levels	  due	   to	   the	  initiation	  of	  mRNA	  decay	  (Gehring	  et	  al.,	  2008;	  Lykke-­‐Andersen	  et	  al.,	  2000).	  The	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Figure	   9.	   BTZ	   domains	   elicit	   NMD.	   (A)	   Schematic	   representation	   of	   full-­‐length	   BTZ	   and	  mutants	  (black:	  N-­‐terminus,	  white:	  SELOR,	  grey:	  C-­‐terminus	  domains).	  NSC-­‐short	  corresponds	  to	  the	  aa	  1-­‐480;	  N-­‐long	   to	   the	  aa	  1-­‐160;	  S-­‐long	   to	   the	  aa	  110-­‐372;	  C-­‐short	   to	   the	  aa	  255-­‐480.	   (B)	  Northern	  blot	  analysis	  (upper	  panel)	  of	  RNA	  samples	  extracted	  from	  HeLa	  cells	  transfected	  with	  the	   indicated	  BTZ	  mutants,	   β-­‐globin	  4boxB	   reporter	  mRNA	  and	  β-­‐globin	  wt	  300+e3	  as	   control	  mRNA	   (n=3).	   Western	   blot	   analysis	   (bottom	   panel)	   of	   the	   same	   samples	   with	   an	   anti-­‐V5	  antibody,	   anti-­‐GFP	   is	   used	   as	   transfection	   control.	   The	   asterisk	   indicates	   a	   fast	   running	   band	  detected	  only	  upon	  tethering	  of	  BTZ	  C.	  For	  the	  quantification	  in	   lane	  7	  the	  upper	  running	  band	  was	  considered.	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4.1.2	  BTZ	  C-­terminus	  activates	  polyadenylation	  When	   the	  C-­‐terminus	  of	  BTZ	  was	   tethered,	   two	   reporter	  bands	  were	  observed	  (Figure	  9B,	  lane	  7).	  In	  addition,	  the	  upper	  reporter	  band	  appeared	  to	  run	  slightly	  slower	   than	   in	   all	   other	   lanes	   (Figure	  9B,	   compare	   lane	  7	  with	   the	  others).	   To	  define	   if	   tethering	   of	   BTZ	   C	   induced	   the	   decrease	   of	   the	   reporter	   mRNA,	   the	  upper	  band	  was	  used	  for	   the	  quantification	  (Figure	  9B,	   lane	  7).	  However	  when	  the	  amounts	  of	  both	  bands	  were	  combined	  (i.e.	  upper	  and	  lower	  bands),	  66%	  of	  the	   reporter	   mRNA	   was	   still	   present	   at	   the	   steady	   state	   level.	   It	   seems	   that	  tethering	  of	  BTZ	  C	  does	  not	  degrade	  the	  reporter	  mRNA,	  but	  a	  different	  process	  occurs	  leading	  to	  the	  formation	  of	  the	  faster	  migrating	  band.	  To	  confirm	  that	  the	  two	   bands	   derived	   from	   the	   β-­‐globin	   4boxB	   reporter	   and	   that	   they	   were	   not	  unspecific	   products	   of	   the	   β-­‐globin	  wt	   300+e3	   control	  mRNA,	   the	   λNV5	  BTZ	  C	  was	  tethered	  to	  the	  reporter	  construct	   in	  absence	  of	   the	  control	  mRNA	  (Figure	  10A,	   lane	  2).	  Even	   in	   this	   condition,	   two	  bands	  were	  detected,	  one	  with	   faster,	  the	   other	  with	   slower	  motility	   compared	   to	   the	   reporter	   band	   in	   the	   negative	  control	  (Figure	  10A,	  compare	  lane	  2	  with	  lane	  1).	  The	  same	  mRNA	  samples	  that	  were	  analysed	  by	  Northern	  blotting,	  were	  used	  for	  PCR	  amplification	  and	  cloning	  into	   the	   pGEM-­‐T	   Easy	   Vector	   (Promega).	   Clones	   were	   sequenced	   using	   the	  following	   strategy.	   For	   the	   retrotranscrition	   a	   oligo(dT)	   adaptor	   primer	   was	  used	   (oPR1628).	   This	   primer	   adds	   an	   adaptor	   sequence	   5ʹ	   to	   the	   oligo(dT)	  sequence.	   This	   adaptor	   sequence	   is	   complementary	   to	   the	   antisense	   primer	  oRP1630	   used	   for	   PCR	   amplification	   (Harigaya	   and	   Parker,	   2012).	   As	   sense	  primer	   an	   internal	   globin	   primer	   was	   used.	   The	   result	   of	   the	   sequencing	   is	  schematically	   shown	   in	   Figure	  10B.	   The	  β-­‐globin	  4boxB	   reporter	   has	   a	   cryptic	  polyadenylation	  signal	  (AUUAAA,	  white	  box)	  upstream	  of	  the	  4boxB	  binding	  site	  (black	  box),	  while	  the	  canonical	  polyadenylation	  signal	  (AAUAAA,	  second	  white	  box)	   is	   downstream	   of	   4boxB	   binding	   site.	   The	   faster	   migrating	   band	   lacked	  completely	   the	  4boxB	  binding	   site	   and	  was	  polyadenylated	  downstream	  of	   the	  cryptic	  polyadenylation	  signal	  AUUAAA	  (β-­‐globin	  short).	  In	  contrast,	  the	  slower	  migrating	   band	   corresponded	   to	   the	   full-­‐length	   reporter	   β-­‐globin	   4boxB.	   A	  possible	  reason	  for	   its	  slower	  migration,	  might	  be	  a	   longer	  poly(A)	  tail,	  but	  the	  length	  of	  the	  poly(A)	  tail	  could	  not	  be	  measured	  by	  this	  experimental	  approach.	  I	  hypothesized	  that	  tethering	  of	  BTZ	  C	  to	  the	  reporter	  stimulates	  3ʹ	  end	  processing	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Figure	  10.	  BTZ	  C-­terminus	  induces	  polyadenylation	  at	  a	  cryptic	  polyadenylation	  signal.	  (A)	  Northern	  blot	   analysis	  of	  RNA	  samples	   transfected	  with	   the	   indicated	   constructs.	   In	   lane	  2	   the	  control	   mRNA	   β-­‐globin	   wt	   300+e3	   was	   omitted.	   (B)	   Schematic	   representation	   of	   β-­‐globin	  reporter	  products	  detected	  upon	  BTZ	  C	  tethering.	  In	  black	  the	  boxB	  binding	  site	  is	  shown	  while	  the	  non-­‐canonical	  polyadenylation	  site	   (AUUAAA)	  and	   the	  canonical	   (AAUAAA)	  are	  depicted	   in	  white.	  The	  3ʹUTR	  of	  the	  β-­‐globin	  4boxB	  reporter	  is	  representedin	  grey.	  (C)	  Northern	  blot	  analysis	  of	  RNA	   samples	   and	  western	  blot	   analysis	   of	   proteins	  derived	   from	  HeLa	   cells	   as	   described	   in	  Figure	  9B.	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Tethering	  of	  CFIm68	  did	  not	  alter	  the	  behavior	  of	  the	  reporter	  mRNA,	  indicating	  that	   polyadenylation	   occurs	   at	   the	   canonical	   polyadenylation	   signal.	   On	   the	  northern	   blot	   this	   band	   migrated	   at	   the	   same	   level	   of	   the	   negative	   control	  sample,	   suggesting	   that	   the	  poly(A)	   tail	   length	  was	  also	  unaltered	   (Figure	  10C,	  compare	   lane	   5	   with	   lane	   1).	   On	   the	   contrary,	   tethering	   of	   CSTF1	   and	   CSTF3	  resulted	  in	  a	  faster	  migrating	  band	  (Figure	  10C,	  compare	  lane	  3	  and	  4	  with	  lane	  1),	   suggesting	   that	   the	   upstream	   cryptic	   polyadenylation	   signal	   was	   used.	   A	  similar	  phenotype	  was	  observed	  upon	  tethering	  of	  BTZ	  C	  and	  therefore	  implies	  that	   the	   C-­‐terminus	   of	   BTZ	   is	   directly	   or	   indirectly	   involved	   in	   alternative	  polyadenylation.	  	  In	  order	  to	  investigate	  if	  this	  function	  depends	  on	  the	  interaction	  with	  the	  EJC,	  I	  tested	  the	  binding	  of	  the	  C-­‐terminal	  domain	  of	  BTZ	  to	  the	  other	  EJC	  components.	  Due	   to	   the	   low	  expression	  of	   FLAG-­‐tagged	  BTZ	  C,	   a	   shorter	   C-­‐terminal	  mutant	  was	  used,	  C-­‐short	  (Figure	  9A).	  FLAG-­‐tagged	  S-­‐long	  (see	  paragraph	  4.1.3)	  and	  C-­‐short	  expressing	  Flp-­‐In	  T-­‐REx	  293	  stable	  cell	  lines	  were	  established	  to	  facilitate	  the	  analysis	  of	  interaction	  with	  cellular	  EJC	  components.	  Endogenous	  eIF4A3	  and	  MAGOH	   served	   as	   positive	   controls	   for	   the	   EJC	   binding	   in	   co-­‐immunoprecipitation	  experiments.	  While	  S-­‐long	  co-­‐immunoprecipitated	  the	  EJC	  components,	   C-­‐short	   failed	   to	   do	   so	   (Supplementary	   figure	   S1).	   This	   is	   in	   line	  with	   previous	   observations	   showing	   that	   the	   C-­‐terminal	   domain	   of	   BTZ	   is	   not	  required	   for	   the	   EJC	   binding	   (Degot	   et	   al.,	   2004).	   Hence,	   the	   polyadenylation	  altering	  function	  of	  the	  C-­‐terminal	  domain	  of	  BTZ	  is	  EJC-­‐independent.	  This	  3ʹ	  end	  processing	   function	   of	   the	   isolated	   C-­‐terminus	   of	   BTZ	   has	   not	   been	   previously	  described	   and	   further	   analyses	   will	   be	   required	   to	   elucidate	   the	   molecular	  mechanism	  of	  this	  phenomenon.	  	  	  
4.1.3	  Point	  mutations	  in	  the	  SELOR	  domain	  affect	  NMD	  function	  So	  far,	  I	  observed	  that	  two	  independent	  regions	  of	  BTZ	  can	  induce	  the	  reduction	  of	   reporter	  mRNA	   levels,	  namely	   the	  N-­‐terminus	  and	   the	  SELOR	  domain.	  Since	  no	  structural	  information	  is	  available	  for	  the	  N-­‐terminus,	  I	  focused	  on	  the	  SELOR	  domain	  and	  aimed	  to	  identify	  the	  residues	  responsible	  for	  its	  activity.	  The	  crystal	  structure	  of	   SELOR	  bound	   to	  eIF4A3	   (Andersen	  et	   al.,	   2006;	  Bono	  et	   al.,	   2006)	  shows	   two	  main	   sites	   of	   interaction	   between	   the	   two	   proteins,	   the	   SELOR	   N-­‐
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terminal	  and	  C-­‐terminal	  binding	  sites.	  Taking	  advantage	  of	  the	  crystal	  structure,	  point	  mutations	  were	  designed	  to	  disrupt	  this	  binding.	   In	  Figure	  11A	  eIF4A3	  is	  shown	  in	  green,	  SELOR	  in	  red	  and	  the	  designed	  mutations	  of	  SELOR	  in	  blue.	  The	  residues	   for	   the	   mutational	   study	   were	   selected	   due	   to	   the	   position	   at	   the	  SELOR-­‐eIF4A3	  interface	  and	  because	  they	  were	  previously	  tested	  in	  the	  context	  of	   the	   full-­‐length	   BTZ	   (Gehring	   et	   al.,	   2009a).	   Gehring	   and	   colleagues	   showed	  that	   these	  mutations	  weaken	   the	  binding	  of	  BTZ	  with	   the	  EJC,	  but	   they	  had	  no	  effect	   on	   the	   function	   of	   the	   protein	   in	   the	   tethering	   assay,	   since	   the	   reporter	  mRNA	  levels	  were	  still	  reduced.	  I	  decided	  to	  study	  the	  effect	  of	  those	  mutations	  in	  the	  isolated	  SELOR	  domain.	  The	  mutants	  were	  cloned	  as	  λNV5-­‐tagged	  fusion	  proteins	  and	  tested	  for	  their	  ability	  to	  decrease	  the	  reporter	  mRNA	  levels	  in	  the	  tethering	  assay.	  Surprisingly,	  the	  effect	  of	  the	  mutations	  was	  more	  prominent	  in	  the	  SELOR	  domain	  alone	  than	  in	  the	  full-­‐length	  protein.	  While	  the	  mutations	  in	  the	   C-­‐terminal	   binding	   site	   (e.g.	   HD220AK)	   strongly	   affected	   or	   completely	  abolished	  the	  ability	  of	  the	  SELOR	  domain	  to	  decrease	  the	  reporter	  mRNA	  level	  in	   the	   tethering	   assay,	   the	   mutations	   in	   the	   N-­‐terminal	   binding	   site	   (e.g.	  DED173KRK)	  resulted	  in	  a	  weaker	  impairment	  of	  SELOR	  function	  (Figure	  11B).	  This	   is	   in	   line	   with	   previous	   observations	   according	   to	   which	   the	   C-­‐terminal	  binding	  site	  is	  required	  for	  the	  binding	  of	  SELOR	  and	  eIF4A3	  in	  vivo	  and	  in	  vitro,	  while	  mutations	  in	  the	  N-­‐terminal	  binding	  site,	  despite	  disrupting	  the	  interaction	  
in	  vivo,	  do	  not	  affect	  the	  in	  vitro	  binding	  (Bono	  et	  al.,	  2006).	  To	  analyze	  the	  ability	  of	  these	  mutants	  to	  interact	  with	  the	  core	  EJC	  proteins,	  I	  decided	  to	  establish	  Flp-­‐In	  T-­‐REx	  293	  cell	  lines	  expressing	  FLAG	  tagged	  SELOR	  and	  mutants.	  Since	  FLAG-­‐tagged	   SELOR	   was	   weakly	   expressed	   either	   as	   stable	   cell	   line	   or	   in	   transient	  transfection,	  a	  longer	  version,	  S-­‐long	  (Figure	  9A),	  was	  used.	  FLAG-­‐tagged	  S-­‐long	  in	  contrast	  to	  FLAG-­‐tagged	  SELOR	  could	  indeed	  be	  expressed	  in	  Flp-­‐In	  T-­‐REx	  293	  cell	  lines	  (Figure	  11C,	  lanes	  2-­‐8,	  input).	  To	  investigate	  the	  ability	  to	  assemble	  the	  EJC,	  immunoprecipitation	  of	  endogenous	  eIF4A3	  and	  MAGOH	  was	  tested.	  S-­‐long	  wt	  immunoprecipitated	  endogenous	  eIF4A3	  and	  MAGOH	  (Figure	  11C,	  lane	  2,	  IP),	  whereas	   the	   binding	   to	   eIF4A3	   and	   MAGOH	   was	   observed	   to	   be	   gradually	  weaker	  in	  the	  mutants	  DED173KRK	  and	  PR183AE	  (Figure	  11C,	  lanes	  3	  and	  4,	  IP).	  The	   binding	   was	   completely	   lost	   for	   all	   the	   other	   point	   mutants	   (Figure	   11C,	  lanes	  5-­‐8,	  IP).	  Therefore	  the	  result	  of	  the	  tethering	  assay	  in	  Figure	  11B	  is	  in	  line	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with	  the	  interaction	  data,	   indicating	  that	  SELOR	  requires	  the	  binding	  to	  the	  EJC	  in	  order	  to	  exert	  a	  function	  on	  the	  reporter	  mRNA.	  Moreover	  to	  confirm	  that	  S-­‐long	  is	  functionally	  identical	  to	  the	  shorter	  SELOR	  domain	  in	  tethering	  assays,	  I	  selected	   two	   repesentative	   mutations,	   one	   for	   each	   binding	   site,	   F188D	   and	  W218D.	   As	   expected,	   it	   was	   likewise	   observed	   that	   the	   mutation	   in	   the	   C-­‐terminal	   binding	   site	   more	   extensively	   affects	   the	   function	   of	   the	   tethered	  protein	  than	  the	  mutation	  in	  the	  N-­‐terminal	  binding	  site	  (Supplementary	  figure	  S2).	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In	   addition,	   I	   observed	   that	   S-­‐long	   F188D	   and	   S-­‐long	  W218D	   have	   a	   different	  nuclear	   localization	  compared	   to	   the	  wt	  protein.	  S-­‐long	   localizes	   to	   the	  nuclear	  speckles,	  similar	  to	  the	  other	  EJC	  components	  (Holzmann	  et	  al.,	  2000;	  Schmidt	  et	  al.,	  2009).	  The	  mutants,	  on	  the	  other	  hand,	  despite	  being	  in	  the	  nucleus,	  have	  lost	  their	   speckle	   localization,	   but	   are	   located	   diffusely	   in	   the	   entire	   nucleus	  (Supplementary	  figure	  S3).	  This	  phenotype	  is	  most	  probably	  the	  consequence	  of	  the	   inability	  of	   the	  mutants	  to	  bind	  the	  EJC	  (Figure	  11C).	  Taken	  together,	   these	  results	   show	   that	   BTZ	   induced	   mRNA	   reduction	   upon	   tethering	   is	   directly	  proportional	   to	  BTZ	  capability	   to	   form	  a	  completely	  assembled	  EJC	  with	   the	  C-­‐terminal	   binding	   site	   of	   SELOR	  playing	   a	  major	   role	   for	   this	   binding.	  A	   similar	  connection	   between	   mRNA	   degradation	   and	   EJC	   assembly	   was	   reported	   for	  mutations	  in	  MAGOH	  and	  Y14	  that	  affect	  their	  ability	  to	  be	  assembled	  in	  the	  EJC.	  Mutations,	  which	  abolished	  binding	  to	  the	  EJC,	  also	  resulted	  in	  inefficient	  mRNA	  degradation	   in	   the	   tethering	  assay	  (Gehring	  et	  al.,	  2005;	  Gehring	  et	  al.,	  2009a).	  Therefore,	  the	  reduction	  of	  mRNA	  levels	  upon	  SELOR	  tethering	  can	  be	  attributed	  to	   recruitment	   of	   EJCs	   to	   positions	   downstream	   of	   the	   stop	   codon,	   which	  ultimately	  leads	  to	  NMD	  upon	  translation	  termination.	  	  
4.1.4	   EJC	   binding	   and	   NMD	   inducing	   domains	   influence	   RNA	  
decay	  	  Hitherto	   it	   was	   shown	   that	   the	   N-­‐terminal	   region	   and	   the	   SELOR	   domain	   in	  isolation	   can	   induce	  NMD	  and	   that	   the	   SELOR	  domain	   requires	   the	   interaction	  with	  the	  EJC	  to	  induce	  NMD.	  	  I	  decided	  to	  study	  the	  effect	  of	  these	  two	  regions	  in	  combination.	   Two	   mutations	   (F188D	   and	   W218D)	   were	   selected	   for	   further	  studies,	  one	  for	  each	  binding	  site	  of	  the	  SELOR-­‐eIF4A3	  interaction.	  Flp-­‐In	  T-­‐REx	  293	   cell	   lines	   expressing	   FLAG-­‐tagged	   BTZ	   FL	   wt	   and	   the	   two	   mutants	   were	  established.	   Similarly	   to	   what	   was	   observed	   for	   the	   SELOR	   domain,	   the	   point	  mutations	  impaired	  the	  binding	  to	  the	  EJC	  (Figure	  12A).	  Interestingly,	  when	  BTZ	  FL	  F188D	  and	  W218D	  were	  tethered	  to	  the	  reporter	  β-­‐globin	  4boxB	  mRNA,	  the	  mRNA	   was	   degraded	   to	   the	   same	   extent	   as	   with	   wt	   BTZ	   (Figure	   12B).	   It	   is	  conceivable	  that	  in	  order	  to	  induce	  the	  reporter	  degradation,	  the	  full-­‐length	  BTZ	  does	   not	   require	   the	   EJC	   binding	   and	   that	   the	   N-­‐terminus	   functionally	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compensates	  the	  inability	  of	  the	  protein	  to	  be	  assembled	  in	  the	  EJC.	  To	  validate	  this	   hypothesis,	   the	  N-­‐terminus	  was	   added	   to	   the	   SELOR	   containing	   construct,	  which	  alone	  strictly	  requires	  proper	  EJC	  assembly	  for	  NMD	  activation,	  and	  BTZ	  NS	  wt	  and	  mutants	  were	  tethered	  to	  the	  mRNA	  (Figure	  12C).	  	  	  	  
	  	  	  
Figure	  12.	  NMD	  dependence	  upon	  number	  of	  NMD	  inducing	  domains	  and	  EJC	  binding.	  (A)	  WB	  analyses	  of	  full-­‐length	  BTZ	  as	  in	  Figure	  11C.	  The	  asterisk	  indicates	  an	  unspecific	  band.	  (B,	  C)	  Northern	  blot	  analysis	  of	  RNA	  samples	  and	  western	  blot	  analysis	  of	  proteins	  derived	  from	  HeLa	  cells	  as	  described	  in	  Figure	  9B.	  (D)	  Quantification	  of	  mRNA	  level	  at	  the	  steady	  state	  level	  of	  figure	  12B	  and	  C	  and	  of	  Figure	  11C,	  normalized	  to	  the	  negative	  control	  λNV5	  (100	  %).	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The	  steady	  state	  mRNA	   levels	  detected	  upon	   tethering	  of	   the	  NS	  mutants	  were	  elevated	   compared	   to	   tethering	   of	   the	   full-­‐length	   protein,	   but	   still	   reduced	  compared	  to	  the	  same	  mutations	  in	  the	  isolated	  SELOR	  domain.	  Furthermore,	   I	  noticed	  that	  comparing	  the	  wt	  proteins,	  FL,	  NS	  and	  S,	  respectively,	  1	  %,	  4	  %	  and	  9	  %	  were	  the	  mRNA	  levels	  detected	  (Figure	  12B,	  lane	  2,	  Figure	  12	  C	  lane	  2	  and	  Figure	  11B	  lane	  2),	  suggesting	  that	  the	  NMD	  induction	  was	  increased	  when	  the	  tethered	  protein	  was	  longer.	  It	   is	  possible	  to	  conclude	  that	  the	  activation	  of	  the	  NMD	  by	  BTZ	  depends	  on	   two	  determinants:	   the	  presence	  of	   the	  NMD	  inducing	  domains,	   SELOR	   and	   N-­‐terminal	   region,	   and	   the	   ability	   to	   associate	   with	   the	  other	   EJC	   components.	   The	   SELOR	   domain	   mediates	   this	   association,	   for	   this	  reason	   the	   mutants	   containing	   the	   N-­‐terminus	   (FL	   and	   NS)	   are	   less	   sensitive	  than	  SELOR	  to	  the	  F188D	  and	  W218D	  mutations	  (Figure	  12D).	  	  
4.1.5	  Conservation	  of	  the	  SELOR	  domain	  in	  different	  species	  The	  EJC	  core	  components	  are	  highly	  conserved	  even	  between	  distant	  species	  like	  Human,	  Drosophila	  and	  C.elegans.	  Two	  regions	  of	  BTZ	  are	  conserved	  between	  the	  three	  species:	  aa	  173-­‐192	  and	  aa	  218-­‐244	  (in	  the	  human	  sequence),	  comprising	  most	  of	  the	  SELOR	  domain.	  Indeed	  these	  are	  the	  same	  two	  stretches	  responsible	  for	   eIF4A3	  binding	   (Bono	   et	   al.,	   2006)	   (Figure	   13A).	   In	   human	  Drosophila	   and	  
C.elegans	   NMD	   exists,	   but	   the	   molecular	   mechanism	   of	   NMD	   activation	   is	  different.	  Although	  in	  mammals	  NMD	  can	  be	  activated	  by	  the	  EJC,	  in	  C.elegans	  EJC	  is	   dispensable	   while	   contradicting	   results	   were	   reported	   for	   Drosophila	   (see	  paragraphs	   2.3	   and	   2.5).	   To	   study	   if	   the	   three	   orthologues	   are	   functionally	  similar,	  I	  tethered	  human	  (aa	  110-­‐372),	  Drosophila	  (aa	  64-­‐270)	  and	  C.elegans	  (aa	  36-­‐203)	   SELOR	   to	   the	   β-­‐globin	   4	   boxB	   reporter	   to	   observe	   the	   effect	   of	   these	  proteins	   in	   the	   human	   cells.	   Human	   SELOR	   served	   as	   positive	   control	   for	   EJC	  binding	  (Figure	  13C,	  lane	  2)	  and	  for	  inducing	  EJC-­‐dependent	  NMD	  as	  showed	  in	  Figure	  11.	  The	  Drosophila	  protein	  induced	  the	  degradation	  of	  the	  reporter	  RNA	  to	   levels	   comparable	   to	   tethered	   human	   SELOR	   (Figure	   13B,	   compare	   lanes	   2	  and	   3).	   Interestingly,	   the	   Drosophila	   SELOR	   protein	   was	   able	   to	  immunoprecipitate	   human	   eIF4A3	   (Figure	   13C,	   lane	   3).	   On	   the	   contrary	  
C.elegans	  SELOR	  was	  not	  able	  to	  induce	  mRNA	  reporter	  degradation	  (Figure	  13B,	  lane	  4)	  nor	   to	   immunoprecipitate	  human	  EJC	  components	  (Figure	  13C,	   lane	  4).	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Although	   the	   SELOR	   domain	   is	   conserved	   in	   the	   three	   species,	   human	   and	  





Figure	   13.	   BTZ	   orthologues	   are	   not	   functionally	   identical	   (A)	   Alignment	   of	   Human	   (Hs),	  
D.melanogaster	   (Ds)	   and	   C.elegans	   (Ce)	   BTZ.	   Conserved	   aa	   are	   marked	   in	   red.	   Above	   the	  alignment,	   yellow	   circles	   indicate	   residues	   required	   for	   eIF4A3	   binding,	   black	   circle	   for	   RNA	  binding	   and	   blue	   circles	   for	   MAGO	   binding.	   Black	   squares	   indicate	   tested	   positions	   where	  mutations	   affect	   protein-­‐protein	   interactions	   (Ballut	   et	   al.,	   2005).	   The	   figure	   is	   adapted	   from	  Bono	   et	   al.,	   2006.	   (B)	   Northern	   blot	   analysis	   of	   RNA	   samples	   and	   western	   blot	   analysis	   of	  proteins	   derived	   from	   HeLa	   cells	   as	   described	   in	   Figure	   9B.	   (C)	   WB	   analyses	   of	   human,	  
D.melanogaster	  and	  C.elegans	  SELOR,	  FLAG	  tagged	  transfected	  in	  HeLa	  cells.	  Endogenous	  eIF4A3	  and	  MAGOH	  were	  detected	  with	  specific	  antibodies.	  	  	  
4.2	  BTZ-­induced	  NMD	  The	   full-­‐length	  BTZ	   induces	  NMD	  when	   tethered	  downstream	  of	   a	   stop	   codon.	  The	  isolated	  SELOR	  domain	  (S)	  and	  the	  small	  N-­‐terminus	  (N)	  retain	  this	  function	  (Figure	  9B).	  My	  aim	  is	  to	  identify	  the	  specific	  pathways	  activated	  upon	  tethering	  of	  BTZ	  and	  its	  deletion	  mutants.	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4.2.1	  BTZ	  domains	  induce	  NMD	  via	  different	  pathways	  Heretofore	  I	  showed	  that	  NMD	  could	  be	  triggered	  by	  the	  SELOR	  domain	  and	  by	  the	  N-­‐terminal	   region.	  When	   tethered	   to	   the	  mRNA,	   they	   activate	   a	   cascade	   of	  reactions	   that	   terminate	   with	   the	   degradation	   of	   the	   reporter	   mRNA.	   Starting	  from	  the	  tethered	  protein,	  two	  pathways	  have	  been	  described	  for	  the	  activation	  of	  NMD,	  BTZ-­‐dependent	  and	  UPF2-­‐dependent	  pathway.	  The	  first	  one	  is	  mediated	  by	   a	   fully	   assembled	   EJC,	   the	   second	   one	   is	   EJC-­‐independent	   (Gehring	   et	   al.,	  2005)(see	  paragraph	  2.4.2).	  I	  performed	  UPF2	  knockdown	  to	  estabilish	  if	  SELOR	  and	  N-­‐terminus	  NMD	  require	  UPF2	  protein.	  In	  UPF2	  knockdown	  cells,	  the	  UPF2	  protein	   levels	   were	   reduced	   to	   less	   than	   10%,	   as	   shown	   by	   immunoblotting	  (Figure	  14A).	  	  	  	  
	  	  	  
Figure	   14.	   UPF2	   (in)dependent	   NMD.	   (A)	   siRNA	   knockdown	   of	   UPF2	   in	   human	   cell	   culture.	  HeLa	   cells	   were	   transfected	  with	   siRNAs	   targeting	   UPF2	   or	   Luciferase	   (negative	   control).	   The	  knockdown	   efficiency	   was	   assessed	   by	   immunoblotting	   with	   an	   UPF2-­‐specific	   antibody.	   Actin	  served	  as	  a	  loading	  control.	  (B)	  Northern	  blot	  (upper	  panel)	  of	  RNA	  samples	  extracted	  from	  HeLa	  cells	   transfected	   with	   the	   indicated	   siRNAs	   and	   constructs.	   Co-­‐transfected	   β-­‐globin	   wt300+e3	  served	   as	   control	  mRNA	   and	   β-­‐globin	   4	   boxB	   as	   reporter	  mRNA	   (n=3).	  Western	   blot	   analysis	  (bottom	  panel)	  was	  performed	  as	  in	  Figure	  9B.	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Upon	  control	  knockdown	  of	  Luciferase	  (Luc),	   the	  BTZ	  FL,	  as	  well	  as	  BTZ	  S	  and	  BTZ	   N	   stimulated	   degradation	   of	   the	   reporter	   mRNA	   comparable	   to	   earlier	  results	  without	  knockdown	  (compare	  figure	  9B,	  lanes	  2,6	  and	  9	  with	  figure	  14B,	  lanes	  2-­‐4).	  Upon	  depletion	  of	  UPF2,	  BTZ	  FL	  retained	  its	  ability	  to	  induce	  NMD	  in	  agreement	   with	   Gehring	   at	   al.,	   2005	   (Figure	   14B,	   lane	   6).	   Interestingly,	   the	  knockdown	   of	   UPF2	   did	   not	   influence	   the	   degradation	   of	   reporter	   mRNA	   by	  tethered	  BTZ	   S,	  while	  BTZ	  N	   completely	   lost	   its	   ability	   to	   induce	  NMD	   (Figure	  14B,	   lanes	  7	  and	  8).	  This	   finding	  suggests	  that	  the	  two	  NMD	  inducing	  domains,	  SELOR	   and	   N-­‐terminus,	   can	   in	   isolation	   induce	   NMD	   via	   two	   independent	  pathways,	  one	  via	  the	  assembly	  of	  a	  functional	  EJC	  (SELOR),	  the	  other	  via	  UPF2	  (BTZ	  N).	  	  
	  
4.2.2	  XRN1-­dependent	  degradation	  To	  define	  how	  BTZ	  S	  and	  BTZ	  N	  lead	  to	  the	  degradation	  of	  the	  reporter	  mRNA,	  I	  followed	   the	   cascade	   of	   reactions	   that	   they	   activate.	   Both	   pathways,	   EJC-­‐dependent	  and	  UPF2-­‐dependent	  rejoin	  at	  the	  step	  of	  UPF1	  recruitment	  (Gehring	  et	   al.,	   2005).	   The	   events	   that	   follow	   UPF1	   recruitment	   culminate	   in	   the	  degradation	   of	   the	   mRNA.	   SMG6	   is	   responsible	   of	   the	   endocleavage	   at	   the	  termination	   codon,	  which	   is	   stimulated	  by	   the	  presence	  of	  EJCs	  or	  by	   tethered	  EJC	  components	  (see	  paragraph	  2.3).	  Two	  fragments	  are	  generated,	  of	  which	  the	  3ʹ	   fragment	   can	   be	   stabilized	   by	   depletion	   of	   the	   5ʹ-­‐3ʹ	   endonuclease	   XRN1	   (V	  Boehm,	  N	  Haberman,	   F	   Ottens,	   J	   Ule	   and	  NH	  Gehring,	   in	   press).	   Two	   different	  reporters	  were	  used	  to	  detect	   the	  specificity	  of	   the	  3ʹ	   fragment	   formation:	  TPI-­‐4MS2-­‐SMG5	   and	   TPI-­‐SMG5.	   The	   triosephosphate	   isomerase	   (TPI)	   gene	   was	  modified	   by	   the	   addition	   of	   1037	   nt	   of	   the	   SMG5	   3ʹUTR	   (such	   long	   sequence	  increase	  the	  detection	  of	  the	  3ʹ	   fragment,	  data	  not	  shown).	  4	  copies	  of	  a	  100	  nt	  sequence	   of	   β-­‐globin	   third	   exon	   and	   3ʹ	   UTR	   were	   included	   to	   enhance	   the	  detection	   by	   the	   northern	   blotting.	   The	  4MS2	  binding	   sites	   in	  TPI-­‐4MS2-­‐SMG5	  enable	  to	  distinguish	  between	  the	  specific	  effect	  of	  the	  tethered	  protein	  and	  the	  unspecific	   effect	   due	   to	   the	   protein	   overexpression	   (V	   Boehm,	   N	   Haberman,	   F	  Ottens,	  J	  Ule	  and	  NH	  Gehring,	  in	  press)	  (Figure	  15A).	  In	  XRN1	  knockdown	  cells,	  the	   XRN1	   protein	   levels	   were	   reduced	   to	   less	   than	   10%,	   as	   shown	   by	  immunoblotting	  (Figure	  15B).	  In	  Luc	  KD	  cells,	  a	  reduction	  of	  the	  reporter	  (TPI-­‐
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4MS2-­‐SMG5)	  mRNA	  was	   observed	   for	   all	   three	   tethered	   variants	   (Figure	   15C,	  lanes	   2-­‐4).	   In	   XRN1	   KD	   cells	   when	   BTZ	   full-­‐length,	   BTZ	   S	   and	   BTZ	   N	   were	  tethered,	  the	  3ʹ	  fragment	  generated	  from	  the	  TPI-­‐4MS2-­‐SMG5	  reporter	  construct	  specifically	  appeared	  in	  comparison	  to	  the	  control	  (Figure	  15C,	  lanes	  5-­‐8).	  	  	  	  
	  
	  
Figure	   15.	   XRN1	   dependent	   3ʹ	   fragment	   formation.	   (A)	   Schematic	   representation	   of	   the	  triosephosphate	   isomerase	   (TPI)	   reporter	   constructs.	   Exons	   are	  depict	   as	  white	   boxes	   and	   the	  connecting	   introns	   as	   black	   lines.	   Northern	   probe	   binding	   sites	   as	  white	   boxes	  without	   intron	  lines.	  MS2-­‐binding	  is	  shown	  as	  a	  black	  box	  and	  SMG5	  3′	  UTR	  is	  depicted	  as	  a	  gray	  box	  (B)	  Same	  as	  in	   figure	   14A	   for	   siRNA	   targeting	   XRN1.	   (C-­‐D)	   Northern	   blot	   (upper	   panel)	   of	   RNA	   samples	  extracted	  from	  HeLa	  cells	  transfected	  with	  the	  indicated	  siRNAs	  and	  constructs.	  Co-­‐transfected	  β-­‐globin	   wt	   served	   as	   control	   mRNA	   and	   TPI	   4MS2	   as	   reporter	   mRNA.	   The	   position	   of	   the	   3ʹ	  fragment	  is	  indicated	  (n=3).	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It	   was	   previously	   shown	   that	   tethered	   EJC	   components	   could	   lead	   to	  endocleavage	   at	   the	   termination	   codon	   and	   the	   generation	   of	   3ʹ	   fragments	   (V	  Boehm,	  N	  Haberman,	  F	  Ottens,	  J	  Ule	  and	  NH	  Gehring,	  in	  press).	  The	  3ʹ	  fragment	  generation	   upon	   BTZ	   N	   tethering	  was	   surprising	   considering	   that	   this	  mutant	  does	  require	  other	  EJC	  proteins	  to	  induce	  NMD	  (Figure	  14B).	  To	  confirm	  that	  the	  generation	   of	   the	   3ʹ	   fragment	   is	   not	   an	   unspecific	   consequence	   of	   the	   over	  expression	   of	   BTZ	   N,	   two	   different	   reporters,	   TPI-­‐4MS2-­‐SMG5	   and	   TPI-­‐4MS2,	  were	   compared,	   of	  which	  TPI-­‐4MS2	  does	  not	   contain	   the	   tethering	   site	   for	   the	  protein	   (Figure	   15A).	   The	   effect	   of	   BTZ	   N	   is	   indeed	   specific,	   because	   no	   3ʹ	  fragment	  generation	  was	  detected	  with	  TPI-­‐4MS2	  (Figure	  15D).	  Taken	  together,	  my	   results	   show	   that	   BTZ,	   as	   well	   as	   the	   SELOR	   domain,	   induces	   NMD	   in	   an	  UPF2-­‐independent	  manner.	   In	   contrast,	   the	  N-­‐terminus	   requires	  UPF2	   to	   elicit	  NMD	  (Figure	  14B).	  Altough	  the	  specific	  NMD	  activating	  pathways	  are	  different,	  the	  involvement	  of	  UPF1	  and	  the	  recruitment	  of	  the	  SURF	  complex	  is	  common	  to	  both	   (Kashima	  et	   al.,	   2006),	   leading	   to	   the	  degradation	  of	   the	   substrate	  mRNA	  (Figure	  15C).	  
 	  
4.3	  BTZ	  binding	  to	  the	  RNA	  	  In	  addition	   to	   the	  EJC-­‐interacting	   function,	   the	  SELOR	  domain	  of	  BTZ	  has	  been	  reported	   to	   directly	   bind	   the	   mRNA.	   BTZ	   has	   been	   originally	   identified	   as	  component	  of	  mRNPs	   in	  vivo.	  Additionally	   it	  was	  shown	  that	   in	  vitro	   translated	  BTZ	   bound	   selectively	   poly	   G	   and	   poly	   U	   oligonucleotides	   immobilized	   on	  agarose	   beads	   (Degot	   et	   al.,	   2004).	  Moreover	   Ballut	   and	   colleagues	   showed	   in	  2005	  that	  in	  vitro	  purified	  SELOR	  domain	  could	  be	  crosslinked	  to	  a	  synthetic	  32P	  end-­‐labeled	   44-­‐mer	   RNA.	   However	   in	   vivo,	   BTZ	   RNA	   interactome	   has	   not	   yet	  been	   defined.	   Interestingly	   would	   be	   the	   identification	   of	   the	   RNA	   binding	  partnerns	  of	  the	  wt	  and	  EJC	  impaired	  proteins,	   in	  order	  to	  distinguish	  between	  the	  EJC-­‐dependent	  and	  –independent	  interactome.	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Figure	  16.	  PABPC	  binding	   to	  A25	  RNA.	   (A)	  5nM	  of	  γ32P-­‐ATP	  phosphorylated	  A25	  RNA	  were	  incubated	  with	  increasing	  amount	  of	  purified	  PABPC	  (0,	  10,	  50,	  100,	  1000	  nM).	  Electrophoretic	  shift	  was	  observed	  at	  the	  highest	  protein	  concentration.	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Figure	  17.	   S-­long	   and	  PABP	  binding	   to	   the	  RNA.	   (A)	   5nM	  of	  A25	  RNA	  were	   incubated	  with	  increasing	  amount	  of	  purified	  S-­‐long	  and	  PABP	  (0,	  100,1000,	  10000	  nM).	   (B)	  Same	  as	   in	  A,	   for	  
γ32P-­‐ATP	  phosphorylated	  U27	  RNA.	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In	   contrast,	   PABPC	   interacted	   with	   the	   U27	   RNA	   probe,	   with	   much	   weaker	  affinity	   compared	   to	   the	   A25	   probe	   (compare	   figure	   17B,	   lanes	   7	   and	   8,	   with	  figure	  17A,	  lanes	  7	  and	  8).	  Of	  note,	  in	  both	  experiments	  (Figure	  17A,	  lanes	  3	  and	  4	  and	  figure	  17B	  lanes	  3,	  4,	  7	  and	  8),	   the	  amount	  of	   total	  probe	  (free	  +	  bound)	  was	   reduced	   at	   high	   concentration	   of	   the	   proteins	   compared	   to	   the	  corresponding	  negative	  control,	  but	   this	  phenomenon	  would	  require	  a	  more	   in	  depth	   analyses.	   The	   supershift	   observed	   with	   S-­‐long	   and	   the	   U27	   RNA	   might	  derive	  from	  the	  assembly	  of	  a	  high	  molecular	  weight	  complex	  formed	  of	  multiple	  proteins	   and	  RNAs.	  To	  validate	   this	  hypothesis	   the	   experiment	  was	  performed	  incubating	   S-­‐long	   with	   either	   A25	   or	   U27	   RNA	   probe.	   Each	   condition	   was	  performed	   in	  duplicate,	  so	   that	  after	   the	   incubation	  one	  half	  of	   the	  sample	  was	  loaded	  on	  a	  EMSA	  native	  gel	  (Figure	  18A,	  upper	  panel),	  while	  the	  other	  half	  was	  UV	   crosslinked	   at	   254	   nm	   and	   loaded	   on	   a	   12%	   SDS	   gel	   (Figure	   18,	   bottom	  panel).	  When	  S-­‐long	  was	  incubated	  with	  U27	  and	  then	  crosslinked	  to	  the	  probe,	  the	   formation	   of	   two	   protein-­‐RNA	   complexes	   with	   different	   molecular	   weight	  was	  observed.	  	  	  
	  	  
	  
Figure	  18.	   S-­long	   forms	  a	   super	  complex	  with	   the	  RNA	  probe	   (A)	  5nM	  of	  RNA	  probe	  were	  incubated	  with	   increasing	  amount	  of	  purified	  S-­‐long	   (0,	  100,1000,	  10000	  nM)	  and	   loaded	  on	  a	  native	   gel	   (upper	   panel)	   or	   UV	   crosslinked	   at	   254nm	   and	   loaded	   on	   a	   12%	   SDS	   gel	   (bottom	  panel).	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The	   ratio	   between	   these	   complexes	   changed	   according	   to	   the	   protein	  concentration:	   at	   10000	   nM	   of	   S-­‐long	   the	   higher	   molecular	   weight	   (MW)	  complex	   was	   more	   prominent	   (Figure	   18A,	   compare	   lane7	   with	   8).	   This	  phenomenon	   was	   clearly	   visible	   when	   S-­‐long	   was	   incubated	   with	   U27,	   but	   a	  weaker	   signal	   was	   detected	   with	   A25	   as	   well	   (Figure	   18A,	   lanes	   3	   and	   4).	  Summarizing	   the	   results	   obtained	   so	   far,	   S-­‐long	   showed	   differential	   and	  sequence	   specific	   binding	   affinities	   to	   the	   RNAs	   utilized,	   with	   preferential	  binding	  of	  poly(U)	  over	  poly(A)	   (Figure	  17A	  and	  B).	  This	   indicates	   that	  BTZ	   is	  not	   an	   unspecific	   RNA	   binding	   protein,	   but	   selectively	   binds	   certain	   mRNA.	  Moreover	   I	   could	   show	   that	   S-­‐long	   forms	   high	  molecular	  weight	   complexes	   in	  which	   more	   proteins	   and/or	   RNAs	   are	   involved	   (Figure	   18A),	   indicating	   a	  possible	  multimerization	  of	  BTZ	  on	  the	  mRNA.	  	  
4.3.2	  in	  vivo	  RNA	  binding	  My	  results	  so	  far	  raise	  the	  question	  how	  the	  NMD	  activation	  by	  BTZ	  is	  regulated	  in	   living	  cells.	   I	  have	  observed	  that	   in	  vitro	  S-­‐long	  shows	  a	  preferential	  binding	  for	  certain	  mRNAs	  and	  previous	  reports	  suggested	  that	  BTZ	  can	  directly	  interact	  with	  RNA	  in	  vitro	  in	  the	  absence	  of	  any	  other	  EJC	  component	  (Degot	  et	  al.,	  2004).	  To	   gain	   insight	   into	   RNA	   binding	   by	   BTZ	   in	   vivo,	   I	   used	   Flp-­‐In	   T-­‐REx	   293	   cell	  lines,	  which	   express	   the	   S-­‐long	   protein	   as	  wildtype	   or	   as	   EJC-­‐binding	   deficient	  mutants	  F188D	  and	  W218D.	  I	  performed	  crosslinking	  and	  immunoprecipitation	  to	   RNAs	   (CLIP)	   in	   living	   cells	   as	   readout	   for	   RNA	   binding.	   The	   CLIP	   allows	   to	  identify	  RNA	  sites	  in	  direct	  contact	  with	  a	  RNA	  binding	  protein	  (Ule	  et	  al.,	  2005).	  Following	  the	  protocol,	  a	  FLAG-­‐immunoprecipitation	  was	  performed	  on	  the	  UV	  crosslinked	  cell	  lysate,	  thereby	  the	  RNA	  bound	  to	  the	  FLAG	  tagged	  protein	  will	  be	  co-­‐immunoprecipitated,	  γ32P-­‐ATP	  phosphorylated	  and	  subsequently	  detected	  by	  SDS-­‐PAGE.	  As	  negative	  control	  a	  cell	  line	  expressing	  non-­‐fused	  FLAG	  was	  used.	  In	  the	  control	  cells	  no	  signal	  was	  observed	  after	  crosslinking	  and	  IP,	  confirming	  the	  specificity	   of	   the	   approach	   (Figure	   19A,	   lane	   1	   and	   2).	   A	   strong	   signal	   was	  detected	  for	  S-­‐long	  wt	  (Figure	  19A,	  upper	  panel,	   lane	  4),	  whereas	  the	  signals	  of	  W218D	  and	  F188D	  mutants	  were	  markedly	   reduced	   (Figure	  19A,	  upper	  panel,	  compare	   lanes	   6	   and	   8	  with	   4).	   Hence,	   the	   reduced	   ability	   of	   both	  mutants	   to	  
Results	  
	   45	  
bind	   to	   RNA	   in	   living	   cells	   suggests	   that	   S-­‐long	   interacts	  with	   RNAs	  mainly	   as	  part	   of	   the	   EJC.	   I	   aimed	   to	   confirm	   these	   results	   with	   full-­‐length	   BTZ.	   After	   a	  short	   UV	   exposure	   BTZ	   was	   very	   inefficiently	   crosslinked	   to	   the	   RNA	   (Figure	  19B,	  lanes	  2-­‐4)	  when	  compared	  to	  the	  amount	  of	  crosslinked	  S-­‐long	  (Figure	  19A,	  upper	  panel,	  lane	  4).	  In	  addition,	  prolonged	  UV	  irradiation,	  aimed	  to	  increase	  the	  crosslinking	   efficiency,	   resulted	   instead	   in	   a	   reduced	   crosslinking	   efficiency	  (Figure	  19B,	  upper	  panel,	   lanes	  5	  and	  6)	  probably	  due	  to	  destabilization	  of	   the	  protein	  (Figure	  19B,	  bottom	  panel,	  lanes	  5	  and	  6).	  	  	  	  
	  	  
	  
Figure	  19.	  BTZ	  in	  vivo	  binding	  to	  the	  RNA	  (A)	  Flp-­‐In	  T-­‐REx	  293	  cell	  lines	  expressing	  FLAG,	  S-­‐long,	  W218D	  and	  F188D	  were	  subjected	  to	  UV	  crosslinking	  (+)	  or	  not	  (-­‐).	  mRNA	  was	  labeled	  with	  
γ32P-­‐ATP	   (upper	   panel).	   FLAG-­‐tagged	   S-­‐long	   was	   detected	   with	   an	   anti-­‐FLAG	   antibody	   by	  immunoblotting	  prior	   to	   labeling	   (bottom	  panel).	   (B)	   Same	  as	   in	  A	   for	  FLAG-­‐tagged	   full-­‐length	  BTZ,	  increasing	  UV	  crosslinking	  intensities	  are	  shown.	  (C)	  Same	  as	  in	  A	  for	  NSC-­‐short	  and	  S-­‐long	  (D)	   Flp-­‐In	   T-­‐REx	   293	   cell	   lines	   expressing	   FLAG,	   S-­‐long	   and	   hn	   RNP	   C	   were	   subjected	   to	   UV	  crosslinking.	  Two	  different	  RNA	  dilutions	  were	  used,	  1:50	  (L)	  and	  1:500	  (H).	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Nevertheless,	  the	  strong	  RNA	  crosslink	  of	  the	  C-­‐terminally	  truncated	  BTZ	  (NSC-­‐short)	  and	  the	  shorter	  S-­‐long	  mutant	  (Figure	  19C,	   lane	  2	  and	  4)	  suggested	  that	  the	  C-­‐terminal	  part	   of	  BTZ	  prevented	   its	   efficient	   crosslinking	   to	  RNA	   in	   living	  cells.	   Considering	   that	   S-­‐long	   could	   be	   more	   efficiently	   crosslinked	   than	   full-­‐length	  BTZ,	  I	  decided	  to	  use	  it	  for	  mapping	  the	  transcriptome	  wide	  binding	  sites.	  However	   several	   attempts	   to	  obtain	   a	   library	  of	  mRNA	  bound	  by	  S-­‐long	   failed.	  The	  RNA-­‐binding	  protein	  hnRNP	  C	  (Huang	  et	  al.,	  1994)	  has	  been	  previously	  used	  in	   iCLIP	  experiments	  due	   to	   its	   strong	  affinity	   for	  RNA	   (Huppertz	  et	   al.,	   2014).	  Comparing	  the	  binding	  of	  hnRNP	  C	  and	  S-­‐long	  to	  the	  RNA,	  I	  observed	  that	  S-­‐long	  was	   less	   efficientely	   crosslinked	   to	   the	  mRNA	   (Figure	  19	  D).	   Such	   limited	  RNA	  binding	  is	  most	  probably	  the	  reason	  why	  it	  was	  not	  possible	  to	  identify	  the	  RNA	  bound	  by	  BTZ.	  	  
4.4	  BTZ	  protein	  interactome	  To	   identify	   specific	   interaction	  partners	   of	  BTZ	   and	   in	  particular	   of	   the	   SELOR	  domain,	   I	   performed	   a	   mass	   spectrometry	   analysis	   (MS)	   of	   FLAG-­‐tagged	   full-­‐length	  BTZ	  and	  S-­‐long	  in	  Flp-­‐In	  T-­‐REx	  293	  cell	  lines.	  I	  compared	  FLAG-­‐BTZ	  and	  FLAG-­‐S-­‐long	  with	  their	  corresponding	  W218D	  mutants	  (Figures	  11C	  and	  12A)	  to	  specifically	   identify	  EJC-­‐dependent	   interaction	  partners	  of	  both	  proteins.	   In	   the	  MS	  IP,	  each	  single	  protein	  was	  identified	  with	  a	  certain	  number	  of	  peptides	  and	  a	  specific	  concentration.	  The	  proteins	  were	  selected	  according	  to	  the	  relative	  fold	  increase	  (the	  ratio	  between	  the	  concentration	  of	  a	  certain	  protein	  in	  the	  wt	  and	  the	  mutant	   IP)	   and	   only	   the	   proteins	   that	  were	   identified	  with	  more	   than	   one	  peptide	  were	   considered.	  Among	   the	  most	  highly	   enriched	  proteins	   in	   S-­‐long	   I	  found	  all	  EJC	  core	  proteins	  (MAGOH,	  Y14,	  eIF4A3),	  confirming	  the	  specificity	  of	  the	   approach	   (Fig.	   20A).	   Furthermore,	   several	   of	   the	   previously	   identified	  peripheral	  EJC	  proteins,	  many	  spliceosomal	  proteins,	  such	  as	  components	  of	  the	  nineteen	   complex	   (NTC)	   or	   the	   U2	   snRNP,	   and	   several	   members	   of	   the	   SR	  protein	   family	  were	   enriched	   in	   the	   interactome	   of	   FLAG-­‐S-­‐long	   (Fig.	   20A).	   In	  order	  to	  define	  the	  functions	  of	   the	  enriched	  proteins,	   I	  performed	  a	   functional	  annotation	  search	  using	  DAVID	  (Huang	  da	  et	  al.,	  2009a,	  b),	  considering	  only	  the	  proteins	   that	  were	   enriched	  more	   than	   two	   fold.	   Figure	   20B	   shows	   the	   result	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obtained	  for	  the	  S-­‐long	  interactome,	  while	  similar	  results	  were	  obtained	  for	  the	  BTZ	  FL	  interactome.	  Most	  of	  the	  interacting	  partners	  are	  involved	  in	  processes,	  for	  which	  BTZ	  was	  already	  described	  to	  be	  part	  of,	  such	  as	  transcription,	  splicing,	  spliceosome	  assembly,	  RNA	  processing	  or	  NMD	  (Ciriello	  S,	  Boehm	  V.	  and	  Gehring	  N.H.,	  in	  preparation).	  	  	  
	  	  	  
Figure	  20.	  Selected	  S-­long	  binding	  partners.	  (A)	  Selection	  of	  proteins	  interacting	  with	  S-­‐long	  as	  identified	  by	  mass	  spectrometry.	  Increase	  denotes	  the	  enrichment	  in	  wt	  versus	  mutant	  (218)	  complexes.	  Different	  categories	  of	  proteins	  are	  shown	  in	  different	  colors	  (EJC	  component:	  yellow;	  NMD	  factors:	  green;	  EBM-­‐containing	  proteins:	  blue;	  U2snRNP	  components:	  pink;	  NTC	  complex:	  orange;	  SR	  proteins:	  red)	  1These	  proteins	  were	  identified	  only	  in	  S-­‐long	  wt,	  but	  not	  in	  the	  mutant	  218.	  (B)	  Functions	  of	  the	  proteins	  enriched	  more	  then	  two	  times	  in	  S-­‐long	  IP.	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4.4.1	  SRSF	  proteins	  contribute	  to	  NMD	  In	   order	   to	   assess	   the	   functional	   importance	   of	   these	   interactomes,	   I	   further	  characterized	   the	   serine/arginine-­‐rich	   (SR)	   proteins	   that	   were	   found	   to	   be	  enriched	   in	   S-­‐long	   interactome.	   SRSF	   proteins	   contain	   in	   their	   N-­‐terminal	  domain	  one	  or	  two	  RRMs,	  with	  which	  they	  bind	  to	  mRNA	  (Dreyfuss	  et	  al.,	  2002;	  Singh	  and	  Valcarcel,	  2005)	  and	  a	  C-­‐terminal	  domain	  rich	  in	  serines	  and	  arginines	  (Long	  and	  Caceres,	  2009).	  They	  are	  loaded	  on	  the	  mRNA	  cotranscriptionally	  and	  exported	  with	  the	  mRNA	  to	  the	  cytoplasm;	  in	  particular	  SRSF1,	  SRSF3	  and	  SRSF7	  interact	   with	   mRNA	   export	   factors	   and	   promote	   transport	   of	   mRNAs	   to	   the	  cytoplasm	  (Huang	  and	  Steitz,	  2005).	  Moreover	  they	  are	  known	  regulators	  of	  the	  splicing	   process	   (Zhou	   and	   Fu,	   2013)	   and	   the	   overexpression	   of	   SRSF1	  contributes	   to	   NMD,	   enhancing	   the	   degradation	   of	   PTC	   expressing	   reporter	  mRNA	   (Zhang	   and	   Krainer,	   2004).	   Singh	   and	   colleagues	   (Singh	   et	   al.,	   2012)	  proposed	   that	   endogenous	  EJCs	  multimerize	  with	   each	   another	   and	  with	   SRSF	  proteins	   to	   form	   megadalton	   sized	   complexes	   in	   which	   SRSF	   proteins	   are	  stoichiometric	  (SRSF9,	  SRSF10,	  SRSF12)	  or	  super-­‐stoichiometric	  (SRSF1,	  SRSF3	  and	  SRSF7)	  to	  EJC	  core	  factors	  (multimeric	  EJCs).	  In	  this	  complex	  the	  EJC	  and	  the	  SRSFs	   collaborate	   to	   form	   higher-­‐order	  mRNP	   structures,	  which	  may	   facilitate	  overall	   mRNA	   packaging	   and	   compaction	   (Singh	   et	   al.,	   2012).	   In	   the	  immunprecipitation	   presented	   here,	   the	   core	   EJC	   components	   represented	   the	  most	  prominent	  bands	  on	  silver-­‐stained	  gels	  of	  my	  immunoprecipitated	  samples	  and	  I	  could	  not	  detect	  any	  other	  proteins	  with	  the	  same	  intensity	  (Figure	  21A).	  Therefore,	  the	  precise	  abundance	  and	  stochiometry	  of	  SRSF	  proteins	  in	  purified	  EJCs	  needs	  to	  be	  evaluated	  in	  future	  studies.	  Previously,	  SRSF1	  has	  been	  studied	  in	  the	  context	  of	  NMD,	  whereas	  other	  members	  of	  the	  SRSF	  protein	  family	  have	  not	   been	   systematically	   analyzed.	   Therefore,	   I	   used	   the	   tethering	   assay	   to	  investigate	  the	  effects	  of	  SRSF1,	  2,	  3,	  6	  and	  7.	  Variable	  levels	  of	  reporter	  mRNAs	  were	   detected	   upon	   tethering	   of	   different	   SRSF	   proteins.	   The	   strongest	  downregulation	  of	  the	  reporter	  mRNA	  was	  observed	  when	  SRSF1	  or	  SRSF7	  were	  tethered	  (Figure	  20B,	  upper	  panel,	   lanes	  2	  and	  6),	  despite	  SRSF7	  being	  weakly	  expressed	  (Figure	  20B,	  lane	  6,	  bottom	  panel).	  A	  moderate	  downregulation	  of	  the	  reporter	  mRNA	  was	  elicited	  by	  SRSF2	  and	  SRSF6	  (Figure	  20B,	  upper	  panel,	  lanes	  3	  and	  5),	  the	  latter	  showing	  a	  very	  weak	  expression.	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Figure	  21.	  SRSF	  proteins	  contribute	  to	  NMD.	  (A)	  Silver	  staining	  of	  FLAG-­‐immunoprecipitated	  FLAG	  and	  FLAG-­‐S-­‐long	  Flp-­‐In	  T-­‐REx	  293	  cell	  lines	  (B)	  Northern	  blot	  analysis	  of	  RNA	  samples	  and	  western	  blot	  analysis	  of	  proteins	  derived	  from	  HeLa	  cells	  as	  described	  in	  Figure	  9B.	  (C)	  Northern	  blot	  of	  RNA	  samples	  and	  western	  blot	  analysis	  of	  proteins	  extracted	  from	  HeLa	  cells	  transfected	  with	  the	  indicated	  siRNAs	  and	  constructs	  as	  in	  Figure	  14B.	  (D)	  Northern	  blot	  of	  RNA	  samples	  and	  western	  blot	  analysis	  of	  proteins	  extracted	  from	  HeLa	  cells	  transfected	  with	  the	  indicated	  siRNAs	  and	  constructs	  as	  in	  Figure	  15C.	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Tethering	   of	   SRSF3	   had	   no	   detectable	   effect	   on	   reporter	  mRNA	   levels	   (Figure	  20B,	   upper	   panel,	   lane	   4).	   Because	   SRSF1	   and	   SRSF7	   showed	   the	   strongest	  effects,	  I	  continued	  my	  analysis	  with	  these	  two	  proteins.	  In	  order	  to	  define	  how	  their	   tethering	   is	   coupled	   with	   the	   reduction	   of	   the	   reporter	   mRNA	   levels,	   I	  performed	  a	  tethering	  assay	  in	  UPF2	  depleted	  cells.	  The	  activity	  of	  both	  proteins	  was	   partially	   impaired	   by	   the	   depletion	   of	   UPF2	   (Figure	   21C),	   indicating	   that	  they	  require	  UPF2	  in	  order	  to	  activate	  NMD.	  As	  further	  prove	  of	  their	  ability	  to	  induce	  NMD,	  they	  were	  tethered	  in	  XRN1	  depleted	  cells.	  Similarly	  to	  BTZ	  (Figure	  15C)	   and	   other	   EJC	   proteins	   (V	   Boehm,	   N	   Haberman,	   F	   Ottens,	   J	   Ule	   and	   NH	  Gehring,	  in	  press),	  more	  3ʹ	   fragment	  is	  generated	  when	  the	  SRSF	  proteins	  were	  tethered	   (Figure	   21D).	   In	   summary,	   I	   provide	   evidence	   that	   selected	   SRSF	  proteins	   can	   elicit	   NMD	   via	   an	   UPF2-­‐dependent	   and	   endocleavage	   using	  pathway,	  but	  the	  molecular	  basis	  of	  this	  mechanism	  is	  unclear	  at	  the	  moment.	  	  
4.4.2	   The	   NTC	   complex	   induces	   mRNA	   degradation	   in	   a	   NMD-­
independent	  way	  I	   also	   noticed	   that	   several	   components	   of	   the	   NTC	   (PRPF19,	   CDC5L,	   BCAS2,	  PLRG1)	  were	   enriched	   in	   the	   S-­‐long	   interactome.	   The	  NTC	   complex	   associates	  with	  the	  spliciosome	  in	  the	  complex	  B	  and	  remains	  bound	  until	  the	  termination	  of	   the	   splicing	   reaction.	   Moreover	   it	   is	   involved	   in	   genome	   manteinance,	  transcription	   elongation	   and	   recruitment	   of	   ubiquitylated	   proteins	   to	   the	  proteasome	   (Chanarat	   and	   Strasser,	   2013;	   Hogg	   et	   al.,	   2010).	   Since	   I	   failed	   to	  express	  detectable	  amounts	  of	  PRPF19,	  I	  used	  the	  NTC	  components	  BCAS2	  and	  PLRG1,	  which	  were	  highly	  enriched	   in	   the	   interactome,	  but	  not	   included	   in	   the	  final	   list	  as	   they	  were	  only	  detected	  by	  a	  single	  unique	  peptide.	   I	  also	  analyzed	  SNW1	  (SKIP),	  a	  component	  of	  the	  NTC-­‐related	  SKIP	  complex	  that	  is	  presumably	  involved	   in	   the	   activation	   step	   of	   the	   spliceosome	   (Bessonov	   et	   al.,	   2010).	   All	  three	   tested	  proteins	  reduced	   the	   levels	  of	   the	  reporter	  mRNA	   in	   the	   tethering	  assay	  (Figure	  22A).	  However,	  in	  contrast	  to	  the	  SRSF	  proteins,	  this	  effect	  seems	  to	  be	  NMD-­‐independent.	  The	  reduction	  of	  mRNA	   levels	  was	  UPF2-­‐independent	  (Figure	   22	   B,	   C	   and	   D)	   and	   there	   was	   no	   3ʹ	   fragment	   generation	   upon	   their	  tethering	  in	  XRN1	  depleted	  cells	  (Figure	  22E).	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Figure	  22.	  NTC	  complex	  proteins	  and	  SNW1	  do	  not	  activate	  NMD	  (A)	  Northern	  blot	  analysis	  of	  RNA	   samples	   and	  western	  blot	   analysis	   of	   proteins	  derived	   from	  HeLa	   cells	   as	   described	   in	  Figure	  9B.	  (B,C,D)	  Northern	  blots	  of	  RNA	  samples	  and	  western	  blot	  analysis	  of	  proteins	  extracted	  from	   HeLa	   cells	   transfected	   with	   the	   indicated	   siRNAs	   and	   constructs	   as	   in	   Figure	   14B.	   (E)	  Northern	  blots	  of	  RNA	  samples	  and	  western	  blot	  analysis	  of	  proteins	  extracted	  from	  HeLa	  cells	  transfected	  with	  the	  indicated	  siRNAs	  and	  constructs	  as	  in	  Figure	  15C.	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5.	  Discussion	  The	  EJC	  is	  deposited	  on	  the	  mRNA	  as	  a	  consequence	  of	  splicing,	  where	  it	  marks	  the	  exon-­‐exon	  junctions	  (Le	  Hir	  et	  al.,	  2000a).	  The	  pre-­‐EJC	  (eIF4A3,	  MAGOH	  and	  Y14)	   is	   assembled	   in	   the	   nucleus	   and	   then	   is	   exported	   to	   the	   cytoplasm.	   The	  compartment,	  in	  which	  BTZ	  binds	  the	  complex,	  is	  subject	  of	  ongoing	  discussion.	  According	  to	  the	  current	  model,	  BTZ	  joins	  the	  complex	  in	  the	  cytoplasm	  (Gehring	  et	  al.,	  2009b;	  Steckelberg	  et	  al.,	  2012),	  where	  it	  localizes	  at	  the	  steady	  state	  level.	  BTZ	   and	   the	   spliceosome	   were	   reported	   to	   bind	   the	   same	   eIF4A3	   residues.	  Moreover,	  BTZ	  was	  not	  identified	  in	  purified	  spiceosomal	  complexes	  (Bessonov	  et	  al.,	  2008;	  Gehring	  et	  al.,	  2009a).	  This	  suggests	  that	  BTZ	  joins	  the	  complex	  after	  the	  completion	  of	  the	  splicing	  reaction,	  but	  does	  not	  exclude	  the	  possibility	  that	  such	   joining	   happens	   in	   the	   nucleus.	   BTZ	   is	   localized	   to	   the	   cytoplasm,	   even	  though	   it	   contains	   two	   functional	   NLSs,	   which	   mediate	   its	   localization	   to	   the	  nucleus	  when	  nuclear	  export	   is	   inhibited	  by	  Leptomycin	  B	   treatment.	  Even	   the	  isolated	   C-­‐terminal	   domain	   with	   its	   NES,	   localizes	   to	   the	   nucleus	   after	  Leptomycin	  B	  treatment	  (Degot	  et	  al.,	  2004).	  Furthermore,	  Tange	  and	  colleagues	  proposed	  in	  2004	  that	  BTZ	  is	  present	  in	  the	  nucleus	  in	  low	  abundance	  and	  this	  might	  be	  a	  control	  mechanism	  of	  the	  cell	  to	  avoid	  premature	  EJC	  assembly.	  	  	  
5.1	  Separate	  functions	  of	  the	  three	  BTZ	  regions	  BTZ	  can	  be	  divided	  in	  three	  functional	  regions:	  N-­‐terminus,	  SELOR	  domain	  and	  C-­‐terminus.	  In	  this	  thesis,	  I	  showed	  that	  they	  are	  functionally	  independent	  from	  each	  other	  and	  I	  reported	  previously	  undescribed	  functions	  for	  these	  regions.	  	  
5.1.1	  BTZ	  induced	  NMD	  NMD	  inducing	  regions	  Upon	   tethering	   of	   the	  N-­‐terminal	   region	   and	   the	   SELOR	   domain	   of	   BTZ	   to	   the	  reporter	  mRNA,	   I	   observed	   a	   reduction	  of	   the	  mRNA	   levels	   at	   the	   steady	   state	  level.	  Interestingly,	  after	  transfection	  of	  two	  different	  constructs	  (BTZ	  N	  and	  BTZ	  S)	   the	   levels	   of	   reporter	  mRNA	  detected	  were	   in	   the	   same	  order	  of	  magnitude	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(Figure	  9B,	  lane	  5	  and	  9).	  It	  has	  been	  reported	  that	  the	  EJC	  components	  tethered	  downstream	  of	  the	  stop	  codon	  activate	  NMD	  (Gehring	  et	  al.,	  2009a).	  The	  SELOR	  domain	   is	   the	   region	   of	   BTZ	   responsible	   for	   mediating	   binding	   to	   the	   EJC	   via	  eIF4A3	  (Ballut	  et	  al.,	  2005;	  Degot	  et	  al.,	  2004).	  Therefore,	  SELOR-­‐containing	  BTZ	  mutants	   tethered	   to	   the	  mRNA	   can	   function	   as	   a	   binding	   platform	   for	   the	   EJC	  proteins	  and	  activate	  NMD.	  In	  contrast,	   the	  N-­‐terminal	  region	  was	  only	  studied	  by	  Gehring	  and	  colleagues	  in	  2009,	  but	  not	  as	  isolated	  region.	  They	  observed	  that	  removing	   the	   N-­‐terminal	   region	   decreased	   the	   ability	   of	   BTZ	   to	   induce	   NMD.	  Here,	   I	   studied	   this	   region	   in	   isolation	   and	   showed	   that	   it	   can	   indeed	   activate	  NMD	   to	   the	   same	   extend	   as	   the	   SELOR	   domain.	   This	   was	   a	   surprising	   result	  considering	   that	   the	   N-­‐terminus	   is	   not	   involved	   in	   EJC	   binding,	   suggesting	   an	  EJC-­‐independent	   way	   of	   NMD	   activation.	   Moreover,	   Gehring	   and	   colleagues	  observed	   in	  2009	   that	  mutated	   full-­‐length	  BTZ	  proteins,	  which	  were	  unable	   to	  interact	   with	   the	   EJC,	   were	   still	   completely	   functional	   in	   the	   tethering	   assay.	  They	  concluded	  that	  another	  region	  of	  the	  protein	  beside	  the	  SELOR	  domain	  had	  to	  be	   responsible	   for	  NMD	  activation.	  Here,	   I	   showed	   that	   this	   region	   is	   the	  N-­‐terminus.	  When	  the	  same	  mutations	  were	  inserted	  in	  the	  isolated	  SELOR	  domain	  the	  ability	  to	  induce	  NMD	  gave	  different	  results	  for	  different	  SELOR	  mutants.	  The	  constructs	  with	  mutations	  in	  the	  SELOR	  C-­‐terminal	  binding	  site	  (i.e.	  W218D	  and	  HD220AK)	   were	   strongly	   impaired	   and	   inefficient	   in	   NMD	   activation.	   The	  mutants	   in	   the	  SELOR	  N-­‐terminal	  binding	  site	  were	  still	   functional	   instead	   (i.e.	  DED173KRK),	   or	   partially	   affected	  by	   the	  mutations	   (i.e.	   PR183AE,	   F188D	   and	  R194D).	   The	   correlation	   between	   NMD	   activation	   and	   EJC	   binding	   was	  confirmed	  in	  the	  tethering	  assay	  by	  the	  unique	  functional	  mutant	  (DED173KRK)	  which	  was	  the	  only	  one	  able	  to	  immunoprecipitate	  all	  the	  other	  EJC	  components	  (Figure	  11	  B	   and	  C).	   In	   good	   agreement	  with	   these	   observations,	  mutations	   in	  the	  SELOR	  C-­‐terminal	  binding	  site	  have	  a	  stronger	  impact	  on	  the	  function	  of	  the	  protein	  than	  the	  mutations	  in	  the	  SELOR	  N-­‐terminal	  binding	  site.	  Indeed,	  the	  C-­‐terminal	  binding	  site	  is	  required	  for	  binding	  of	  SELOR	  and	  eIF4A3	  in	  vivo	  and	  in	  
vitro.	  Mutations	  in	  the	  N-­‐terminal	  binding	  site,	  despite	  disrupting	  the	  interaction	  
in	  vivo,	  do	  not	  affect	  the	  in	  vitro	  binding	  (Bono	  et	  al.,	  2006).	  So	  far,	  it	  is	  possible	  to	  conclude	   that	   in	   order	   to	   induce	   NMD	   the	   SELOR	   domain	   necessitates	   the	  binding	  with	  the	  EJC	  proteins.	  In	  contrast,	  in	  the	  context	  of	  BTZ	  FL,	  mutants	  that	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were	  unable	  to	  assemble	  an	  EJC	  could	  efficiently	  induce	  NMD	  as	  well	  (Figure	  12	  A	   and	   B).	   Similarly,	   also	   BTZ	   NS	   (containing	   both	   SELOR	   domain	   and	   the	   N-­‐terminal	   region)	   EJC-­‐impaired	   mutants	   (F188D	   and	   W218D)	   activated	   NMD	  (Figure	  12C).	  This	  NMD	  functionality	  can	  be	  explained	  by	  the	  central	  role	  of	  the	  N-­‐terminal	   domain	   during	   activation	   of	   NMD.	   Indeed,	   the	   effect	   of	   the	   point	  mutations	  was	  more	   severe	   in	   the	   isolated	  SELOR	  domain	   than	   in	  BTZ	  NS	  and	  BTZ	   FL.	   The	   N-­‐terminal	   region	   could	   activate	   the	   EJC-­‐independent	   NMD	   and,	  hence,	   was	   dominant	   over	   the	   non-­‐fuctional	   SELOR	   domain.	   Furthermore,	  comparison	  among	  wt	  BTZ	  FL,	  NS	  and	  S	  revealed	  that	   the	  efficiency	  of	  NMD	  in	  the	  S	  protein	  was	  lower	  than	  the	  FL	  and	  NS	  protein.	  These	  data	  suggest	  that	  the	  mRNA	   degradation	   efficiency	   correlates	   with	   the	   number	   of	   NMD-­‐inducing	  regions	  (Figure	  12D).	  	  SELOR	  and	  N-­‐terminal	  region	  activate	  different	  NMD	  pathways	  To	   identify	   the	  pathways	  activated	  by	   tethering	  BTZ	  N	  and	  BTZ	  S,	   I	  performed	  RNA	   silencing	   of	   the	   proteins	   UPF2	   and	   XRN1.	   UPF2	   KD	   allows	   to	   distinguish	  between	  UPF2-­‐dependent	  and	   -­‐independent	  NMD	  (Gehring	  et	  al.,	  2005).	  UPF2-­‐independent	  NMD	  involves	  the	  direct	  interaction	  of	  the	  EJC	  with	  UPF1,	  whereas	  UPF2	  is	  dispensable	  to	  mediate	  this	  binding	  and	  to	  activate	  NMD.	  In	   fact,	  UPF1	  mutants	   lacking	   the	   interaction	   with	   UPF2	   (Ivanov	   et	   al.,	   2008)	   can	   still	  immunoprecipitate	  BTZ	   (Gehring	   et	   al.,	   2009a).	  BTZ	  S	   similarly	   to	  BTZ	  FL	  was	  not	  influenced	  by	  UPF2	  depletion.	  Indeed,	  BTZ	  S	  and	  BTZ	  FL	  could	  assemble	  an	  EJC	   (Figure	   11C	   and	   12A)	   and	   consequently	   activate	   NMD	   independentely	   of	  UPF2.	   On	   the	   contrary,	   BTZ	   N	   could	   not	   induce	   degradation	   of	   the	   reporter	  mRNA	  in	  UPF2	  depleted	  cells	  (Figure	  14B),	  suggesting	  an	  UPF2-­‐depedent	  NMD	  activation.	  The	  UPF2-­‐dependent	  pathway	  does	  not	  necessitate	  a	  fully	  assembled	  EJC	   and	   indeed	   BTZ	   N	   is	   not	   the	   region	   responsible	   for	   EJC	   assembly.	   Both	  degradation	   pathways	   rejoin	   at	   the	   step	   of	   UPF1	   involvement	   (Gehring	   et	   al.,	  2005),	  leading	  to	  the	  recruitment	  of	  SMG6.	  To	  confirm	  that	  BTZ	  N,	  BTZ	  S	  and	  BTZ	  FL	   shared	   the	   same	   NMD	   pathway	   once	   UPF1	   is	   activated,	   I	   evaluated	  mRNA	  endocleavage	  executed	  by	  SMG6.	  Two	  fragments	  are	  generated	  by	  this	  cleavage	  (Eberle	   et	   al.,	   2009;	   Huntzinger	   et	   al.,	   2008),	   of	   which	   the	   3ʹ	   fragment	   can	   be	  stabilized	  by	  XRN1	  KD	  (V	  Boehm,	  N	  Haberman,	  F	  Ottens,	  J	  Ule	  and	  NH	  Gehring,	  in	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press).	  Upon	  tethering	  BTZ	  FL,	  BTZ	  S	  and	  BTZ	  N	   in	  XRN1	  depleted	  cells,	   the	  3ʹ	  fragment	  generated	  from	  the	  TPI-­‐4MS2-­‐SMG5	  reporter	  construct	  is	  stabilized	  in	  comparison	  to	  the	  control	  (Figure	  15C).	  This	  result	  is	  additional	  proof	  that	  BTZ	  tethering	   elicits	   bona	   fide	   NMD	   and	   suggests	   that	   the	   two	   different	   pathways	  activated	   by	   BTZ	   FL,	   BTZ	   S	   and	   BTZ	   N	   rejoin	   at	   the	   step	   of	   reporter	   mRNA	  degradation	  via	  XRN1.	  	  	  
5.1.2	  BTZ	  induced	  polyadenylation	  The	  C-­‐terminal	  region	  of	  BTZ	  tethered	  to	  the	  reporter	  mRNA	  showed	  a	  different	  effect	   compared	   to	   the	   N-­‐terminal	   region	   and	   the	   SELOR	   domain.	   Two	   bands,	  specific	   products	   of	   the	   β-­‐globin	   4boxB	   reporter	   mRNA,	   were	   detected	   in	   the	  northern	  blot,	  when	  BTZ	  C	  was	  tethered	  to	  the	  mRNA.	  These	  two	  bands	  showed	  faster	  and	  slower	  motility	  on	  the	  northern	  gel,	  respectively,	  when	  compared	  to	  the	   negative	   control	   (Figure	   9B	   and	   10A).	   BTZ	   C,	   however,	   did	   not	   induced	  degradation	   of	   the	   reporter	   mRNA.	   When	   the	   intensities	   of	   both	   bands	   were	  added,	  66%	  of	  the	  reporter	  mRNA	  was	  detected	  at	  the	  steady	  state	  level	  (Figure	  9B).	   Cloning	   and	   sequencing	   of	   both	   bands	   showed	   that	   the	   faster	   migrating	  band	   lacked	   the	   4boxB	   binding	   site	   and	  was	   polyadenylated	   downstream	   of	   a	  cryptic	   polyadenylation	   signal	   AUUAAA	   (β-­‐globin	   short)	   (Figure	   10B).	  Analogously,	  when	   protein	   components	   of	   the	   CSTF	   complex	  were	   tethered	   to	  the	  reporter,	  a	  fast	  running	  band	  was	  detected	  (Figure	  10C).	  The	  CSTF	  complex	  binds	   downstream	   of	   the	   polyadenylation	   signal	   and	   induce	   cleavage	   and	  polyadenylation	  upstream	  of	  its	  position	  (Chan	  et	  al.,	  2011;	  Elkon	  et	  al.,	  2013).	  I	  suggest	   that	   BTZ	   C	   and	   the	   CSTF	   proteins	   activate	   usage	   of	   the	   cryptic	  polyadenylation	  signal	  situated	  upstream	  of	  the	  4boxB	  binding	  sequence,	  leading	  to	   cleavage	   and	   polyadenylation	   at	   this	   site	   (Figure	   10).	   Degot	   and	   colleagues	  showed	   in	   2004	   that	   the	   NES	   of	   BTZ	   is	   functional	   and	   responsible	   for	   the	  localization	  of	  the	  protein	  to	  the	  cytoplasm.	  The	  NES	  corresponds	  to	  the	  aa	  462-­‐472	  included	  in	  BTZ	  C,	  which	  indeed	  localizes	  to	  the	  cytoplasm	  (data	  not	  shown).	  However,	  polyadenylation	  activated	  upon	  BTZ	  C	  tethering	  is	  unlikely	  to	  occur	  in	  the	   cytoplasm.	   Cytoplasmic	   polyadenylation	   is	   determined	   by	   the	   cytoplasmic	  polyadenylation	   element	   (CPE;	   consensus	   sequence	   UUUUUAU)	   that	   resides	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within	   100	   bases	   5ʹ	   of	   the	   AAUAAA	   poly(A)	   signal.	   The	   protein	   CBPE	   (CPE	  binding	  protein)	  binds	  this	  sequence	  in	  the	  nucleus	  and	  is	  then	  exported	  with	  the	  mRNA	  to	  the	  cytoplasm	  where	   it	  contributes	  to	  elongate	  the	  short	  poly	  (A)	  tail	  already	  added	  to	  the	  mRNA	  in	  the	  nucleus	  (Ivshina	  et	  al.,	  2014;	  Lin	  et	  al.,	  2012).	  The	  β-­‐globin	  4boxB	  reporter	  does	  not	  contain	  such	  a	  sequence,	  so	  activation	  of	  CBPE	  via	  BTZ	  seems	  rather	  unlikely.	  On	  the	  other	  hand,	  BTZ	  C	  might	  be	  able	  to	  shuttle	   into	  the	  nucleus,	  as	  was	  proposed	  for	   the	   full-­‐length	  BTZ	  (Macchi	  et	  al.,	  2003),	   where	   it	   could	   be	   involved	   in	   nuclear	   polyadenylation.	   More	   in	   depth	  analyses	  will	  be	  necessary	  to	  define	  the	  role	  of	  BTZ	  C	  in	  polyadenylation.	  	  	  
5.2	  RNA	  binding	  
In	  vitro	  binding	  
In	  vitro	  the	  SELOR	  domain	  mediates	  binding	  of	  BTZ	  to	  RNA	  (Ballut	  et	  al.,	  2005;	  Degot	   et	   al.,	   2004).	   In	   agreement	  with	   previous	   results,	   I	   observed	   that	   S-­‐long	  showed	  a	  preference	  for	  the	  U27	  oligo	  compared	  to	  A25	  (Figure	  17)	  (Degot	  et	  al.,	  2004).	   However,	   I	   noted	   that	   S-­‐long	   had	   much	   weaker	   binding	   to	   the	   RNA	  compared	  to	  PABPC	  (Figure	  17).	  The	  differences	  in	  RNA	  affinity	  might	  reflect	  the	  structure	  and	  function	  of	  the	  two	  proteins.	  PABPC	  has	  four	  RRMs,	  of	  which	  RRM1	  and	  RRM2	  are	  mostly	  responsible	  for	  binding	  to	  the	  poly(A)	  sequence	  (Deo	  et	  al.,	  1999).	  On	  the	  other	  hand,	  the	  SELOR	  domain,	  despite	  being	  responsible	  for	  RNA	  recognition,	  does	  not	  contain	  any	  RNA	  recognition	  motif.	  The	  binding	  to	  the	  RNA	  was	   stronger,	   albeit	   still	   limited,	   when	   the	   probe	   was	   incubated	   with	   higher	  protein	   concentrations	   (Figure	   17).	   The	   supershift	   observed	  might	   result	   from	  the	   assembly	   of	   multiple	   proteins	   and	   RNAs.	   To	   verify	   this	   hypothesis	   I	  crosslinked	  the	  samples	  after	  the	  incubation	  in	  the	  EMSA	  conditions.	  Two	  bands,	  designed	  as	  high	   and	   low	  molecular	  weight	   complex,	  were	  detected	  on	   the	   gel	  (Figure	   18,	   bottom	   panel).	   At	   the	   highest	   protein	   concentration,	   the	   high	  molecular	  weight	  band	  was	  more	  prominent	  than	  the	  low	  molecular	  weight	  one	  (Figure	  18,	   bottom	  panel,	   lane	  8).	  The	   ratio	  was	   inverted	   at	   a	   reduced	  protein	  concentration	  (Figure	  18,	  bottom	  panel,	  lane	  7).	  Considering	  that	  the	  increase	  of	  the	  protein	  concentration	  led	  to	  a	  higher	  molecular	  weight	  complex,	  either	  more	  S-­‐long	  proteins	  bind	   the	  same	  small	  RNA,	  or	  S-­‐long	   is	  able	   to	  multimerize.	  The	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hypothesis	  of	  multimerization	  is	  supported	  by	  recent	  results	  suggesting	  that	  EJC	  form	  a	  multimeric	   complex	  binding	  other	  EJCs	  and	  additional	   factors	   (Singh	  et	  al.,	  2012).	  	  
In	  vivo	  binding	  The	  SELOR	  domain	  mediates	  binding	  of	  BTZ	   to	   the	  mRNA	   in	  vivo	   (Ballut	  et	  al.,	  2005;	   Degot	   et	   al.,	   2004).	   Here,	   I	   showed	   that	   this	   binding	   is	   EJC-­‐dependent,	  whereas	   S-­‐long	   W218D	   and	   F188D	   showed	   greatly	   reduced	   RNA	   binding	  compared	  to	  the	  wt	  S-­‐long	  (Figure	  19A).	  Similarly,	  concerning	  the	  NMD	  inducing	  ability	   of	   the	   SELOR	   domain	   (Figure	   10),	   it	   seems	   that	   the	   SELOR	   domain	  requires	  being	  part	  of	  the	  EJC	  to	  exert	  its	  functions.	  To	  extend	  the	  identification	  of	   the	  RNA	   interacting	  with	  BTZ,	   not	   only	   via	   the	   SELOR	  domain,	   I	   planned	   to	  crosslink	   the	   full-­‐length	   protein.	   The	   crosslinking	   efficiency	   of	   BTZ	   FL	   to	   the	  mRNA	   was	   unfortunately	   much	   reduced.	   Increasing	   UV	   intensities,	   aimed	   to	  improve	   the	   crosslinking	   efficiency,	   resulted	   in	   very	   limited	   mRNA	   binding,	  probably	   due	   to	   protein	   degradation	   (Figure	   19B).	   When	   comparing	   the	  crosslinking	  efficiency	  of	  BTZ	  FL,	  S-­‐long	  and	  NSC-­‐short,	  it	  was	  possible	  to	  define	  the	   contribution	   of	   different	   BTZ	   region	   to	   RNA	  binding.	   BTZ	  NSC-­‐short	   had	   a	  higher	   affinity	   for	   RNA	   compared	   to	   S-­‐long	   (Figure	   19C).	   This	   indicated	   a	  positive	   contribution	   of	   the	   N-­‐terminal	   region	   to	   mRNA	   binding.	   Likewise,	   I	  observed	   that	   the	   N-­‐terminal	   region	   enhanced	   NMD	   activity	   of	   the	   SELOR	  domain	   (Figure	   12C).	   BTZ	   FL	   instead	   was	   weakly	   crosslinked	   to	   the	   mRNA,	  suggesting	   that	   the	   C-­‐terminal	   domain	   had	   a	   negative	   effect	   on	  mRNA	  binding	  (Figure	  19B).	  From	  these	  observations	  it	  is	  possible	  to	  argue	  that	  binding	  to	  the	  mRNA	  correlates	  with	  NMD	  function:	  while	  the	  NMD	  competent	  regions	  of	  BTZ	  (SELOR	   and	  N-­‐terminus)	   favour	   this	   binding,	   the	  NMD	   incompetent	   region	   (C-­‐terminus)	   has	   a	   negative	   effect.	   BTZ	   NSC-­‐short	   showed	   the	   strongest	   RNA	  binding.	  However,	  a	  signal	  was	  also	  detected	  in	  the	  lane	  of	  the	  samples	  that	  were	  not	   crosslinked.	   This	   might	   be	   due	   to	   phosphorilation	   of	   the	   protein	   during	  incubation	  with	  the	  PNK	  mix.	  To	  circumvent	  this	  problem,	  I	  planned	  to	  identify	  the	  RNA	  bound	  to	  S-­‐long.	  However,	  several	  attempts	  to	  obtain	  a	  library	  of	  mRNA	  bound	  by	  S-­‐long	  failed.	  A	  possible	  reason	  for	  this	  is	  the	  weak	  mRNA	  affinity	  of	  S-­‐long	  for	  the	  mRNA.	  Comparing	  the	  signal	  for	  hnRNP	  C	  and	  S-­‐long,	  I	  observed	  that	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S-­‐long	  was	  less	  efficiently	  crosslinked	  to	  the	  mRNA	  (Figure	  19	  D).	  Nevertheless,	  I	  cannot	  exclude	  other	  reasons	  for	  the	  failure	  of	  the	  protocol.	  Only	  the	  detection	  of	  the	  complex	  protein	  RNA	  (similar	  to	  Figure	  19)	  can	  be	  verified	  until	  the	  final	  step	  of	   the	   library	   generation.	   In	   2012	   Singh	   and	   colleagues	   defined	   the	   RNA	  interactome	  of	  the	  EJC.	  Upon	  identification	  of	  those	  mRNAs,	  they	  delineated	  six	  processes	   the	   EJC	   was	   involved	   in:	   RNA	   processing,	   chromatin	   organization,	  mitosis,	   cell	   cycle,	   positive	   regulation	   of	   transcription,	   negative	   regulation	   of	  transcription	   and	   cell	   division.	   Considering	   that	   BTZ	   binding	   to	   the	   mRNA	   is	  dependent	  on	  the	  EJC,	  I	  speculate	  that	  the	  RNA	  interactome	  of	  BTZ	  will	  be	  similar	  to	  the	  EJC	  interactome.	  	  
5.3	  SELOR	  protein	  interactome	  To	   gain	   a	   better	   insight	   in	   BTZ	   functions,	   I	   performed	   a	  MS	   analysis	   of	   FLAG-­‐tagged	  S-­‐long	  expressing	  Flp-­‐In	  T-­‐REx	  293	  cell	  lines.	  The	  wt	  protein	  interactome	  was	  compared	  to	  the	  corresponding	  W218D	  mutant,	  to	  distinguish	  between	  EJC-­‐	  dependent	   and	  –independent	  binding	  partners.	  The	   specificity	  of	   the	   approach	  was	   confirmed	  by	   the	   identification	   of	   the	  EJC	   core	   components	   (MAGOH,	   Y14	  and	  eIF4A3),	  which	  were	  among	   the	  most	   enriched	  proteins.	   Similarly,	   several	  members	   of	   the	   SRSF	   proteins	   were	   enriched	   in	   the	   IP	   of	   S-­‐long,	   in	   good	  agreement	  with	  the	  identification	  of	  these	  proteins	  in	  the	  EJC-­‐interactome	  (Singh	  et	  al.,	  2012)	  (Figure	  20A).	  Singh	  and	  colleagues	  proposed	  that	  the	  SRSF	  proteins	  were	  stochiometric	  to	  the	  EJC.	  Nonetheless,	  I	  could	  not	  detect	  any	  other	  protein	  with	   the	   same	   intensity	   of	   the	   EJC	   components	   on	   a	   silver-­‐stained	   gel	   (Figure	  21A).	   Therefore,	   the	   precise	   abundance	   and	   stochiometry	   of	   SRSF	   proteins	   in	  purified	   EJCs	   needs	   to	   be	   re-­‐evaluated.	   Among	   the	   other	   factors	   enriched,	   I	  identified	   the	   NMD	   proteins	   UPF3b	   and	   UPF2,	   components	   of	   the	   splicing-­‐associated	   nineteen	   complex	   (NTC)	   and	   components	   of	   the	   U2	   snRNP	   (Figure	  20A).	  Interestingly,	  eIF3	  was	  enriched	  in	  S-­‐long	  W218D	  IP.	  Chazal	  and	  colleagues	  observed	   that	  BTZ	   is	   the	  only	  EJC	  component	  whose	  overexpression	  correlates	  with	  increased	  translation.	  This	  effect	  was	  mainly	  observed	  for	  intron-­‐containing	  mRNAs	   and	   only	   weakly	   for	   intronless	   mRNAs.	   This	   would	   support	   the	  hypothesis	  that	  BTZ	  mediates	  the	  translation	  stimulation	  function	  of	  the	  EJC.	  On	  
Discussion	  
	   59	  
the	  other	  hand,	  they	  observed	  that	  an	  EJC-­‐impaired	  BTZ	  mutant	  was	  not	  able	  to	  increase	   the	   translation	   of	   spliced	   mRNAs,	   and	   modestly	   stimulated	   the	  translation	   of	   unspliced	   mRNAs	   (Chazal	   et	   al.,	   2013).	   This	   supports	   the	  hypothesis	  that	  BTZ	  could	  also	  work	  independently	  of	  the	  EJC.	  The	  identification	  of	   eIF3	   in	   the	   EJC-­‐impaired	   S-­‐long	   mutant	   IP	   corroborates	   this	   hypothesis.	  Nevertheless,	  more	  studies	  will	  be	  required	  to	  elucidate	  the	  correlation	  between	  translation	  induction	  and	  BTZ.	  In	   general,	   the	   proteins	   enriched	   in	   S-­‐long	   IP	   were	   components	   of	   the	   EJC	   or	  engaged	   in	   processes	   BTZ	   was	   already	   described	   to	   be	   part	   of,	   such	   as	   NMD,	  transcription,	   splicing,	   spliceosome	   assembly	   and	   RNA	   processing.	   Moreover,	  proteins	  involved	  in	  apoptosis	  and	  skin	  development	  were	  identified	  in	  S-­‐long	  IP.	  BTZ	  was	  originally	  identified	  as	  a	  protein	  implicated	  in	  cancer	  progression,	  thus	  the	   interaction	  with	  apoptotic	  and	  skin	  development	  factor	  might	  be	  reconduct	  to	  its	  role	  in	  cancer	  (Arriola	  et	  al.,	  2008;	  Tomasetto	  et	  al.,	  1995)	  (Figure	  20B).	  	  
5.3.1	  Functions	  of	  S-­long	  binding	  partners	  The	   SRSF	   proteins	   were	   highly	   enriched	   among	   the	   identified	   S-­‐long	   binding	  partners.	   The	   role	   of	   SRSF1	   in	   degradation	   of	   PTC-­‐containing	   mRNAs	   was	  already	   described	   (Zhang	   and	   Krainer,	   2004),	   but	   no	   systematical	   analysis	   to	  study	  the	  other	  members	  of	  the	  SRSF	  proteins	  family	  has	  been	  performed.	  Upon	  tethering	   to	   the	  mRNA,	   I	   observed	   a	   reduction	   of	   the	  mRNA	   levels	   for	   SRSF1,	  SRSF2,	  SRSF6	  and	  SRSF7.	  This	  degradation	  was	  NMD-­‐dependent,	  consistent	  with	  the	  observations	  that	  SRSF1	  and	  SRSF7	  seemed	  to	  activate	  an	  UPF2-­‐dependent	  and	   endocleavage-­‐based	   pathway	   (Figure	   21	   C	   and	   D).	   Currently,	   it	   is	   not	  possible	  to	  confirm	  the	  importance	  of	  the	  SRSF	  proteins	  in	  NMD	  activation	  or	  if	  BTZ-­‐induced	   NMD	   requires	   the	   presence	   of	   SRSF	   proteins.	   Similarly,	   it	   is	   not	  clear	   if	   the	   SRSF	   proteins	   can	   independently	   activate	   NMD	   or	   if	   they	   require	  other	  components,	  such	  as	  the	  EJC.	  Nevertheless,	  the	  effect	  of	  the	  SRSF	  proteins	  was	   different	   from	   the	   spliceosomal	   components	   of	   the	   NTC	   complex	   (BCAS2	  and	  PLRG1)	  and	  the	  NTC-­‐related	  SKIP	  complex	  protein	  SNW1,	  also	  enriched	  in	  S-­‐long	   IP.	   The	   reduction	   of	   the	   reporter	   level	  when	   tethering	   these	   components	  was	   not	   affected	   upon	  UPF2	  KD,	   suggesting	   that	   they	  were	  UPF2-­‐independent	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(Figure	   22	   B,	   C	   and	   D).	   In	   addition,	   no	   3ʹ	   fragment	  was	   generated	   upon	   their	  tethering	   in	  XRN1	  depleted	   cells	   (Figure	  22E).	  This	   raises	   the	  question	  of	  how	  the	  proteins	  of	  the	  NTC	  complex	  and	  SNW1	  induce	  the	  reduction	  of	  the	  reporter	  mRNA,	  although	  they	  do	  not	  activate	  NMD.	   Indeed,	   they	  are	  UPF2-­‐independent	  and	  the	  degradation	  of	  the	  reporter	  is	  not	  endocleavage-­‐mediated.	  In	  addition,	  I	  could	  exclude	  that	  the	  reduction	  of	  the	  reporter	  at	  the	  steady	  state	  level	  is	  due	  to	  exonucleolytic	   cleavage,	   because	   UPF1	   activation	   is	   required	   for	   this	   pathway	  (Loh	  et	  al.,	  2013;	  Unterholzner	  and	   Izaurralde,	  2004).	   Instead,	   the	  effect	  of	   the	  tethered	  PLRG1	  and	  SNW1	  was	  not	  affected	  by	  UPF1	  depletion	  (Supplementary	  figure	  S4).	  To	  define	   the	  mechanism	  that	   induces	   the	  reduction	  of	   the	  reporter	  level	  upon	  PLRG1,	  BCAS2	  and	  SNW1	  tethering,	  a	  more	  in	  depth	  analysis	  will	  be	  required.	  Two	   groups	   of	   proteins	  were	   identified	   in	   the	   S-­‐long	   IP,	   SRSF	   family	   and	  NTC	  complex,	  which,	  even	  though	  both	  induced	  reporter	  degradation,	  behaved	  in	  two	  different	  ways.	  The	  SRSF	  proteins	  are	  involved	  in	  NMD,	  while	  the	  NTC	  complex	  proteins	   function	  through	  a	  different	  mechanism.	  This	   is	  a	  clear	   indication	  that	  the	  effect	  observed	  for	  these	  proteins	  is	  specific	  of	  the	  protein	  itself	  and	  not	  just	  a	  consequence	  of	  the	  binding	  with	  S-­‐long.	  	  	  
5.5	  Conclusions	  In	   this	   thesis	  work	   I	   identified	  new	   functions	  of	   the	  N-­‐terminal	  and	  C-­‐terminal	  regions	  of	  BTZ.	  Moreover,	  I	  established	  that	  two	  different	  regions	  of	  BTZ	  activate	  UPF2-­‐dependent	  and	  –independent	  NMD	  and	   that	   the	  C-­‐terminal	   region	  seems	  to	  be	  involved	  in	  polyadenylation.	  The	  N-­‐terminal	  region	  of	  BTZ	  activates	  NMD	  in	  an	  EJC-­‐independent	  way.	  However,	  it	  was	  not	  elucidated	  how	  BTZ	  N	  interacts	  with	   UPF2	   in	   order	   to	   activate	   the	   UPF2-­‐dependent	   NMD.	   A	   preliminary	  experiment	   to	   understand	   better	   BTZ	   N-­‐terminus	   function	   could	   be	   the	  identification	  of	  its	  binding	  partners	  via	  MS.	  Similarly,	  I	  could	  not	  elucidate	  how	  the	   C-­‐terminal	   region	   is	   involved	   in	   polyadenylation.	   In	   this	   respect,	   it	   is	  interesting	   to	   note	   that	   a	   protein	   reported	   to	   localize	   to	   the	   cytoplasm	   has	  instead	   a	   nuclear	   function.	   BTZ	  was	   reported	   to	   join	   the	  EJC	   in	   the	   cytoplasm.	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Considering	  the	  identification	  of	  a	  nuclear	  function	  and	  with	  the	  support	  of	  more	  studies,	  the	  model	  of	  BTZ	  joining	  to	  the	  EJC	  might	  be	  revised.	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6.	  Materials	  and	  Methods	  
6.1	  Materials	  
6.1.1	  Cell	  lines	  Flp-­‐In	   T-­‐REx	   293	   cell	   lines	   (Life	   Technologies),	   containing	   stably	   inserted	  Tetracycline-­‐inducible	   expression	   cassette	   were	   generated	   and	   cultured	  according	   to	   the	   manufacturerʹs	   recommendations.	   All	   transfections	   were	  performed	  in	  HeLa	  Tet-­‐off	  (HTO)	  cells	  (Clontech).	  All	  the	  cells	  were	  grown	  at	  37	  °C	   and	   5%	  CO2	   in	   Dulbeccoʹs	  Modified	   Eagle	  Medium	   (DMEM)	   GlutaMAX	   (Life	  Technologies),	   supplemented	   with	   10%	   fetal	   bovine	   serum	   (FBS)	   and	   1%	  penicillin/streptomycin.	  	  
6.1.2	  Bacterial	  strains	  For	   cloning	   purposes,	   XL1-­‐blue	   E.coli	   (Stratagene)	   were	   used.	   For	   bacterial	  expression	   of	   recombinant	   proteins,	   BL21	   star	   (DE3)	   (Invitrogen)	   were	   used.	  Cells	  were	  grown	  in	  LB	  medium	  or	  plates	  with	  the	  appropriate	  antibiotic.	  
6.1.3	  Plasmids	  Plasmid	   constructs	   β-­‐globin	   wt,	   pCI-­‐FLAG,	   pCI-­‐MS2,	   pCI-­‐PP7,	   pCI-­‐λNV5,	   pCI-­‐Venus,	   β-­‐globin	  4MS2,	  β-­‐globin	  4boxB,	  β-­‐globin	  4PP7,	  β-­‐globin	  wt300+e3,	  pCI-­‐TPI	   and	   expression	   vectors	   for	   BTZ	  were	   described	   previously	   (Gehring	   et	   al.,	  2009a)	  (V	  Boehm,	  N	  Haberman,	  F	  Ottens,	  J	  Ule	  and	  NH	  Gehring,	  in	  press).	  
6.1.4	  Antibodies	  	  
Antibody	   From	   Dilution	  UPF2	   Dr.	  Jens	  Lykke-­‐Andersen	   1:2000	  GFP	  	   Abcam	  (ab290)	   1:3000	  FLAG	   Sigma-­‐Aldrich	  (F7425)	   1:3000	  V5	   QED	  Bioscinscience	  (18870)	   1:3000	  Actin	   Sigma-­‐Aldrich	  (A5441)	   1:5000	  RMB8	  (Y14)	   Sigma-­‐Aldrich	  (R07935)	   1:1500	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XRN1	   Bethyl	  (A300-­‐443A)	  	   1:3000	  MAGOH	   Santa	  Cruz	  Biotechnology	  (sc-­‐271365)	  	   1:2000	  eIF4A31	   Genscript	   1:1000	  Mouse-­‐HRP	  	   Jackson	  ImmunoResearch	   1:5000	  Rabbit-­‐HRP	   Jackson	  ImmunoResearch	   1:5000	  	  
1raised	   in	   rabbits	   and	   affinity-­‐purified	   by	   Genscript	   with	   a	   KLH-­‐conjugated	   peptide	  (ATSGSARKRLLKEED)	  	  
6.1.5	  siRNAs	  and	  Primers	  
siRNA	  name	   siRNA	  sequence	  5ʹ-­3ʹ	  Luciferase	   AACGTACGCGGAATACTTCGA	  XRN1	   AAAGATGAACTTACCGTAGAA	  UPF2	   CACGTTGTGGATGGAGTGTTA	  UPF1	   AAGATGCAGTTCCGCTCCATT	  	  
Primer	  name	   Primer	  sequence	  5ʹ-­3ʹ	  BTZ	  480	  as	   TTTTTTTGCGGCCGCTTACTTGCCCCGGACTTCCAA	  BTZ	  160	  as	   TTTTTGCGGCCGCTTAGTTCTCCACAGGCTCT	  	  BTZ	  137	  as	   TTTTTGCGGCCGCTTAGTCAGGCTTTTCTTCTCCC	  BTZ	  372	  as	   TTTTTTTGCGGCCGCTTAGCCAAGCACTGGAGCA	  BTZ	  110	  se	   TTTTCTCGAGTCCAAAGTGAGCTGAAA	  pCI	  se	   GGTGTCCACTCCCAGTTCA	  pCI	  as	   TGCATTCTAGTTGTGGTTTGTC	  BTZ	  286	  as	   TTTTTTTGCGGCCGCTTAACCCTGGTGGCGATG	  BTZ	  137	  se	   TTTTCTCGAGGACACCAAAAAGCACTGTGA	  BTZ	  255	  se	   TTTTCTCGAGACCGAAGAATCCGG	  BTZ	  286	  se	   TTTTCTCGAGGACCTTGGGGGCACCTACCAC	  SNW1	  se	   TTTTCTCGAGATGGCGCTCACCAGCT	  SNW1	  as	   TTTTTTTGCGGCCGCCTATTCCTTCCT	  SRSF6	  se	   TTTTCTCGAGATGCCGCGCGTCTACA	  SRSF6	  as	   TTTTTTTGCGGCCGCTTAATCTCTGGA	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BCAS2	  se	   TTTTCTCGAGATGGCGGGCACAGGT	  BCAS2	  as	   TTTTTTTTGCGGCCGCTCAGAAGTCTTG	  PLRG1	  se	   TTTTCTCGAGATGGTCGAGGAGGTACA	  PLRG1	  as	   TTTTTTTGCGGCCGCTTAAAATCTCTTT	  SRSF7	  se	   TTTTCTCGAGATGATGTCGCGTTACGGGC	  SRSF7	  as	   TTTTTTTGCGGCCGCTCAGTCCATTCT	  CSTF1	  se	   CTTTGCTGCTGGGACTCCAGGACAGCCG	  CSTF1	  as	   TTTTCTCGAGATGTACAGAACCAAAGTGG	  CSTF3_1800	  as	   TTTTTTTGCGGCCGCTTATGGAGGTGCTA	  CSTF3_60	  se	   TTTTCTCGAGGCGGAAAAGAAATTAGAA	  	  All	  the	  primers	  in	  this	  table	  contain	  XhoI	  restriction	  site	  in	  the	  5ʹand	  NotI	  in	  the	  3ʹ	  	  	  
Primer	  name	   Primer	  sequence	  5ʹ-­3ʹ	  oRP1628	   CGAGCACAGAATTAATACGACTTTTTTTTTTTTTTTTTTV1	  oRP1630	   CGAGCACAGAATTAATACGAC	  	  1V,	  could	  be	  A,	  C,	  G.	  
6.1.6	  Buffers	  
Bacteria	  culture	  Autoinduction	  medium	  LBM5052	  480	  ml	  LB	  medium	  10	  ml	  50xM	  1	  ml	  MgSO4	  10	  ml	  50x5052	  0.1 ml	  1000xTrace	  metals	  50xM	  134	  g	  Na2HPO4	  x	  7	  H2O	  68	  g	  KH2PO4	  53.5	  g	  NH4Cl	  14.2	  g	  Na2SO4	  H2O	  up	  to	  400	  ml	  	  	  
LB	  medium	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  10	  g	  Tryptone	  10	  g	  NaCl	  5	  g	  Yeast	  extract	  H20	  up	  to	  1L	  	  NP	  lyses	  buffer	  	  100	  μg/ml	  DNAse	  	  125	  μg/ml	  Lysozyme	  	  250	  μg/ml	  RNAse	  	  	  Protease	  Inhibitor	  dilution	  1:250	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NP	  buffer	  	  50	  mM	  NaH2PO4	  	  300	  mM	  NaCl	  	  pH	  8.0	  	  	  50x5052	  125	  ml	  Glycerol	  12.5	  g	  Glucose	  50	  g	  α-­‐D-­‐Lactose	  H2O	  up	  to	  500	  ml	  	  	  1000xTrace	  metals	  25	  ml	  50	  mM	  FeCl3	  500	  μl	  20	  mM	  CaCl2	  250	  μl	  10	  mM	  MnCl2	  250	  μl	  10	  mM	  ZnSO4	  H20	  up	  to	  50	  ml	  
	  
Transfection	  	  2x	  BBS	  50	  mM	  BES	  1.5	  mM	  Na2HPO4	  280	  mM	  NaCl	  pH	  6.96	  
	  
Northern	  Blot	  RNA	  loading	  dye	  50	  %	  glycerol	  1	  mM	  EDTA	  0.25	  %	  brome-­‐phenol	  blue	  	  	  	  
10x	  MOPS	  buffer	  0.2	  M	  MOPS	  80	  sodium	  acetate	  10	  mM	  EDTA	  pH	  7.0	  	  RNA	  sample	  buffer	  500	  μl	  formamide	  (deionized)	  200	  μl	  37%	  formaldehyde	  100	  μl	  10x	  MOPS	  buffer	  1	  drop	  of	  10	  mg/ml	  ethidiumbromide	  	  20x	  SSC	  3	  M	  NaCl	  0.3	  M	  Trisodium-­‐citrate	  pH	  7.0	  	  Church	  buffer	  0.5	  M	  NaH2PO4	  1	  mM	  EDTA	  7	  %	  SDS	  pH	  7.2	  	  Northern	  wash	  buffer	  I	  2x	  SSC	  0.1	  %	  SDS	  	  Northern	  wash	  buffer	  II	  0.2x	  SSC	  0.1	  %	  SDS	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Western	  Blot	  1x	  Transfer	  buffer	  25	  mM	  Tris	  192	  mM	  glycine	  0.1	  %	  SDS	  10	  %	  MeOH	  	  10x	  TBS	  500	  mM	  Tris	  pH	  7.4	  1500	  mM	  NaCl	  	  1x	  TTBS	  1x	  TBS	  0.2	  %	  Tween-­‐20	  	  Blocking	  solution	  1x	  TBST	  5	  %	  low	  fat	  milk	  powder	  
	  
SDS	  Page	  6x	  SDS-­‐PAGE	  loading	  buffer	  0.35	  M	  Tris/HCl	  pH	  6.8	  10.28	  %	  (w/v)	  SDS	  36	  %	  (v/v)	  glycerol	  0.6	  M	  dithiothreitol	  0.2	  %	  brome-­‐phenol	  blue	  	  4x	  Separating	  gel	  buffer	  1.5	  M	  Tris/HCl	  pH	  8.8	  0.4	  %	  SDS	  4x	  Stacking	  gel	  buffer	  0.5	  M	  Tris/HCl	  pH	  6.8	  0.4	  %	  SDS	  
10	  %	  Separating	  gel	  mix	  42	  ml	  H2O	  33	  ml	  30	  %	  acrylamide	  (37.5	  :	  1)	  25	  ml	  4x	  separating	  gel	  buffer	  	  Stacking	  gel	  mix	  57.8	  ml	  H2O	  17.2	  ml	  30	  %	  acrylamide	  (37.5	  :	  1)	  25	  ml	  4x	  stacking	  gel	  buffer	  	  1x	  SDS	  running	  buffer	  25	  mM	  Tris	  192	  mM	  glycine	  0.1	  %	  SDS	  
	  
Immunoprecipitation	  Lysis	  buffer	  50	  mM	  Tris	  [pH	  7.2]	  150	  mM	  NaCl	  0.5%	  Tween	  	  50	  µg/ml	  RNase	  A	  
complete	  protease	  inhibitor	  [Roche]	  	  Wash	  buffer	  	  50	  mM	  Tris	  [pH	  7.2]	  	  150	  mM	  NaCl	  	  0.5%	  Tween	  	  
	  
CLIP	  PNK	  Buffer	  20	  mM	  Tris-­‐HCl,	  pH	  7.4	  10	  mM	  MgCl2	  0.2%	  Tween-­‐20	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Immunofluorescence	  Permeabilising	  solution	  0.5%	  Triton	  PBS	  up	  to	  1	  ml	  
	  
EMSA	  Reaction	  buffer	  100mM	  KCl	  50	  mM	  Hepes	  10%	  glycerol	  2mM	  EDTA	  	  Native	  gel	  1.3	  ml	  acrylamide	  (37.5	  :	  1)	  1ml	  TBE	  10%	  10	  µl	  Temed	  100	  µl	  APS	  H2O	  up	  to	  10	  ml	  	  10X	  TBE	  108	  g	  of	  Tris	  base	  	  55	  g	  of	  boric	  acid	  7.5	  g	  of	  EDTA	  H2O	  up	  to	  1L	  
6.2	  Methods	  
6.2.1	  Cloning	  pCI-­‐FLAG,	  pCI-­‐MS2,	  pCI-­‐PP7,	  pCI-­‐λNV5	  plasmids	  were	  already	  available	  and	  they	  were	  used	  as	  vector.	  BTZ	   full-­‐length	  wt	  and	  all	   the	  point	  mutants	  were	  as	  well	  already	   available.	   BTZ	   full-­‐length	   was	   used	   as	   template	   DNA	   for	   the	   PCRs	  required	  to	  amplify	  the	  entire	  set	  of	  length	  mutants.	  SRSFs,	  CSTF1,	  CSTF3,	  SNW1,	  BCAS2	   and	   PLRG1	   DNAs	   were	   PCR-­‐amplified	   from	   HeLa	   cDNA	   using	   Phusion	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DNA	  polymerase	  (Finnzymes).	  XhoI	  and	  NotI	  restriction	  site	  were	  inserted	  with	  the	  primers.	  The	  primers	  used	   for	   the	  amplification	  are	   listed	   in	   the	  paragraph	  6.1.5.	   After	   separating	   the	   PCR	   product	   by	   agarose	   gel	   electrophoresis,	   the	  fragment	  was	   cut	   from	   the	   gel	   and	  purified	   using	   the	  NucleoSpin	  Gel	   and	  PCR	  Clean-­‐up	  kit	  (Macherey-­‐Nagel).	  Subsequent	  digestion	  with	  XhoI	  and	  NotI	  (NEB)	  was	  performed	  o/n	  at	  37	  °C	  and	  the	  resulting	   fragment	  was	  again	  purified	  and	  ligated	  with	  XhoI/NotI	  cut	  pCI-­‐FLAG	  vector.	  After	  4h	  of	  ligation,	  transformation	  in	   chemically	   competent	   XL1-­‐blue	  E.coli	  was	   performed	   and	   the	   bacteria	  were	  grown	  o/n	  at	  37	  °C	  on	  LB	  plate	  with	  the	  appropriate	  antibiotic.	  Single	  colonies	  containing	   the	   intended	   insert	   were	   identified	   by	   colony	   PCR	   and	   sequenced	  (GATC	  Biotech).	  The	  colony	  containing	  the	  insert	  was	  then	  grown	  in	  LB	  medium	  and	  DNA	  obtained	  with	  Midi	   prep	   kit	   (Macherey	  Nagel)	   and	   sequenced	   (GATC	  Biotech).	  
6.2.2	  Plasmid	  transfections	  For	   tethering	   experiments	   HeLa	   cells	   were	   transfected	   with	   1.5	   µg	   tethering	  construct,	  2	  µg	  4boxB	  or	  4PP7	  construct,	  0.6	  µg	  control	  construct	  (wt	  300+e3),	  0.5	   µg	   GFP	   expression	   vector	   and	   0.5	   µg	   of	   rescue	   construct	   in	   the	   rescue	  experiments.	   For	   the	   detection	   of	   the	   3ʹ	   fragment,	  HeLa	   cells	  were	   transfected	  with	   1.5	   µg	   tethering	   construct,	   2	   µg	   TPI	   4MS2,	   0.75	   µg	   control	   construct	   (β-­‐globin	   wt),	   0.5	   µg	   GFP	   expression	   vector.	   Transfections	   for	  immunoprecipitations	   were	   done	   with	   1.5	   µg	   of	   the	   FLAG-­‐expression	   plasmid	  and	   0.5	   µg	   of	   GFP-­‐	   and	   0.5	   µg	   V5-­‐expression.	   For	   tethering	   experiments	   HeLa	  cells	  were	  seeded	  in	  6	  well	  plates,	  240.000	  cells/well	  one	  day	  prior	  transfection.	  For	   immunoprecipitations	  experiments	  HeLa	   cells	  were	   seeded	   in	  6	   cm	  dished	  70.000	   cell/dish.	   4h	   prior	   transfection	   the	   medium	   was	   changed.	   For	   6-­‐well	  plates,	  the	  indicated	  amount	  of	  plasmids	  was	  filled	  up	  with	  ultrapure	  H2O	  to	  90	  μl,	  10	  μl	  2.5	  M	  CaCl2	  and	  100	  μl	  2x	  BBS.	  For	  6	  cm	  dishes,	  the	  indicated	  amount	  of	  plasmids	  was	  filled	  up	  with	  ultrapure	  H2O	  to	  180	  μl,	  20	  μl	  2.5	  M	  CaCl2	  and	  200	  μl	  2x	  BBS.	  The	  mix	  was	  incubated	  at	  RT	  for	  15	  min	  before	  applying	  to	  the	  cells.	  
6.2.3	  siRNA	  and	  plasmid	  transfection	  For	  UPF2	   siRNA	   transfections,	  106	  HeLa	   cells	  were	  grown	  over	  night	   in	  10	   cm	  plates	   in	   minus	   antibiotic	   medium	   and	   transiently	   transfected	   with	   600	   pmol	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siRNA	   using	   Lipofectamine	   RNAiMAX	   (Life	   Technologies).	   The	   day	   post	  transfection	   the	   cells	  were	   seeded	   in	  minus	  antibiotic	  medium	   in	  6	  well	  plates	  and	  8	  hours	   later	   transfected	  again	  with	  150	  pmol	  siRNA.	  24	  h	   later	   they	  were	  transfected	  with	  plasmid	  constructs.	  For	  XRN1	  siRNA	  transfections,	  5x105	  HeLa	  cells	   were	   grown	   over	   night	   in	   6	   cm	   plates	   in	   minus	   antibiotic	   medium	   and	  transiently	   transfected	   with	   300	   pmol	   siRNA.	   24	   h	   post	   transfection	   the	   cells	  were	   split	   1:2	   in	   10	   cm	   plates	   in	   minus	   antibiotic	   medium	   and	   the	   day	   after	  transfected	  again	  with	  600	  pmol	  siRNA.	  24	  h	  later	  the	  cells	  were	  transferred	  to	  6	  well	  plates	  and	  the	  day	  after	  transfected	  with	  DNA	  constructs.	  For	  UPF1	  siRNA	  transfection,	   10x105	   HeLa	   cells	   were	   grown	   over	   night	   in	   10	   cm	   plates	   and	  transiently	   transfected	   with	   600	   pmol	   siRNA.	   The	   day	   post	   transfection	   cells	  were	  seed	  in	  6	  well	  plates	  and	  the	  8	  hours	  later	  transfected	  with	  DNA	  constructs.	  
6.2.4	  RNA	  extraction	  and	  Northern	  blot	  Total	   RNA	   was	   extracted	   with	   TRIzol	   (Life	   Technologies)	   according	   to	   the	  manual.	  The	  samples	  were	  analyzed	  by	  northern	  blot.	  3	  µl	  of	  RNA	  were	  mixed	  with	  16	  µl	  of	  RNA	  sample	  buffer	  and	  incubated	  15	  minutes	  at	  65	  °C.	  Then	  2µl	  of	  RNA	  loading	  dye	  were	  added.	  The	  samples	  were	  loaded	  on	  the	  Northern	  gel	  (1%	  agarose,	  1x	  MOPS	  buffer	  and	  7.5	  %	  formaldehyde)	  and	  run	  at	  33V.	  When	  the	  run	  was	   completed,	   the	   gel	  was	  washed	   twice	   in	  water,	   once	   in	  NaOH	  50	  mM	  and	  incubated	  in	  20X	  SSC	  for	  40	  minutes.	   	  For	  the	  capillary	  transfer	  a	  neutral	  nylon	  membrane	   (Hybond-­‐NX	   [GE	   Healthcare]	   or	   Roti®-­‐Nylon	   0.2	   [Carl-­‐Roth])	   was	  used.	   	   Subsequently,	  RNA	  was	   cross-­‐linked	  by	  UV	   irradiation	  at	  254	  nm	   to	   the	  membrane	  by	  applying	  120	  mJ/cm2	  in	  a	  UV	  crosslinker,	  incubated	  1h	  in	  Church	  Buffer	  and	  then	  with	  the	  in	  vitro	  transcribed	  α-­‐32P-­‐GTP	  labeled	  RNA	  probe	  o/n	  at	  65	  °C.	  The	  membrane	  was	  washed	  twice	  for	  15	  minutes	  in	  Northern	  wash	  I	  and	  twice	   for	   15	   minutes	   in	   Northern	   wash	   II.	   It	   was	   dried	   for	   40	   minutes	   and	  exposed	  to	  a	  phosphoimager	  screen	  (Fuji	  BAS-­‐MP	  IP)	  for	  about	  4	  h.	  Signals	  were	  quantified	  using	  a	  Typhoon	  Trio	  (GE	  Healthcare).	  	  
6.2.5	  Tethering	  assay	  The	   tethering	   assay	   is	   a	   method	   used	   to	   study	   NMD	   inducing	   proteins.	   The	  protein	  of	  interest	  is	  modified	  with	  the	  addition	  of	  a	  specific	  tag	  that	  recognizes	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its	  binding	  sequence	  in	  the	  3ʹ UTR	  of	  the	  reporter	  mRNA.	  In	  this	  work	  several	  tag	  were	  used	  that	  recognized	  specific	  binding	  sequences.	  	  
TAG	   Reporter	  mRNA	  MS2	   TPI	  4MS2-­‐SMG5	  λN	   β-­‐globin	  4boxB	  PP7	   β-­‐globin	  4PP7	  	  Figure	  23	  is	  a	  schematic	  representation	  of	  the	  tethering	  assay.	  The	  3ʹUTR	  of	  the	  reporter	   is	  modified	  with	   the	   addition	   of	   a	   specific	   binding	   sequence	   (1).	   The	  tagged	  protein	  binds	   this	   sequence	  downstream	   the	  normal	   stop	   codon	   (2).	   In	  case	  of	  an	  EJC	  protein	  this	  mimics	  the	  situation	  of	  an	  EJC	  protein	  downstream	  of	  a	  PTC.	  The	  protein	  then	  can	  exhibit	  an	  effect	  on	  the	  mRNA	  itself	  or	  by	  recruiting	  additional	   factors	   (3).	   Transfections	   are	   performed	   as	   indicated	   in	   paragraph	  6.2.2.	  Two	  days	  later	  the	  cells	  are	  harvested	  in	  TRIzol	  (Life	  Technologies).	  RNA	  extraction	  and	  northern	  blot	  are	  performed	  as	  indicated	  in	  paragraph	  6.2.4.	  	  
	  	  	  
Figure	  23.	  Schematic	   representation	  of	   the	   tethering	  assay	  1)	  Modified	   reporter	  mRNA.	  2)	  Binding	  of	  the	  tagged	  protein.	  3)	  Effect	  on	  the	  mRNA	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6.2.6	  Immunoprecipitation	  	  FLAG-­‐complexes	   were	   immunoprecipitated	   from	   HeLa	   cell	   lysates.	   Cells	   were	  harvested	  2	  days	  after	  transfection	  (see	  paragraph	  6.2.2)	  in	  400	  µl	  of	  lysis	  buffer.	  The	  samples	  were	  frozen	  for	  at	  least	  2h	  and	  then	  centrifuged	  for	  10	  minutes	  at	  10000	  x	  g.	  40	  µl	  of	  each	  sample	  were	  set	  aside	  as	  input	  for	  the	  western	  blot.	  The	  rest	  of	  the	  sample	  was	  mixed	  with	  12	  µl	  of	  M2	  anti-­‐FLAG	  magnetic	  beads	  (Sigma)	  pre-­‐washed	   in	   lysis	   buffer	   and	   incubated	   at	   4	   °C	   over	   night.	   The	   next	   day	   the	  beads	  were	  washed	  three	  times	  (each	  of	  5	  minutes)	  with	  600	  µl	  wash	  buffer	  and	  complexes	  were	  eluted	  with	  40	  µl	  of	  SDS-­‐sample	  buffer.	  	  
6.2.7	  Western	  blot	  	  Protein	   samples	   mixed	   with	   SDS-­‐PAGE	   loading	   buffer	   were	   loaded	   on	   SDS-­‐polyacrylamide	   gels.	   The	   proteins	   were	   then	   transferred	   on	   Hybond-­‐ECL	  nitrocellulose	  membrane	  (GE	  Healthcare)	  using	  1x	  transfer	  buffer	  and	  the	  semi-­‐dry	   system.	   The	   transfer	   was	   performed	   for	   90-­‐120	   minutes	   at	   10	   V.	   The	  membrane	  was	  incubated	  in	  blocking	  solution	  for	  1h	  at	  RT	  and	  incubated	  o/n	  at	  4	  °C	  with	  the	  primary	  antibody	  diluted	  in	  the	  blocking	  solution.	  After	  3	  washings	  of	  10	  minutes	  in	  TTBS,	  the	  membrane	  was	  incubated	  for	  1h	  RT	  in	  the	  secondary	  antibody	  diluted	  in	  the	  blocking.	  After	  other	  3	  washings	  of	  10	  minutes	  in	  TTBS,	  the	  membrane	  was	   incubated	  with	  ECL	  western	  blotting	  detection	  reagent	   (GE	  Healthcare)	  and	  developed	  with	  ImageQuant	  LAS	  4000.	  	  
6.2.8	  Silver	  stain	  	  Silver	   staining	   was	   performed	   with	   the	   SilverQuest	   Silver	   Staining	   Kit	  (Invitrogen)	  according	  to	  the	  manufacturer’s	  protocol.	  
6.2.9	  Crosslinking	  and	  immunoprecipitation	  (CLIP)	  Flp-­‐In	  T-­‐REx	  293	  cell	  lines	  were	  induced	  for	  3	  days	  with	  1	  µg/ml	  of	  tetracycline.	  After	  medium	  removal,	  cells	  were	  washed	  once	  with	  PBS	  (Gibco)	  and	  crosslinked	  in	   1	  ml	   of	   PBS	  with	   variable	   intensities	   of	   UV	   light	   at	   254	   nm,	   harvested	   and	  frozen	   as	   pellet.	   	   The	   day	   of	   use,	   the	   pellet	   was	   resuspendend	   in	   1m	   of	   lyses	  buffer	  (with	  protease	  inhibitor	  added	  freshly).	  The	  sample	  was	  sonicated	  2	  times	  with	  10s	  bursts	  at	  5	  decibels.	  2µl	  of	  Turbo	  DNAse	  (Ambion)	  and	  10	  µl	  of	  RNAse	  If	  (NEB)	  (1:50	  (low,	  L)	  or	  1:500	  (high,	  H)	  dilution)	  were	  added	  and	  samples	  were	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shaken	  at	  37	  °C	  for	  3	  minutes	  at	  1100	  rpm	  followed	  by	  3	  minutes	  on	  ice.	  When	  low	   RNAse	   dilution	   is	   added	   to	   the	   sample,	   the	   RNA	   bound	   to	   the	   protein	   is	  cutted	   in	   small	   fragments	   that	   minimally	   affect	   the	   molecular	   weight	   of	   the	  protein	  and	  its	  running	  behavior;	  this	  condition	  is	  used	  to	  control	  the	  specificity	  of	   the	   IP.	   The	   high	   RNA	   dilution	   instead	   generates	   bigger	   RNA	   fragments	   that	  affect	  the	  molecular	  weight	  of	  the	  protein,	  which	  will	  appear	  a	  smear	  on	  the	  gel.	  	  Subsequently	  the	  samples	  were	  centrifuged	  at	  max	  speed	  for	  20	  minutes.	  40	  µl	  of	  each	  sample	  were	  set	  aside	  as	  input	  for	  the	  western	  blot,	  the	  rest	  of	  the	  sample	  was	  incubated	  with	  12	  µl	  of	  M2	  anti-­‐FLAG	  magnetic	  beads	  (Sigma)	  pre-­‐washed	  in	  lyses	  buffer.	  After	  2h,	  the	  beads	  were	  washed	  twice	  with	  high	  salt	  buffer	  and	  twice	  with	  PNK	  buffer.	  1/10	  of	  the	  last	  wash	  was	  set	  aside	  and	  eluted	  with	  20	  µl	  of	  SDS-­‐sample	  buffer	  and	  used	  for	  western	  blot	  together	  with	  the	  input	  to	  check	  protein	  expression	  and	  IP.	  The	  last	  wash	  was	  removed	  from	  the	  beads	  that	  were	  incubated	  with	  8	  µl	  PNK	  mix	  for	  5	  minutes	  at	  37	  °C	  and	  shaken	  at	  1100	  rpm.	  The	  PNK	  mix	  was	  removed	  and	  the	  samples	  were	  eluted	  in	  20	  µl	  of	  loading	  buffer	  at	  70	  °C	  for	  5	  minutes.	  The	  entire	  sample	  was	  load	  on	  a	  4-­‐12%	  pre-­‐cast	  gel	  (Novex)	  and	  run	  according	  to	  the	  producer.	  The	  gel	  was	  subsequently	  dried	  and	  exposed	  to	   a	   phosphoimager	   screen	   (Fuji	   BAS-­‐MP	   IP)	   for	   about	   2h.	   Signals	   were	  quantified	  using	  a	  Typhoon	  Trio	  (GE	  Healthcare).	  	  
6.2.10	  Mass	  spectrometry	  FLAG-­‐complexes	  were	  immunoprecipitated	  from	  lysates	  of	  Flp-­‐In	  T-­‐REx	  293	  cell	  lines,	   which	   were	   induced	   for	   3	   days	   with	   tetracycline,	   using	   M2	   anti-­‐FLAG	  magnetic	   beads	   (Sigma)	   at	   4	   °C	   over	   night	   in	   western	   blot	   lyses	   buffer	   and	  analysed	  with	  MALDI	  TOF/TOF	  Analyzer	  (AB	  SCIEX).	  
6.2.11	  EMSA	  assay	  	  The	   oligo	   used	   as	   probe	   was	   5ʹend	   labelled	   for	   1h	   at	   37	   °C	   according	   to	   the	  following	  reaction	  :	  20	  pmol	  oligo	  1	  µl	  PNk	  4	  µl	  PNK	  buffer	  	  1	  µl	  γ32P-­‐ATP	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35	  µl	  H20.	  	  The	  probe	  was	  then	  precipitated	  o/n	  with	  the	  addition	  of	  40	  µl	  of	  NaoAc	  pH	  5.5	  and	  1	  ml	  EtOH	  and	  diluted	  in	  H20.	  For	  the	  EMSA	  assay,	  the	  desired	  amount	  of	  protein	  and	  5nM	  of	  oligo	  probe	  were	  incubated	  with	  the	  reaction	  buffer	  and	  1mM	  DDT	  for	  20	  minutes	  at	  20	  °C.	  Native	  gel	  electrophoresis	  (4%	  acrylamide	  gel	  in	  0.5	  X	  TBE	  running	  buffer)	  was	  used	  to	  separate	  the	  free	  and	  bound	  probe.	  
6.2.12	  in	  vitro	  protein	  purification	  	  PABP	   RRM1-­‐4	  was	   already	   available	   in	   the	   lab	   as	   GST	   fusion	   tag	   in	   pGEX6p3	  vector	   (GE	  Healtcare),	  while	  S-­‐long	  was	  cloned	   in	  pETDuet-­‐1	  vector	   (Novagen)	  and	   fused	   to	   a	   N-­‐terminal	   FLAG	   tag	   and	   C-­‐terminal	   Strep	   tag.	   BL21	   star	   DE3	  
E.coli	   strain	  was	   used	   for	   the	   plasmid	   transformation.	  A	   single	   bacteria	   colony	  was	  pre-­‐inoculate	  at	  37	  °C	  o/n	  in	  10	  ml	  of	  LB	  medium	  containing	  Ampicillin.	  The	  pre	  culture	  was	   then	  added	   to	  500	  ml	  of	  autoinduction	  LBM5052	  medium	  and	  grown	   o/n	   at	   28	   °C.	   The	   following	   day	   the	   bacteria	   were	   harvested	   by	  centrifugation	  at	  4700	  rpm	  for	  15	  minutes,	  resuspended	  in	  NP	  lyses	  buffer	  and	  stored	  at	  -­‐20	  °C.	  Prior	  to	  purification	  the	  suspension	  was	  thawed	  and	  let	  rotate	  at	  4°C	   for	   2h.	   Afterwards,	   bacteria	   cells	   were	   lysed	   by	   sonication	   (4x	   1	   minute	  sonication	  at	  50%	  duty	  cycle	  and	  output	  set	  to	  5)	  using	  a	  Branson	  Sonifier	  250.	  The	  sample	  was	  centrifuged	  at	  20	  000	  rpm	  for	  30	  minutes	  to	  separate	  cell	  debris	  from	  crude	  extract.	  The	  crude	  extract	  was	  loaded	  on	  StrepTactin	  Superflow	  Plus	  Cartridge	   (QIAGEN)	   and	   purified	   with	   the	   Äkta	   FPCL	   (GE	   Healthcare).	   The	  column	  was	   washed	   with	   10	  ml	   of	   NP	   buffer	   and	   the	   protein	   eluted	   with	   NP	  supplemented	   with	   2.5	   mM	   desthiobiotin	   (Sigma-­‐Aldrich).	   The	   column	   was	  regenerated	  by	  washing	  with	  15	  ml	  of	  NP	  buffer	  supplemented	  with	  1	  mM	  HABA	  (2-­‐(4-­‐	   Hydroxyphenylazo)benzoic	   acid)	   and	   washed	   again	   with	   15	   ml	   of	   NP	  buffer.	   The	   purified	   protein	   concentration	   was	   measured	   with	   the	   NanoDrop	  (Thermo	  Fisher).	  	  
6.2.13	  Immunofluorescence	  	  Cells	  were	  transfected	  in	  6	  well	  plates	  as	  indicated	  in	  paragraph	  6.2.2,	  with	  the	  difference	  that	  only	  100	  ng	  of	  the	  Venus-­‐tagged	  protein	  were	  transfcted.	  The	  day	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after	   transfection,	   the	   cells	  were	   splitted	   1:2	   on	   cover	   slip	   in	   6well	   plate.	   The	  second	  day	  after	   transfection	   the	  medium	  was	   removed,	   the	  cells	  washed	  with	  PBS	   and	   fixed	   for	   15	  minutes	   in	   fresh	   prepared	   3%	  paraformaldehide.	   After	   3	  washes	  of	  10	  minutes	   in	  PBS,	   the	   cells	  were	   incubated	   for	  5	  minutes	  on	   ice	   in	  permeabilising	   solution	   and	   washed	   again.	   After	   the	   last	   wash	   DAPI	   1:10000	  diluted	  in	  PBS	  was	  added	  to	  the	  cells	  for	  10	  minutes	  at	  RT	  in	  the	  dark.	  The	  cells	  were	   washed	   again	   PBS	   and	   the	   cover	   slip	   were	   mounted	   on	   the	   microscope	  slide	  (Roth).	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7.	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Supplementary	   figure	   S1.	   C-­short	   does	   not	   bind	   the	   EJC.	   Western	   blot	   of	   samples	   derived	  from	  Flp-­‐In	  T-­‐REx	  293	  stable	  cell	  lines,	  analyzed	  as	  in	  figure	  11C.	  	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
	  
Supplementary	   figure	   S2.	   S-­long	   induced	  NMD.	   Northern	   blot	   analysis	   of	   RNA	   samples	   and	  western	  blot	  analysis	  of	  proteins	  derived	  from	  HeLa	  cells	  as	  described	  in	  Figure	  9B.	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Supplementary	  figure	  S3.	  S-­long	  mutants	  localization.	  GFP	  tagged	  proteins	  were	  transfected	  in	  Hek	  293	  cells.	  Dapi	   is	  used	   to	   stain	   the	  nucleus.	   .	   Images	  were	   taken	  using	  FV1000	  confocal	  microscope	  (Olympus).	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Supplementary	   figure	   S4.	   PLRG1	   and	   SNW1	   are	   UPF1-­independent.	   (A,	   B)	  Northern	   blot	  (upper	  panel)	  of	  RNA	  samples	  extracted	   from	  HeLa	  cells	   transfected	  with	   the	   indicated	  siRNAs	  and	  constructs.	  Co-­‐transfected	  β-­‐globin	  wt300+e3	  served	  as	  control	  mRNA	  and	  β-­‐globin	  4	  boxB	  as	  reporter	  mRNA	  (n=3).	  Western	  blot	  analysis	  (bottom	  panel)	  was	  performed	  as	  in	  Figure	  9B.	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